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1ABSTRACT
This Thesis presents chemical asymmetry and
reconstitution studies of mammalian nucleoside transporters.
Nucleosides cross the human erythrocyte membrane by a
facilitated-diffusion process which is selectively inhibited
by nanomolar concentrations of nitrobenzylthioinosine
(NBMPR). The chemical asymmetry of this transporter was
investigated by studying the effects of the slowly-permeating
organomercurial, p-chloromercuriphenyl sulphonate (PCMBS),
on uridine transport and high-affinity NBMPR binding in
inside-out and right-side-out membrane vesicles, unsealed
erythrocyte ghosts and intact cells. PCMBS was found to be
an effective inhibitor of the transporter (50% inhibition
at 30 uM), but only when the organomercurial had access to
the cytoplasmic membrane surface. Inhibition of NBMPR
binding to ghosts was reversed by incubation with
dithiothreitol, suggesting that PCMBS inhibits transporter
function by binding to membrane thiols. It was also
established that uridine and NBMPR were able to protect the
transporter against PCMBS inhibition.
The human erythrocyte nucleoside transporter has been
,r.
identified as a band 4.5 polypeptide (Mr 45,000-66,000) on
the' basis of reversible binding and photoaffinity labelling.
experiments with NBMPR. On the basis of reversible high-
affinity[ 3H] NBMPR binding activity, the transporter. has
been purified 13-fold by means of Triton X-100 extraction of
human erythrocyte -membranes and subsequent DEAE-cellulose
2ion-exchange chromatography (Jarvis and Young, 1981). The
partially-purified preparation consisted largely of band 4.5
polypeptides, a protein fraction also implicated in glucose
transport (see e. g. Wheeler and Hinkle, 1985). When this
preparation and the starting crude human erythrocyte
membrane extract were reconstituted into proteoliposomes,
they exhibited NBTGR-sensitive uridine transport. The
specific activity of uridine transport and NBMPR. binding
increased in parallel during the isolation of band 4.5
polypeptides. Transport of uridine by the reconstituted band
4.5 preparation was saturable (apparent Km and Vmax were
0.21 mM and 9 nmol/mg of protein/5 s (15°C), respectively)
and was'inhibited by dipyridamole, dilazep, adenosine, and
inosine. The reconstituted vesicles also exhibited
stereospecific glucose transport which was inhibited by
cytochalasin B, but unaffected by NBTGR. In contrast,
cytochalasin B was a poor inhibitor of NBTGR-sensitive
uridine transport. These experiments strongly implicate
band 4.5 polypeptides in both nucleoside and sugar
permeation.
The kinetic properties of the reconstituted 'human
erythrocyte nucleoside transporter were investigated in
detail under the conditions of zero-trans influx and efflux,
and equilibrium exchange influx.. The results demonstrated'
that a simple carrier model (Lieb, 1982) is sufficient to
describe the characteristics of uridine transport in' the
reconstituted vesicles. The. transport protein was
3reconstituted with high efficiency but with low transport
activity. The reconstituted transporter exhibited.6-7%
activity relative to intact erythrocytes when assayed under
zero-trans efflux and influx conditions, but 18% when
assayed under equilibrium exchange influx conditions. This
was because the mobilities for the-loaded and empty carriers
in the reconstituted system were both reduced compared with
intact cells, the mobility of the empty carrier being more
severely impaired. Decreased transporter activity was
probably related to modification of the transporter's lipid
environment. Preliminary reconstitution experiments with
liposomes of differing lipid composition supported this view
and it appeared that the nature of the polar phospholipid
headgroup played a key role in determining transporter
activity. The orientation of the transporter in the
reconstituted system was investigated using PCMBS which was
previously shown to inhibit the transporter by interacting
with sulphydryl group(s) on its the cytoplasmic domain.
The results suggest that the transporter was distributed in
an 40:60 outside:inside orientation in the reconstituted
proteoliposomes.
Recently, the pig erythrocyte nucleoside transporter
has been purified 65-fold by gradient-elution DEAE-cell.ulose
ion-exchange chromatography, again based on high-affinity
NBMPR binding activity (Kwong et al, 1986 1987). Sodium
dodecyl sulphate/polyacrylamide gel electrophoresis of the
purified material revealed the presence of only two
detectable protein bands, one which co-migrated with the
4radiolabelled NBMPR-binding protein (Mr 64,000) and a lower
molecular weight species with an Mr of 43,000. The latter
protein is considered to be a degradation product of the
band 3 anion-exchange transporter. When this preparation
and crude n-octylglucoside pig erythrocyte membrane extract
were reconstituted into proteoliposomes, both preparation
exhibited NBTGR-sensitive uridine transport. Again, NBMPR
binding and uridine transport activities co-purified. Unlike
the equivalent human erythrocyte preparation, the crude pig
membrane extract was incapable of stereospecific glucose
transport.
The methodology of reconstitution was extended to study
the kinetic properties of the lung nucleoside transporter.
Uridine transport into vesicles reconstituted with an n-
octylglucos-ide extract from guinea-pig lung plasma membranes
was inhibited by NBMPR, dilazep and dipyridamole. The
kinetic properties of uridine transport by the reconstituted
lung nucleoside transporter were also consistent with the
simple carrier model (Lieb, 1982) and compared favourably
with those of the reconstituted human erythrocyte nucleoside
transporter.
An Appendix presents a study of non-metabolised 3-0-
methyl-D-glucose (3-0MG) transport in erythrocytes from
three different fish species (Anguilla japonica, Monopterus
albus and Salmo gairdneri). Erythrocytes from the yellow
eel and rainbow trout (M. albus and S. gairdneri,
respectively) were found to. be totally deficient with
5respect to cytochalasin B-sensitive 3-0MG transport
activity. Catecholamines had no effect on sugar transport
in these cells. In contrast, erythrocytes from the white
eel (A. japonica) exhibited highly variable rates of
cytochalasin B-sensitive 3-0MG transport ranging from 0-19.5
mmol/1. cells per h (5 mM extracellular sugar, 20°C) in
different fish. Cytochalasin B-sensitive 3-0MG uptake in
this species was inhibited by phloretin and stimulated by
both adrenaline and noradrenaline.
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Nucleosides have diverse physiological and biochemical
functions (see Section 1.2). There is therefore
considerable interest in the mechanisms by which this class
of biomolecules are transported across biological membranes.
Kinetic studies using rapid sampling techniques, 'stopper'
solutions, and methods to avoid intracellular metabolism
have identified a non-concentrative, reversible facilitated
diffusion system common to a wide variety of cell types
(Cabantchik: and Ginsburg, 1977 Koren et al, 1978
Wohlhueter et al, 1979a Jarvis et al, 1982b Harley et al,
1982). However, at the beginning of the present project,
information regarding the molecular properties of the
membrane components responsible for nucleoside transport was
very limited. Several important advances had however been
made. Thus, NBMPR had been shown to interact specifically
with functional elements of the erythrocyte nucleoside
transporter and had subsequently been employed as a
photoaffinity probe for covalent radiolabelling of the
nucleoside transport protein (Young et al, 1983 1984 Wu
et al, 1983a). In addition, measurements of reversible
high-affinity NBMPR binding activity had been developed as a
specific quantitative assay for the NBMPR-sensitive
nucleoside transport protein (see e. g. Young and Jarvis,
1983). Using this ligand binding activity as an assay for
the nucleoside transporter, a 13-fold purification of the
carrier from human erythrocyte ghosts was achieved by means
2of Triton X-100 extraction and DEAF-cellulose ion-exchange
chromatography (Jarvis and Young, 1981). The partially-
purified preparation consisted largely of band 4.5
polypeptides (nomenclature of Steck (1974)), a fraction that
included proteins implicated in hexose transport (see e. g.
Wheeler and Hinkle, 1985).
A possible danger in the use of a ligand binding assay
to purify transport proteins is that only one component of
the transport complex might be isolated. The immediate aim
of the present study was therefore to incorporate purified
nucleoside transporter preparations into phospholipid
liposomes and to characterise in detail the kinetic
properties of the nucleoside transporter in the
reconstituted state. The experiments reported in this
Thesis established that purified band 4.5 polypeptides from
human erythrocytes exhibited NBTGR-sensitive uridine
transport when reconstituted into proteoliposomes. The
kinetics of transport were consistent with the simple
carrier model (Lieb, 1982). These reconstitution
experiments were extended to partially-purified band 4.5
proteins from pig erythrocytes, cells which are deficient in
glucose transport (Kowng et al, 1986 1987) and to
nucleoside transporter solubilised from guinea-pig lung
plasma membranes.
In erythrocytes, trypsin and PCMBS inhibit NBMPR-
binding activity, but this only occurs in broken membranes
and is not observed in intact cells (Jarvis and Young,
1982). This observation suggests that the trypsin and
3PCMBS-sensitive sites are located on the inner surface of
the cell membrane. The chemical asymmetry of the
erythrocyte nucleoside transporter was further investigated
in this Thesis by using inside-out and right-side-out
membrane vesicles. Additional experiments characterising
sugar transport in fish erythrocytes are presented in the
form of an Appendix.
The major section of the present Chapter is a brief
review of the literature on molecular and kinetic aspects of
nucleoside transport in mammalian cells. This is followed
by a description of the experimental strategy adopted in the
present investigation and its aims. Finally, the
organisation of the remainder of the Thesis is outlined.
1.2 PHYSIOLOGICAL AND PHARMACOLOGICAL IMPORTANCE OF
NUCLEOSIDES
Nucleosides have a multitude of biochemical and
physiological effects. For example, adenosine is believed
to participate in processes such as modulation of immune
responses, regulation of blood flow, platelet aggregation,
renal function,. neuromodulation in the central nervous
system, neurotransmission, muscle contraction, and numerous
other biological processes (Harmon et al 1978 Walker et al,
1979 Berne et al, 1983). Its unique mechanism of formation
has led to the suggestion that adenosine functions as a
novel form of cellular regulator for which the term
'retaliatory metabolite' has been proposed (Newby, 1984).
4Inosine has been postulated as an in vivo energy source for
adult pig erythrocytes, cells unable to metabolise glucose
(Young et al, 1985 1986 Zeidler et al, 1985). In
addition, nucleoside analogues are widely used as
therapeutic agents for neoplastic and viral diseases in man
and to a lesser extent as antiparasitic agents (Walker et
al, 1979 De Clercq, et a.1 1980 Gauri, 1981 Tattersall and
Fox, 19819 De Clercq, 1984). Of various nucleoside
analogues with clinical application as antineoplastic
agents, the best known is cytosine arabinoside (ara C) which
is an essential part of the current treatment of acute
myeloid leukaemia (Wiemik, 1980 Hess and Zirkle, 1980). As
well, 5-azacytidine has established clinical applications.
Several nucleoside derivatives, notably acyclovir, are
effective inhibitors of the proliferation of DNA viruses (De
Clerq et al, 1980 De Clercq, 1984). The nucleoside
analogue, 3'-azido-3'-thymidine (AZT), is currently
undergoing clinical trials to assess its efficacy against
the RNA virus responsible for acquired immunodeficiency
1
syndrome (AIDS). Nucleoside analogues may also have
application in the chemotherapy of parasitic infections (el
Kouni et al, 1983).
Each of these actions of nucleosides and nucleoside
analogues requires their transport into or out of cells.
Thus, the coronary vasodilator actions of dipyridamole,
dilazep, hexobendine and lidoflazine are mediated through
1. See Nature (1987), 325:564.
5their actions as adenosine transport inhibitors (Berne et
al, 1983), while NBMPR is an in vivo inhibitor of pig
erythrocyte energy metabolism (Young et al, 1986).
Similarly, the nucleoside transport capacity of target cells
and the 'transportability' of a nucleoside analogue, that is
its acceptability as a substrate for the nucleoside
transporter, are important determinants of cytotoxicity.
For example, measurements of NBMPR binding capacity are
likely to prove useful in assessing the therapeutic
potential of ara C in human acute leukaemias (Wiley et al,
1983, 1985).
1.3 TRANSPORT OF NUCLEOSIDES BY ANIMAL CELLS
This Section is not a comprehensive review of the large
literature on nucleoside uptake. Instead, I have attempted
to highlight and discuss observations relevant to the
general mechanism and kinetics of nucleoside transport in




Nucleoside transport in animal cells is mediated by a
rapid, reversible, non-concentrative 'facilitated-diffusion'
process. The specificity of this mechanism is sufficiently
broad that the physiological nucleosides (purine or
pyrimidine ribosides and deoxyribosides) and a wide variety
6of nucleoside analogues are accepted as substrates (Young,
1978 Paterson et al, 1981). For example, 2-
chloroadenosine, once thought to be a non-transported
inhibitor of nucleoside transport, has now been shown to be
a good substrate for the human erythrocyte nucleoside
transporter (Jarvis et al, 1985).
The best-studied nucleoside transport system is found
in human erythrocytes. Using both fresh and out-dated
blood, it has been shown that the kinetic properties of the
system are consistent with a simple carrier mechanism
(Cabantchik and Ginsburg, 1977 Plagemann and Wohlhueter,
1984bc Jarvis et al, 1983a). Table 1.1 summaries the
kinetic parameters for uridine transport in erythrocytes
from fresh and out-dated human blood. Interestingly, the
Vmax for zero-trans uridine influx is 4-fold higher in cells
from fresh blood than from out-dated blood although the Vmax
for uridine equilibrium exchange influx is similar in the
two .,cell types (Jarvis et al, 1983a). Molecular rate
constants, estimated using the procedures described by Lieb
(1982) (see also Stein, 1986) and interpreted in terms of a
two-complex formulation of the simple carrier model. (Fig.
1.1) are also shown in Table 1.1. The carrier is
symmetrical in erythrocytes from fresh blood, k1 being equal
to k2, but is asymmetrical in cells from out-dated blood,
k2 being approximately 4-fold larger than k1. This kinetic
difference between nucleoside transport in fresh and. out-
dated erythrocytes is attributed to differences in the
'mobility' (conformational change) of the unloaded carrier
Table 1.1 Uridine transport in erythrocytes from fresh and
n1i+r-a+Ar1 human hl and
Outdated bloodFresh bloodParameter
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0.099+0.0080.101+0.023Mean K
Table 1.1 cont'd.
(d) Bounds for the rate constants of the simple carrier (b,
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Uridine transport in erythrocytes from fresh and outdated
blood is compared at 22°C (Jarvis et al, 1983a) and is
interpreted in terms of the simple carrier model (see Fig.
1.1). Solution 1 is arbitrarily chosen to be the cytoplasm.
The unit mM in both Vmax and the resistance parameters is
shorthand for mmoles uridine per liter of isotonic cell
water. The value for n was obtained from the average number
of NBMPR high-affinity binding sites (11,000 sites per cell
(Cass et al, 1974)), assuming one site per nucleoside
carrier, and taking the average red cell volume to be 87 ur3
and the average water content to be 71.7% (v/v) (Lieb,
1982). The inequalities involving b1, b2, g1, g2, f1, f2,
k1 and k2 are calculated using the relationships given in
Table 4.5 of Stein (1986) (see also Fig. 1.1). This Table,
is adapted from Stein (1986). The terms R, nR and K are
defined in Chapter 4.









E represents the substrate-free form of the carrier, ES
represents the carrier-substrate complex. Rate constants as
indicated next to the appropriate reaction steps.
Subscripts represent carrier forms available at, or steps
originating in, sides 1 or-2 of the membrane, respectively.
7and is accentuated at low temperature (Plagemann and
Wohlhueter, 1984bc Jarvis and Martin, 1986).
Nucleoside transport in erythrocytes from other
mammalian species has also been extensively studied
particularly in pig, guinea-pig, rat and sheep (Young, 1978
Jarvis et al, 1980a Young et al, 1985,1986 Jarvis and
Martin, 1986 Jarvis and Young, 1986a). It has been shown
that the rates of nucleoside transport vary over two orders
of magnitude between species with rabbit human pig
mouse rat sheep (nucleoside permeable type) guinea-pig
dog= sheep (nucleoside impermeable type) (Duhm, 1974
Jarvis et al, 1982b Young and Jarvis, 1983). These
differences in transport capacity are largely attributable
to species differences in the cellular density of
nucleoside -transporters as determined by measurements of
NBMPR binding (Jarvis and Young, 1982 Young and Jarvis,
1983 see Section 1.3.2a).
1.3.1b Cultured mammalian cells
Transport of nucleosides in cultured cells, HeLa
Oells and Novikoff rat hepatoma cells, also conforms to the
simple carrier model (Wohlhueter et al, 1979a Wohlhueter
and Plagemann, 1982). Transport is symmetrical with respect
to direction. However, nucleoside transporters in
erythrocytes and cultured cells seem to differ significantly
in their translocation capacities (Young and Jarvis, 1983).
The 'mobilities' of substrate-loaded and empty carrier are,
8in contrast to erythrocytes, equal in cultured cells
(Wohlhueter et al, 1979a Wohlhueter and Plagemann, 1982).
Another difference in nucleoside transporter properties
between cultured cells and erythrocytes is that nucleoside
transporters from some cell types may, in addition, exhibit
a significant affinity for free nucleobases (Wohlhueter et




The best characterised and most useful ligand in the
study of the nucleoside transport complex is NBMPR. NBMPR
and certain related S6-derivatives of 6-thiopurine
nucleosides are very potent, reversible inhibitors of
nucleoside transport in a wide variety of cell types and
tissues (Paterson et al, 1981 Young and Jarvis, 1983). The
apparent Kd for NBMPR binding to the transporter is in the
range of 0.1-1 nM (Cass et al, 1974 Jarvis and Young, 1980
Dahlig-Harley et al, 1981 Jarvis et al, 1982a Plagemann
and Wohlhueter 1984a). A direct proportionality between
binding site occupancy by NBMPR and fractional inhibition of
uridine transport in human erythrocytes has been
demonstrated (Cass et al, 1974). Genetic transport-.
deficient variants of both sheep erythrocytes and S49 mouse
lymphoma cells do not possess high-affinity NBMPR binding
sites (Jarvis and Young, 1980 Cass et al,•1981). As well,
in erythrocytes from various species, the maximum cellular
9transport capacity (Vmax) for uridine was found to be
directly related to the number of membrane transporter
elements (NBMPR binding sites) present in each of the cell
types studied (Jarvis and Young, 1980, 1982 Jarvis et al,
1982b).
Kinetically, NBMPR is a simple competitive inhibitor
of zero-trans uridine influx and equilibrium exchange in
human, nucleoside-permeable sheep and guinea-pig
erythrocytes, but a non-competitive inhibitor of uridine
zero-trans efflux (Eilam and Cabantchik, 1977 Jarvis et
al,. 1982a 1983b). Conversely, transported nucleosides are
competitive inhibitors of high-affinity NBMPR binding
(Jarvis et al 1982a, b). These data are consistent with a
simple transporter model that in which NBMPR inhibits
nucleoside transport by binding selectively to the outward-
facing conformation of the substrate permeation site, this
binding being stabilized by the interaction of the
nitrobenzene ring with an adjacent hydrophobic domain on the
transporter (Jarvis and Young, 1982 Jarvis, et al, 1982a,
1983b see also Fig. 1.2). However, the possibility that
NBMPR binds to a separate allosteric inhibitor site cannot
be ruled out. Evidence that NBMPR binds to a separate
allosteric site comes from the finding that both nucleosides
and vasodilators such as dipyridamole and dilazep are able
to• modulate the rate of NBMPR dissociation from the
transporter (Koren et al, 1983 Hammond and Clanachan, 1985
Shi and Young, 1986a'). Also, a cloned line of cultured
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Novikoff rat hepatoma cells has been described which possess
high-affinity NBMPR binding sites but which exhibit pure
NBMPR-insensitive nucleoside transport (Gati et al, 1986).
Nevertheless, the answer to this controversial problem will
only be resolved by the isolation and complete molecular
characterisation of the transporter.
A new and important perspective on nucleoside transport
has been provided by the recent recognition of the existence
of NBMPR-insensitive nucleoside transport mechanisms in
several lines of neoplastic cells. Nucleoside transport in
some cells types (e. g. the Walker 250 rat carcinoma and the
Novikoff rat hepatoma cells) is purely insensitive to
nanomolar concentrations of NBMPR (Wohlhueter et al, 1978
Belt, 1983a b), while other cultured neoplastic cells such
as L12102. L5178Y and P388 murine leukaemia cells,
transformed hamster fibroblasts and Hela cells exhibit mixed
NBMPR-sensitive and NBMPR-insensitive transport (Dahlig-
Harley et al, 1981 Belt, 1983a,b Eilam and Cabantchik,
1977 Plagemann and Wohlhueter, 1985). These two
transporters are indistinguishable with respect to substrate
specificity, affinity for nucleosides and *'dipyridamole
(Belt, 1983a, b Plagemann and Wohlhueter, 1984a). The
molecular properties of this transport system remain to be
resolved.
1.3.2b Dipyridamole and Other Coronary Vasodilators
Dipyridamole and several other.coronary vasodilators
(dilazep, hexobendine and lidoflazine)are potent inhibitors
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of nucleoside transport in many cell types and tissues.
These compounds inhibit adenosine transport, thus
potentiating the actions of adenosine on coronary blood
flow.
The mechanism of dipyridamole inhibition of nucleoside
transport is still in dispute (Jarvis and Young, 1983). It
behaves as a competitive inhibitor of zero-trans uridine
influx and equilibrium exchange in guinea pig erythrocytes,
but as a non-competitive inhibitor of uridine zero-trans
efflux (apparent Ki value 0.6-1.0 nM Jarvis, 1986a). In
related experiments, [3H]dipyridamole was shown to bind to a
single class of high-affinity binding sites (apparent Kd
0.6-2 nM) on human erythrocyte membranes and guinea pig lung
plasma membranes with a maximum number of binding sites
similar to that obtained with [3H]NBMPR (Jarvis, 1986a Shi
and Young, 1986). Nucleosides are competitive inhibitors of
dipyridamole binding and dipyridamole also inhibits
[3 H]NBMPR binding in a competitive fashion (Hammond et al,
1981 Jarvis, 1986a). These results suggest that
dipyridamole inhibits NBMPR-sensitive nucleoside transport
in a similar manner to that of NBMPR and that both ligands
interact at common or overlapping sites-on the carrier.'
Nucleoside transporter heterogeneity is also. apparent
with respect to inhibition by dipyridamole. Nucleoside
transport in JPA4 cells, a mutagenized clone.derived --from
S49 murine T lymphoma cells (cells exhibiting pure NBMPR-
sensitive and dipyridamole-sensitive nucleoside transport),
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is partially insensitive to dipyridamole inhibition (Aronow
et al, 19851986). Rat tissues are resistant to
dipyridamole inhibition (see for example, Kolassa and
Pfleger, 1975 Shi et al, 1984 Wu and Young, 1984 Jarvis
and Young, 1986a) and are deficient with respect to high-
affinity dipyridamole binding sites (Shi and Young, 1986b).
Rat tissues are also less sensitive than other systems to
dilazep inhibition (Shi and Young, 1986a).
1.3.2c Other inhibitors
A number of other substances chemically unrelated to
nucleosides (e. g. PCMBS) have also been found to inhibit
the uptake of nucleosides by cultured animal cells and
erythrocytes (Belt and Noel, 1985 Jarvis et al, 1986). The
mechanism by- which PCMBS inhibits the human erythrocyte
nucleoside transporter was investigated in the present
.project and is the subject of Chapter 2 of this Thesis.
1.3.3 Sodium-Dependent. Nucleoside Transport
A Na -dependent, concentrative, NBMPR-insensitive
nucleoside transport system has been identified in brush
border vesicles from rat kidney (Le Hir and Dubach, 1984
1985) and in intestinal enterocytes from guinea pigs
(Schwenk et al, 1984). This system has high-affinity (Km
10 uM) for physiological nucleoside permeants (Le Hir and
Dubach, 1984). A joint presence of the Na -dependent,
concentrative (NBMPR-insensitive) and the 'NBMPR-sensitive,
apparently equilibrative nucleoside transport systems has
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been reported in cultured rat intestinal epithelial cells
(Jakobs and Paterson, 1986). The properties of the Nat-
dependent nucleoside transport system remain to be
investigated.
1.3.4 Regulation of Nucleoside Transport
Early studies demonstrating that nucleoside uptake by
cultured cells could be modified by a variety of factors
including hormones and cyclic nucleotides (see e. g.
Plagemann and Richey, 1974) can be attributed to effects on
intracellular nucleoside phosphorylation rather than
transport per se (Koren et al, 1978 Rozengurt et al, 1978
Wohlhueter et al. 1979b). Physiological regulation of
nucleoside transport activity does, however, occur during
reticulocyte. maturation (Tucker and Young, 1980 Jarvis and
Young, 1982). Maturation of sheep reticulocytes during in
vivo culture results in the parallel loss of transport
activity and NBMPR binding (Jarvis and Young, 1982). This
loss of transport activity and NBMPR binding during
reticulocyte maturation is restricted to certain species
(e. g. sheep but not pig or human) and may involve release
from the cell of transporter polypeptides in vesicular form
(Johnstone et al,1985).
1.3.5 Molecular Properties of the Nucleoside Transporter
The development of NBMPR and related compounds as
specific high-affinity probes of the nucleoside transporter
has allowed rapid recent progress in studies of the
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molecular properties of the carrier. The protein nature of
the transporter has been formally demonstrated by studies of
the effects of proteases and organomercurials on NBMPR
binding and nucleoside transport (Jarvis and Young, 1982).
A simple molecular model of the nucleoside transporter
consistent with the known properties of the carrier has been
proposed by Jarvis and Young (1982) and is summarised in
Fig. 1.2.
Detergent extraction of human erythrocyte.. membranes in
combination with DEAE-cellulose ion-exchange chromatography
results in a 13-fold enrichment of NBMPR binding activity
(Jarvis and Young, 1981). The partially-purified
preparation consists largely of band 4.5 polypeptides
(nomenclature of Steck (1974)), a fraction that includes
proteins implicated in hexose transport (see e. g. Wheeler
and Hinkle, 1985). Binding of [3H]NBMPR or [3H]N6-(p-
azidobenzyl) adenosine (ABA) to the transport protein is
reversible (Jarvis and Young, 1980 Young et al, 1983).
However, it can be covalently attached to its binding site
simply by exposure to UV light (Young et al, 1983).
Photoactivation of site-bound [3H]NBMPR or [3H]ABA of human
erythrocyte 'ghosts' in the presence of dithiothreitol as
free-radical scavenger results in selective incorporation. of
radioactivity into band 4.5 polypeptides (apparent Mr
45,000-:»,000) (Young et al, 1983 Wu et al, 1983).
Radiolabelling by [3H]NBMPR and [3H]ABA of band 4.5 protein
is abolished by. transported nucleosides, NBTGR and











When the transport site is in the outward-facing
conformation (A) (panel 1), it can bind nucleoside (2) and
then undergo a reorientation to the inward-facing form (3)
after which the nucleoside is released (4) (conformation B).
The conformational change can occur both in the presence and
absence of bound nucleoside. NBMPR occupies the transport












dipyridamole (Young et al, 1983; Wu et al, 1983).
Partially-purified band 4.5 polypeptides isolated from human
erythrocyte membranes were also found to be covalently
labelled by NBMPR (Wu et al, 1983b). In contrast, no
radiolabeling of protein occured in membranes from
nucleoside-impermeable sheep erythrocytes, cells which lack
functional nucleoside transporters (Wu et al, 1983a). These
experiments strongly implicate band 4.5 membrane proteins in
erythrocyte nucleoside permeation. NBMPR photoaffinity
labelling experiments have been extended to a variety of
tissues and other cell types. Exposure of membranes from
cultured mouse S49 lymphoma cells, rat and guinea pig liver
and lung and guinea pig cardiac muscle and brain to UV light
in the presence of [3H]NBMPR results in the covalent
radiolabelling of a membrane protein(s) which migrates on
SDS-polyacrylamide gels with an apparent Mr of 66,000-
45,000 (Almeida et al, 1984 Wu and Young, 1984 Shi et al,
1984 Kwan and Jarvis, 1984 Young, et al, 1984 Jarvis and
Ng, 1985). These results suggest that NBMPR-sensitive
nucleoside transport activity in different tissues and cells
is catalysed by proteins with similar molecular properties.
Radiation-inactivation analyses of reversible NBMPR-binding
activity estimate that the erythrocyte transporter has an in
situ molecular weight of 120,000, suggesting that the
carrier may exist in the membrane as a dimer (Jarvis et
al, 1980b 1986b).
To explore the transmembrane topology of the nucleoside
transporter, [3H]NBMPR covalently-labelled human
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erythrocytes and unsealed membrane 'ghosts' have been
subjected to controlled proteolysis (Janmohamed et al,
1985). Low concentrations of trypsin under iso-osmotic
saline conditions were found to have no effect on [3H]NBMPR-
photolabelled. band 4.5 in intact human erythrocytes
(Janmohamed et al, 1985). In contrast, two radioactive
fragments of apparent Mr 38,000 and 23,000 were produced
when unsealed erythrocyte membranes are treated with
trypsin, suggesting that the trypsin-sensitive regions of
the transporter are exposed on the inner surface of the
erythrocyte membrane (Janmohamed et al, 1985).
Endoglycosidase-F treatment of partially-purified human
erythrocyte band 4.5 polypeptides converts both the
[3H]NBMPR-labelled peak and the Coomassie blue staining
profile on SDS-gels from the broad band of Mr 55,000 to a
sharp Mr 46,000 band, providing evidence that the
nucleoside transporter of human erythrocytes is a
glycoprotein (Kwong et al, 1986).
1.4 COMPARISON OF MOLECULAR PROPERTIES OF ERYTHROCYTE
NUCLEOSIDE AND GLUCOSE TRANSPORT PROTEINS
Nucleoside and glucose are transported in erythrocytes
by separate carrier systems. Transport of D-glucose -is
stereospecific and inhibited by other monosaccharides such
as 2-deoxy-D-glucose and D-galactose and by inhibitors like
cytochalasin B and phloretin (see for example, Widdas,
1980). This system is not inhibited by nucleosides, NBMPR
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and dipyridamole, potent inhibitors of the nucleoside
transport system (Wheeler and Hinkle, 1985 Jarvis et al,
1986a). Conversely, transport of nucleosides is not
inhibited by monosaccharides, cytochalasin B and phloretin
(Jarvis and Young, 1983 Jarvis et al, 1986a). However,
the proteins responsible for these two transport activities
share a number of molecular similarities. The two
transporters are co-purified during detergent extraction and
subsequent ion-exchange chromatography (Jarvis and Young,
1981 Baldwin et al, 1982). Also, they have the same
electrophoretic mobility on SDS-polyacrylamide gels and are
both identified as band 4.5 polypeptides (Mr 45,000-66,000,
nomenclature of Steck (1974)) (Kwong, et al, 1986).
Partial-deglycosylation by endo-L-galactosidase reduced the
apparent Mr. (average) of the two proteins from 56,000 to
47,000 and 48,000, respectively, for the nucleoside and
glucose transporters. Complete deglycosylation by
endoglycosidase-F reduces the apparent Mr (average) to
44,000 and 45,000, respectively (Cairns, et al, 1984 Deziel
and Rothstein, 1984 Lienhard et al, 1984 Kwong et al,
1986). These results suggest that these two transporters
have similar protein and carbohydrate structures. The human
liver and erythrocyte glucose transporter has recently been
sequenced '(Mueckler et al, 1985). Elucidation of the
structure and protein sequence of nucleoside transporter
would provide invaluable information on the molecular
evolution of membrane transport systems.
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1.5 EXPERIMENTAL APPROACH AND AIMS
One way to study the asymmetric properties of integral
membrane proteins is to make use of membrane vesicles which
are either inside-out or right-side-out, thus providing
sidedness differences for both chemical and functional
studies. This approach is adopted in the present study
(experiments described in Chapter 2) to demonstrate the
asymmetric binding of PCMBS to the human erythrocyte
nucleoside transporter.
In protein purification experiments, it is possible to
use ligand-binding assays to monitor the degree of
purification achieved. As detailed in the previous section,
Jarvis and Young (1981) purified the human erythrocyte
nucleoside transporter by 13-fold on the basis of reversible
NBMPR-binding activity, the resulting DEAE-cellulose
fraction consisting largely of band 4.5 polypeptides.
Recently, the pig erythrocyte nucleoside transporter has
been purified 65-fold by gradient-elution DEAE-cellulose
ion-exchange chromatography, again based on high-affinity
NBMPR binding activity (Kwong et al, 1986 1987). This
purified preparation exhibits 1450 pmoles/mg of protein
high-affinity NBMPR binding activity and also consists of
band 4.5 polypeptides. However it is possible that only one
component of the nucleoside transport complex might have
been isolated under such conditions. Therefore,- a
functional assay of nucleoside transporter activity is also
required. It is.necessary to establish that transporter
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preparations are capable of permeant transport when
reconstituted into phospholipid vesicles.
The detailed aims of the reconstitution study presented
in this Thesis (Chapters 3-6) were:
1) to establish optimal conditions for the
reconstitution of nucleoside transport activity into
asolectin liposomes
2) to investigate the ability of the band 4.5
polypeptides isolated from both human and pig
erythrocytes to transport nucleosides
3) to study in detail the kinetic properties of the
reconstituted human erythrocyte nucleoside transporter
4) to investigate the orientation of the reconstituted
human erythrocyte nucleoside transporter
5) to provide some preliminary information on lipid
requirments for the nucleoside transport activity of
the reconstituted human erythrocyte nucleoside
transporter
6) to extend these reconstitution studies to
investigate the kinetic properties of the reconstituted
nucleoside transporter soLubilised from another
mammalian cell type. The guinea-pig lung was* chosen
for these experiments because of its high density -of
NBMPR binding sites.
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1.6 ORGANISATION OF THESIS
The remainder of my Thesis is divided into seven
Chapters. In Chapter 2, the chemical asymmetry of the human
erythrocyte nucleoside transporter was investigated by
studying the effects of PCMBS on uridine transport and
high-affinity NBMPR binding in inside-out and right-side-out
membrane vesicles, unsealed erythrocyte ghosts and intact
cells.
Chapter 3 describes optimal conditions for the
reconstitution of nucleoside transport activity into
asolectin liposomes using crude Triton X-100 extracts
derived from human erythrocyte membranes depleted of
extrinsic membrane proteins. These conditions were
subsequently applied to investigate the ability of isolated
human erythrocyte band 4.5 polypeptides to transport
nucleosides.
Chapter 4 presents a detailed kinetic analysis of the
reconstituted system under zero-trans influx, zero-trans
efflux and equilibrium exchange influx conditions. Kinetic
parameters obtained in these experiments were analysed by
the method of Lieb (1982). The orientation of the
reconstituted nucleoside transporter was investigated
using PCMBS which binds asymmetrically to the transporter.
This Chapter also describes the effects of lipid
composition on the uridine transport activity of the
reconstituted human erythrocyte nucleoside transporter.
In Chapter 5, the ability of the partially-purified pig
erythrocyte nucleoside transporter preparation to catalyse
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NBTGR-sensitive uridine transport when reconstituted into
proteoliposomes was investigated. The methodology of
reconstitution was extended to study the kinetic properties
of the lung nucleoside transporter in Chapter 6. Finally,
Chapter 7 presents a general discussion of the results
presented in the preceding Chapters. The Appendix details
experiments characterising sugar transport of fish
erythrocytes.
CHAPTER 2
EVIDENCE FOR THE ASYMMETRICAL BINDING OF P-




In 1982, Jarvis and Young established that p-chloro-
mercuriphenyl sulphonate (PCMBS) has no effect on uridine
transport or NBMPR binding in intact erythrocytes but inhi-
bits NBMPR binding to disrupted membrane preparations. Since
PCMBS permeats slowly across cell membranes at low
temperature, these results suggest that the erythrocyte
nucleoside transporter exhibits chemical asymmetry, with the
PCMBS-sensitive thiols located on the inner membrane sur-
face. It was not, however, established whether addition of
PCMBS to the internal membrane surface had the expected
inhibitory effect on nucleoside transport activity. The
experimental strategy used in the present series of ex-
periments was is to compare the effects of PCMBS on intact
cells, unsealed erythrocyte ghosts and sealed inside-out
membrane vesicles and sealed right-side-out membrane vesi-
cles, using both high-affinity NBMPR binding and uridine
transport as assays for nucleoside transporter function.
The results demonstrate that PCMBS is an effective inhibitor
of erythrocyte nucleoside transport and NBMPR binding, but
only when the'organomercurial has access to the cytoplasmic
membrane surface. It is also established that uridine and
NBMPR protect the transporter against PCMBS inhibition.
2.2 METHODS
2.2.1 Membrane Preparation
Blood was withdrawn from healthy human volunteers by
syringe into heparin. Erythrocytes were washed three times
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in 150 mM NaCl, 5 mM sodium phosphate (pH 8.0) by repeated
centrifugation and resuspension. The buffy coat was
discarded. To prepare erythrocyte ghosts, 2 ml of washed
packed cells were haemolysed in 40 ml ice-cold 5 mM sodium
phosphate (pH 8.0) (5P8). Ghosts were harvested by
centrifugation (30,000X for 10 min) and washed three times
in 5P8. The final haemoglobin-free membrane pellet was
resuspended in 2 ml of the same buffer.
2.2.2 Vesicle Preparation
2.2.2a Inside-out vesicles
Inside-out vesicles were prepared by the method of
Steck and Kant (1974) as modified by Macintyre and Gunn
(1981) and Macintyre (1982). Briefly, 2 ml of ghost
membranes (approximately 4 mg protein per ml) were diluted
to 70 ml with ice-cold vesiculation medium containing 0.5 mM
sodium phosphate and 0.5 mM EDTA (pH 8.4). This suspension
was placed in a prewarmed water bath and incubated at 35°C
for 15 min. Membranes were recovered by centrifugation
(30,000X for 20 min), resuspended in 2 ml ice-cold
vesiculation medium, and then passed five times through a
No. 27 gauge needle attached to a 5 ml syringe to complete
vesiculation. The homogenised vesicle suspension was
layered onto 3 ml of Dextran T-70 barrier solution (4.5%
(w/v) Dextran T-70 in 0.5 mM sodium phosphate, pH 8.0)..in a
5 ml Beckman SW 50L centrifuge tube and centrifuged at
30,000X for 1 h. Sealed-inside-out vesicles were recovered
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from the barrier interface and washed twice in ice-cold 5P8.
The final vesicle pellet was resuspended in the same
solution at a protein concentration of 2-4 mg per ml and
stored at 0-4°C before use.
2.2.2b Right-side-out vesicles
Right-side-out vesicles were also prepared according to
the procedure of Steck and Kant (1974) as modified by Cohen
and Solomon (1976). Ghost membranes (5 ml) prepared as
described above were diluted to 120 ml with 0.5 mM sodium
phosphate (pH 8.0), and left on ice for 30 min. At the end
of this time, 200 mM MgC12 was added to the suspension to
give a final MgC12 concentration of 0.1 mM. Membranes were
then pelleted by centrifugation (30,OOOXg., 1 h) and the
pellet kept at 4°C overnight. After overnight incubation,
the membrane pellet was resuspended into 2 ml of 0.1 mM
MgCl22 0.5 mM sodium phosphate (pH 8.0). The suspension was
then, homogenised by passing 5 times through a No. 27 gauge
needle, and afterwards, was diluted into 5 ml of the same
solution. This diluted suspension of vesicles was layered
onto 8.5 ml of Dextran T-70 barrier-solution (4.5% (w/v)
Dextran T-70, 0.1 mM MgC12, 0.5 mM sodium phosphate, pH 8.0)
in a 13.5 ml Beckman SW 40 centrifuge tube and centrifuged
at 30,000Xg.for 4 h. Sealed right-side-out vesicles were
recovered from the barrier interface, washed twice in 5P8,
and finally resuspended in the same buffer (2-4 me
nrnt-Pi n/m1)_
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2.2.3 Vesicle Sidedness Assays
Vesicle sidedness was established by determining the
accessibility of acetyicholinesterase (Achase), a marker for
the extracellular membrane surface, and glyceraldehyde-3-
phosphate dehydrogenase (G3PDH), a marker for the
intracellular membrane surface, as described by Steck and
Kant (1974). My inside-out vesicle preparations typically
contained 70-80% inside-out vesicles while the right-side-
out:vesicle preparations ranged from 90-100% pure.
2.2.3a Acet_ylcholinesterase accessibility assay
Membrane vesicles (approximately 50 ug protein/ml) were
incubated in 5P8(+ 0.1% (v/v) Triton X-100) for 10 min at
room temperature. An aliquot (200 ul) of membrane vesicle
suspension was then pipetted to the bottom of a 1 cm path
length semi-microcuvette, followed by 0.5 ml of sodium
phosphate (100 mM, pH 7.5) and then 50 ul of 5,5'-dithiobis-
2-nitrobenzoate (DTNB) (10 mM in 100 mM sodium phosphate, pH
7.0). Finally, 50 ul of acetylthiocholine iodide (12.5 mM
in water) was added, the cuvette contents mixed by
inversion and the cuvette placed in a recording
spectrophotometer. An increase in absorbance at 412 nm of
17.0 corresponds to 1 umol of product and the enzyme
activity in unsealed ghosts is approximately .2
umoles/min/mg of protein (Steck'and Kant, 1974).
Percentage inside-out vesicles=
[1-(Achase activity in 5P8/Achase activity in Triton X-100)]X100
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2.2.3b Glyceraldehyde 3-phosphate dehydrogenase accessibi-
lity assay
200 ul of vesicle suspension (50 ug protein/ml, +0.1%
(v/v) Triton X-100) was added to the bottom of a 1 ml semi-
microcuvette, followed by 0.62 ml sodium pyrophosphate (30
mM, pH 8.4), 30 ul of sodium arsenate (0.4 M), and 50 ul of
IB-NAD (20 mM). Finally, 100 ul of DL-glyceraldehyde-3-
phosphate (15 mM, pH 7.0) was added. The cuvette contents
were mixed by inversion and placed in -a recording
spectrophotometer. An increase in absorbance of 6.22 at 340
.nm corresponds to 1 umole of NADH generated. The enzyme
activity in unsealed ghosts at room temperature is
approximately 2.5 umol/min/mg of protein (Steck and Kant,
1974).
Percentage right-side-out vesicles=
[1-(G3PDH activity in 5P8/G3PDH activity in Triton X-100)]X100
2.2.4' NBMPR Binding Studies
2.2.4a Erythrocytes
High-affinity NBMPR binding to intact erythrocytes was
measured at a saturating concentration of[ 3H] NBMPR.
Briefly, 0.04 ml of [3H]NBMPR (50 nM,, +20 uM NBTGR as
competing nonradioactive ligand) was added to an equal.
volume of erythrocyte suspension (10% haematocrit) at room
temperature. Incubation (30 min) was terminated by
centrifugation at 15,000Xg,_ in an Eppendorf 3200
microcentrifuge (15 s). An aliquot of,the supernatant was
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retained for radioactivity determination and the cell pellet
was washed four times with 1 ml ice-cold isotonic medium.
Radioactivity present in cell pellets was extracted
with methanol (1 ml) and precipitated protein removed by
centrifugation (2 min, 15,000Xg). 0.9 ml of methanol
extract was added directly to scintillation fluid (7 ml).
Radioactivity was determined using a Beckman LS 7000 beta
counter with appropriate quench correction. High-affinity
(NBTGR-sensitive) NBMPR binding was calculated from the
difference in pellet radioactivity measured in the presence
and in the absence of NBTGR with appropriate allowance for
the difference in the concentration of unbound radioligand
in the two conditicns.
2.2.4b Ghosts and membrane vesicles
High-affinity NBMPR binding to erythrocyte ghosts and
membrane vesicles (both inside-out and right-side-out
vesicles) was determined by a high-speed centrifugation
procedure employing a Beckman Airfuge ultracentrifuge
(Jarvis et al, 1984). Portions of membrane or membrane
vesicles (0.6 ml, 0.2-0.4 mg protein per ml) were
equilibrated with a saturating concentration of[ 3H] NBMPR
(50 nM) at room temperature for 30 min in the absence and in
the presence of 20 uM NBTGR as competing nonradioactive
ligand. After incubation, duplicate 0.2 ml aliquots were
removed and centrifugated at 120,000XA for 10 min.
Supernatants were carefully removed by suction and retained
for radioactivity determination. The bottom half of each
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microcentrifuge tube was then placed in a scintillation
minivial, and the membrane pellet dissolved in 0.5 ml 5%
(w/v) Triton X-100. Radioactivity was determined by liquid
scintillation spectrometry with appropriate quench
correction.
2.2.5 PCMBS Studies
Intact erythrocytes (10% haematocrit), ghosts and
membrane vesicles (2 mg protein per ml) were treated with
PCMBS on ice to minimise diffusion of the organomercurial
through the lipid bilayer. After 30 min incubation, cells,
membranes and vesicles were pelleted by centrifugation and
resuspended in 20 vol. of the appropriate ice-cold medium
(either 150 mM NaCl, 5 mM sodium phosphate (pH 8.0) or 5P8).
Samples were recentrifuged and the washed pellets suspended
in ice-cold medium in preparation for NBMPR binding and
uridine transport assays.
2.2.6 Uridine Transport Measurements
Transport studies were performed at room temperature
(22°C) using [2- 14C] uridine as the radioactive permeant.
2.2.6a Erythrocytes
Initial rates of NBTGR-sensitive uridine uptake (0.2 mM
extracellular concentration, 6 s incubation) were measured
by an oil-stop procedure employing n-dibutylphthalate
(Jarvis et al, 1980a). Briefly, 0.2 ml cell suspension (20%
haematocrit) was mixed with an equal volume of[ 14C]uridine
and incubated for. 6 s. -A 0.2- ml- aliquot of incubation
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mixture was then added to 0.8 ml ice-cold stopping solution
(iso-osmotic NaCl medium containing 10 uM NBTGR) layered on
top of 0.5 ml ice-cold n-dibutylphthalate in an Eppendorf
microcentrifuge tube (volume 1.5 ml). The tube was
immediately centrifuged at 15,000Xg for 15 s using an
Eppendorf 3200 microcentrifuge. The upper layer of cell-
free aqueous medium and the majority of n-dibutylphthalate
was removed by suction, leaving the cell pellet at the
bottom of the tube. After carefully wiping the inside of
the centrifuge tube with dentist rolls, the cells were lysed
with 0.5 ml 0.5% (v/v) Triton X-100 in water and 0.5 ml 5 %
(w/v) trichloroacetic acid was added. The precipitate was
removed by centrifugation (30 s, 15,000Xg.) and 0.9 ml of the
supernatant transferred to 7 ml scintillation fluid.
Radioactivity was determined by liquid .,scintillation
spectrometry as described in. Section 2.2.4a. Blank values
were obtained using erythrocyte samples which had been mixed
with radioactive permeant at 0°C, and processed just after
mixing.
2.2.6b Vesicles
Nucleoside uptake by membrane vesicles was assayed by a
modified Millipore-filtration technique (Macintyre and Gunn,
1981). Briefly, uridine uptake was initiated by addition of
50 ul [14C]uridine (0.4 mM, 10 uCi/umol) in 5P8 to an equal
volume of membrane vesicle suspension (approximately 0.3 mg
of protein per ml). At the appropriate time thereafter,
uptake was terminated by the rapid addition of 2 ml ice-cold
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stopping solution (20 uM NBTGR in 5P8), followed by
immediate filtration under vacuum using Millipore HAWP 0.45
um filters which had been prewashed with 2 ml stopping
solution. Filters were rapidly washed four times with 2 ml
aliquots of ice-cold stopping solution and the resulting
washed filters transferred into 10 ml scintillation fluid
for radioactivity determination. Blank values were obtained
by processing samples in which ice-cold uridine solution was
mixed with ice-cold membrane vesicles pretreated with 20 uM
NBTGR and immediately diluted with stopping solution.
Vesicle uridine uptake was calculated after subtraction of
these blanks.
2.2.7 Protein Determination
Protein was assayed by the method of Lowry et al
(1951).
2.3 RESULTS
2.3.1 NBMPR Binding Studies
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2.3.1a PCMBS inhibition of[3H]NBMPR binding to intact human
erythrocytes, unsealed ghosts, inside-out- and
right-side-out membrane vesicles
In a previous study (Jarvis and Young, 1982), it was
noted that pretreatment of intact fetal sheep erythrocytes
with 1 mM PCMBS at 11C for periods of up to 40 min had no
significant effect on either high-affinity NBMPR binding
activity or NBTGR-sensitive uridine zero-trans influx. In
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contrast, NBMPR binding to unsealed membrane ghosts prepared
from these cells was inhibited 90% after 10 min exposure to
organomercurial. These experiments suggested that the
erythrocyte nucleoside transporter may exhibit chemical
asymmetry with respect to its distribution of PCMBS-
sensitive thiol groups. To investigate this possibility
further, I compared the effects of PCMBS (0.01-2 mM) on
high-affinity NBMPR binding to (a) intact human
erythrocytes, (b) unsealed human erythrocyte ghosts, (c)
sealed inside-out vesicles, (d) sealed right-side-out
vesicles (Fig. 2.1). As expected, these low concentrations
of PCMBS had little effect on NBMPR binding to intact cells
(5% inhibition at 0.2 mM PCMBS). Higher concentration of
PCMBS resulted in progressive inhibition of NBMPR binding
activity (50% inhibition at 1.5 mM PCMBS).. (Fig. 2.2).
Similarly, NBMPR binding to right-side-out vesicles was
relatively insensitive to PCMBS inhibition (30% at 0.2 mM
PCMBS). However, these results contrast markedly with those
obtained for ghosts and inside-out vesicles. NBMPR binding
to these preparations was approximately 50-fold more
sensitive- to organomercurial than intact cells, and right-
side-out vesicles, 50% inhibition occurring at 20-30 uM
PCMBS (30 min exposure at 10C). At 0-.2 mM PCMBS, NBMPR
binding to inside-out vesicles and ghosts was inhibited by.
85% and 90%, respectively.
Fig. 2.1 PCMBS inhibition of[ 3 H]NBMPR binding to intact human
erythrocytes, unsealed erythrocyte ghosts, inside-out
and right-side-out membrane vesicles
100
0.05 0.10 0.15 0.200
PCMBS(mM)
Samples were pretreated with varying concentrations of PCMBS at
1 C for 30 min, washed free of excess inhibitor and assayed for
high-affinity (NBTGR-sensitive) NBMPR binding activity using a
Beckman Airfuge as described in the text. The inside-out and
right-side-out vesicle preparations contained 71% and 95%
sealed inside-out and right-side-out vesicles, respectively.
Values are means of duplicate estimates and are expressed as
Percentages of control NBMPR binding activities measured in the
absence of organomercurial. Symbols:, intact cells: 0,





Fig. 2.2 Inhibition of [3H]NBMPR binding and [14C] uridine uptake
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Erythrocytes were pretreated with varying concentrations of PCMBS
at 1°C for 30 min, washed free of excess inhibitor and assayed
for high-affinity NBMPR binding activity and NBTGR-sensitive
zero-trans uridine uptake (0.2 mM extracellular concentration).
Values are means of duplicate estimates and are expressed as
Percentages of control activities measured in the absence of






2.3-lb Effect of uridine on PCMBS inhibition of[ 3H] NBMPR
binding to human erythrocyte ghosts
The results presented in Fig. 2.3 demonstrate that
uridine had the ability to protect ghosts against PCMBS
inhibition, the degree of protection achieved being
dependent upon the concentration of nucleoside present
during exposure of membranes to PCMBS. The concentration of
uridine required to give 50% protection was 0.3 mM. This
compares favourably with an estimates of 0.28 mM (5°C) for
the apparent Km of uridine equilibrium exchange in intact
human erythrocytes (Plagemann and Wohlhueter, 1984b).
Uridine concentrations above 1.5 mM gave complete protection
against PCMBS inhibition.
2.3.1c Effect of NBMPR pretreatment and dithiothreitol on
PCMBS inhibition of[ 3 H]NBMPR binding to human
erythrocyte ghosts
I also investigated the ability of NBMPR itself to
protect ghosts against PCMBS inhibition. NBMPR binding to
the transporter is reversible. However, at 1°C the rate of
dissociation of the transporter-inhibitor complex is very
slow. It was therefore possible to study the influence. of
site-bound NBMPR on PCMBS inhibition of transporter function
in the absence of unbound NBMPR. In the experiment shown in
Table 2.1, unsealed ghosts were preincubated at room
temperature in the presence and absence of sufficient
nonradioactive NBMPR (50.nM) to occupy all the available
Fig. 2.3 Effect of uridine on PCMBS inhibition of [3H]NBMPR




0 0.5 1.0 2.0 1.5 2.5
Uridine (mM)
Ghosts were preincubated with 0.1 mM PCMBS at 1°C for 30 min. in
the absence and in the presence of varying concentrations of.
uridine, washed free of excess inhibitor and nucleoside and
assayed for high-affinity NBMPR binding activity. Values. are
means of duplicate estimates and are expressed as percentages of





Table 2.1 PCMBS inhibition of[ H]NBMPR binding to human













Membranes were incubated in the presence and absence of 50 nM
nonradioactive NBMPR at room temperature for 30 min (A) and then
washed free of unbound ligand using ice-cold medium. The
membrane pellets were resuspended in ice-cold medium (+0.1 mM
PCMBS) and left on ice for a further 30 min (B). Excess
organomercurial was removed by washing and the membranes
incubated at room temperature for 30 min in the presence .and
absence of 10 mM,dithiothreitol (C). The membranes were washed
once more to remove dithiothreitol and dissociated NBMPR and then
assayed for high-affinity [3H]NBMPR binding activity as detailed
in METHODS.--, denotes incubations without additions. Values
are means of duplicate estimates.
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NBMPR binding sites. Membranes were then washed free of
unbound ligand prior to exposure to 0.1 mM PCMBS on ice for
30 min. As expected, PCMBS treatment of membranes in the
absence of unbound ligand resulted in substantial inhibition
of [3H]NBMPR binding activity. This inhibition was reversed
to 74 % of the control value by subsequent incubation of the
PCMBS-treated ghosts with dithiothreitol, confirming that
PCMBS was inhibiting transporter function by binding to
membrane thiols. The results presented in Table 2.1
further demonstrate that site-bound NBMPR protected the
transporter against PCMBS inhibition. This phenomenon was
studied further using [3H]NBMPR to accurately correlate the
degree of protection achieved with the fraction of high-
affinity NBMPR binding sites occupied by ligand during PCMBS
treatment. In the experiment shown in Fig. 2.4, membranes
were preincubated (30 min at room temperature) with graded
concentrations of [3H]NBMPR (1-50 nM) and then washed free
of unbound ligand prior to exposure to 0.1 mM PCMBS at 1°C
for 30 min. The amounts of[ 3H]NBMPR bound to the
transporter during PCMBS treatment ranged from 3-34 pmol/mg
protein, corresponding 9-100% of maxium binding activity.
After PCMBS treatment, membranes were washed free of
unreacted organomercurial and assayed for high-affinity
NBMPR binding capacity. This was achieved by incubating
membranes for a further 30 min-at room temperature in the
presence of excess (50 nM) [3H]NBMPR (see METHODS). The
incubation period was sufficient to allow reequilibration of
bound and free 3H-ligand, The results demonstrate a linear
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relationship between NBMPR-bound during PCMBS exposure and
NBMPR binding activity remaining after PCMBS treatment.
There was therefore a direct correlation between the degree
of protection achieved and the number of high-affinity sites
occupied by NBMPR. Thus, the fraction of sites capable of
binding NBMPR after PCMBS treatment was equal to the
fraction of sites occupied by NBMPR during exposure to
PCMBS. In other words, NBMPR and PCMBS binding to the
transporter were mutually exclusive.
2.3.2 Effects of PCMBS and NBTGR on Uridine Uptake by
Human Erythrocyte Membrane Vesicles
The NBMPR binding data presented in the preceding
section suggest that PCMBS inhibits the nucleoside
transporter by binding to transporter thiol groups exposed
to the cytoplasmic membrane surface. In agreement with this
conclusion, it was found that PCMBS was a relatively poor
inhibitor of NBTGR-sensitive uridine zero-trans uptake by
intact human erythrocytes, significant inhibition of
transport activity only occurring at PCMBS concentrations
in excess of 0.2 mM. Higher concentrations of
organomercurial resulted in parallel losses of uridine
transport and NBMPR binding activity (Fig. 2.2).
As a further test of nucleoside transporter asymmetry,
I investigated the ability of PCMBS to inhibit uridine
transport in membrane vesicles prepared from human
erythrocyte ghosts. The results presented in Fig. 2.5 and
Fig. 2.6 demonstrate that both inside-out vesicles and
Fig. 2.5 Effects of PCMBS and NBTGR on[ 14C]uridine uptake by
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C14C]Uridine uptake (0.2 mM) was measured at room temperature by.
the Millipore-filtration technique described in the text.
Values are means of duplicate estimates. Symbols:•, control





Fig. 2.6 Effects of PCMBS and NBTGR on [14C] uridine uptake by
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14C]Uridine uptake (0.2 mM) was measured at room temperature- by
the Millipore-filtration technique described in the text.
Values are means of duplicate estimates. Symbols:, control






right-side-out vesicles are capable of rapid uridine uptake
at room temperature. The half-time for nucleoside
equilibration was approximately 3 s for the two vesicle
preparations (0.2 mM uridine). At equilibrium, inside-out
vesicles contained 2.3 nmol uridine per mg protein compared
with 2.4 nmol/mg protein for the right-side-out vesicle
preparation. In both cases, uridine permeation was almost
completely abolished in the presence of 20 uM NBTGR, the
residual uptake in the presence of NBTGR giving only 15 %
and 9 % equilibration after 60 s for inside-out vesicles and
right-side-out vesicles, respectively. As far as I am
aware, this is the first demonstration of nucleoside
transport in erythrocyte membrane vesicles. NBTGR-sensitive
uridine uptake by inside-out vesicle was almost completely
inhibited by pretreatment of vesicles with 0.1 mM PCMBS
(Fig. 2.5). In contrast, this concentration of
organomercurial had no detectable effect on uridine uptake
by right-side-out vesicles (Fig. 2.6).
2.4 DISCUSSION
The results presented in this Chapter demonstrate that
PCMBS inhibits uridine transport and NBMPR binding by
interacting with nucleoside transporter thiol group(s)
exposed to the cytoplasmic membrane surface. Both uridine
and NBMPR had the ability to protect the transporter against
PCMBS inhibition of NBMPR binding activity. The simplest
interpretation of these results is that PCMBS, NBMPR and
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uridine bind to the same site on the nucleoside tranporter,
namely the nucleoside permeation site. This permeation site
may exist in two orientations, previous kinetic studies
indicating that NBMPR interacts preferentially with its
outward-facing conformation (Jarvis et al, 1982a Jarvis and
Young, 1982) (see also Chapter 1, Section 1.3.2a). In
contrast, the present experiments suggest that PCMBS binds
selectively to the inward-facing conformation of the site,
as judged by the finding that the organomercurial requires
access to the cytoplasmic membrane surface. It is therefore
envisaged that the inward-facing conformation of the
nucleoside permeation site possesses a thiol group reactive
to PCMBS. This thiol group is presumably not exposed when
the permeation site is in its outward facing conformation
(e.g. in the presence of NBMPR) or when the inward-facing
conformation-is occupied by substrate. Our results would,
of course, be consistent with more complex models of the
nucleoside transporter. One such model proposes the NBMPR
inhibits carrier function by binding to a separate
inhibitory allosteric site (Koren et al, 1983).
An important question is the extent to which the
erythrocyte nucleoside transporter can be regarded as a
model for nucleoside carriers in other, more complex cells.
Nucleoside transporters sensitive to inhibition by 6-
thiopurine ribonucleosides such,as NBMPR and NBTGR appear to
be widely distributed in mammalian cells (Plagemann and
Wohlhueter, 1980 Paterson et al, 1981; Young and Jarvis,
1983) and photoaffinity labelling experiments with [3H]NBMPR
37
have demonstrated that the nucleoside transporters from rat
and guinea pig lung and liver, guinea pig heart and brain
and cultured S49 mouse lymphoma cells have similar molecular
weights on sodium dodecyl sulphate polyacrylamide gels as
the erythrocyte system (Wu and Young, 1984; Shi et al, 1984;
Young et al, 1984; Kwan and Jarvis, 1984; Jarvis and Ng,
1985). However, some lines of cultured cells such as Walker
250 rat carcinoma and the Novikoff rat hepatoma have
nucleoside transporters insensitive to. nanomolar
concentrations of NBMPR (Wohlhueter et al, 1978; Slaughter
et al, 1981; Belt, 1983a; b). Other cultured neoplastic
cells such as L1210 murine leukemia cells exhibit mixed
NBMPR-sensitive and NBMPR-insensitive transport (Belt,
1983). The mechanism of this NBMPR-insensitivity remains to
be determined.
Interestingly, uridine zero-trans uptake by intact S49
cells resembles that in erythrocytes by being unaffected by
low concentrations of PCMBS, whereas the IC50 for PCMBS
inhibition of uridine zero-trans uptake by Walker 250 cells
is less than 25 uM (Belt, 1983a b Belt and Noel, 1985). A
similar difference in PCMBS reactivity has been reported for
the NBMPR-sensitive and NBMPR-insensitive nucleoside
transporters in L1210 cells and rat erythrocytes (Belt,
1983ab Jarvis and Young, 1986a). In contrast, the.
related organomercurials, p-hydroxymercuribenzoate and p-
hydroxymercuriphenyl sulphonate have been 'reported to
inhibit both cultured cell transport systems when used at
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37°C (Plagemann and Wohlhueter, 1984a). PCMBS may therefore
have use in functional and molecular comparisons of NBMPR-
sensitive and NBMPR-insensitive nucleoside transporters.
CHAPTER 3




Using high-affinity [3H]NBMPR binding activity as an
assay for nucleoside transport protein, a 13-fold
purification of the carrier from human erythrocyte ghosts
was achieved by means of Triton X-100 extraction and DEAE-
cellulose ion-exchange chromatography (Jarvis and Young,
1981). The partially-purified preparation consisted largely
of band 4.5 polypeptides (nomenclature of Steck (1974)), a
fraction that includes proteins implicated in hexose
transport (e.g. see Baldwin et al, 1982). Photolysis
6
experiments with N -(p-azidobenzyl)adenosine (ABA) and NBMPR
resulted in selective incorporation of radioactivity into
band 4.5 polypeptides. These protein purification and
photolysis experiments strongly implicate band 4.5 membrane
proteins (Mr 45,000-66,000) in nucleoside permeation in
erythrocytes.
However, it is possible that only one component of the
transport complex might be purified when using a ligand
binding assay in purification procedures. It is therefore
essential to incorporate partially-purified band 4.5
polypeptides into phospholipid liposomes and to measure
nucleoside transport activity directly.
The objective of the present series of experiments was
to establish optimal conditions, for the reconstitution of
nucleoside transport activity into asolectin liposbmes using
crude Triton X-100 extracts derived from human erythrocyte
membranes depleted of extrinsic membrane-proteins by the
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freeze-thaw sonication procedure of Kasahara and Hinkle
(1977), then, to investigate the ability of isolated band
4.5 polypeptides to transport nucleosides under identical
reconstitution conditions.
The results presented in this Chapter demonstrate that
crude Triton X-100 extracts of human erythrocyte membranes
and partially-purified band 4.5 proteins are capable of
catalysing NBTGR-sensitive uridine transport when
reconstituted into phospholipid vesicle::, suggesting that
uridine transport activity co-purified with NBNPR-binding
activity during preparation of the band 4.5 fraction from
the initial membrane extract.
3.2 METHODS
3.2.1 Membrane Preparation and Solubilisation
Erythrocyte ghosts, prepared from freshly collected,
I*ieparinised human blood, were depleted of extrinsic membrane
proteins by treatment with 0.1 mM EDTA (pH 11.2). One
volume of membrane suspension was homogenised with 7 volumes
of EDTA solution for 15 min on ice. The 'ghosts' were
pelleted by centrifugation (35,000 g for 25 min) and washed
twice with 7 volumes of 50 mM Tris-HC1. Protein-depleted
membranes were stored at -70°C.
The protein-depleted membranes (approximately 2 mg
protein/ml) were solubilised at 4°C by suspension in 1
(w/v) Triton X-100, 1 mM dithiothreitol in 50 mM Tris/HC1
(pH 8.2) with stirring for 60 min after which the
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preparation was centrifuged at 130,000 for 1 h with
retention of the supernatant. Inclusion of dithiothreitol
in this and all subsequent steps was to protect membrane
thiol groups essential for NBMPR binding and uridine
transport activity (see Chapter 2). The crude Triton
extract of erythrocyte membranes (the 130,000 a supernatant)
was treated overnight with SM-2 Bio-Beads (0.4 g of wet
beads/ml) to remove detergent or immediately applied to an
ion-exchange column to prepare band 4.5 proteins.
3.2.2 Preparation of Partially Purified Nucleoside
Transporter
To prepare partially-purified nucleoside transporter,
two volumes of Triton X-100 supernatant were applied to 1
volume of DEAE-cellulose ion-exchange column equilibrated
with detergent buffer (50 mM Tris-HC1, pH 8.2, 1% (w/v)
Triton X-100 and 1 mM dithiothreitol) at a flow rate of 1.5
column volume/h. After application of the sample, the
column was washed with 3 volumes of detergent buffer and 0.4
volume fractions were collected. Where appropriate, the
void volume fractions were pooled and treated with
methanol/water-washed SM-2 Bio-Beads to remove detergent
(Holloway, 1973). Samples were shaken with Bio-Beads (0.4
g of wet beads/ml) overnight at 4°C (Jarvis and Young, 1981)
and concentrated by placing the sample contained in a
dialysis bag into solid sucrose. Dissolved sucrose was
removed by dialysis against 10 mM Tris/HC1, 0.1 mm
dithiothreitol (pH 8.2 at 4°C).
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Both the crude and the partially-purified preparations
were stored at -70°C. SDS-polyacrylamide gel
electrophoresis (Wu et al, 1983a) confirmed that the
partially-purified preparation consisted largely( 95%) of
band 4.5 polypeptides (see also Chapter 4, Fig. 4.1). The
major protein in the crude Triton extract was band 3, with
smaller amounts of proteins of band 4.2, 4.5 and 7 present.
3.2.3 NBMPR Binding Assays
The high-affinity, NBTGR-sensitive NBMPR binding
activities of the two membrane extracts were measured at a
3
saturating concentration (50-nM) of[3 H]NBMPR by equilibrium
dialysis (Jarvis and Young, 1981). The samples with high
NBMPR binding activity (purified-band 4.5 proteins) were
diluted 5-fold with 10 mM Tris (pH 7.4 at 4°C) before
analysis.
3.2.4 Reconstitution of the Nucleoside Transporter
3.2.4a Preparation of washed asolectin
Crude asolectin was washed according to Kagawa and
Racker (1971). Briefly, 25 g of crude asolectin was mixed
with 250 ml acetone in a brown glass bottle with a magnetic
stirring bar. The contents of the bottle. were bubbled
vigorously with N for 15 min while stirring. The bottle
2
was then capped and stirring continued overnight. The
extracted lipid was collected by centrifugation and the
Pellet dissolved in 100 ml anhydrous diethyl ether. This
material was again centrifuged and the supernatant
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evaporated to dryness in a rotatory evaporator. The residue
was dissolved in 100 ml choloroform:methanol (4:1) to give a
concentration of 100-200 umoles phospholipid/ml. This final
washed asolectin preparation was centrifuged if necessary
and stored at -20°C under N2.
3.2.4b Preparation of liposomes
Acetone-washed asolectin (13-40 umol in
chloroform/methanol) was placed in a 13X100 mm pyrex tube
and dried under a stream of nitrogen. The dried asolectin
was re-dissolved in 0.5 ml diethyl ether and dried again
under N2 to remove traces of chloroform and methanol. After
all the organic solvents had been blown away, the pellet was
suspended in 0.5 ml 10 mM Tris-HC1 (pH 7.4 at 4°C). The
tube was covered by parafilm and sonicated to clarity (10
min at 20-300C) in a bath type sonicator containing 0.02 %
(w/v) Triton X-100 in distilled water (Kasahara and Hinkle
(1977)).
3.2.4c Reconstitution of the nucleoside transporter
Protein fractions were reconstituted into phospholipid
vesicles using the method described previously by Kasahara
and Hinkle (1977) for reconstitution of the human
erythrocyte glucose transporter. Crude Triton extract or
partially-purified band 4.5 protein (0.033-0.14 mg of
protein) was added to the sonicated vesicles (2.5-8 umol) in
a final volume of 0.4 ml. The phospholipid:protein ratio
(umol/mg) was kept in the range 50-80:1. The mixture was
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rapidly frozen in dry ice/ethanol, slowly thawed at room
temperature, and then sonicated briefly (5 s). These
preparations were then used for uridine uptake studies.
3.2.5 Transport Measurements in the Reconstituted
Proteoliposomes
1
Uptake of [14C] uridine by liposomes and reconstituted
vesicles was measured by a centrifugal gel filtration method
(Penefsky, 1977 Fry et al, 1978 Baldwin et al, 1981).
Briefly, columns of Sephadex G-50 (fine), which had been
pre-equilibrated with 20 uM NBTGR, 10 mM Tris/HC1, were
poured to the 1 ml mark in disposable -1 ml (tuberculin)
syringes. The columns were centrifuged at 200 g. for 2 min
in the swinging bucket rotor of a bench centrifuge shortly
before use. The prepared columns were kept on ice.
Uptake was measured at 15°C. All other procedures were
carried out at 4°C in a cold room. Typically, incubations
were initiated by adding 45 ul of reconstituted vesicles(+
20 uM NBTGR) to 45 ul of [14C] uridine (2 uCi/ml, final
concentration of 50 uM) in the same 10 mM Tris/HC1 buffer.
Uptake was terminated by the rapid addition of 20 ul of an
ice-cold stopping solution containing 20 uM NBTGR in Tris
buffer, and a 75 ul sample of the reaction mixture-was
1. The term 'uptake' refers to the appearance of nucleoside.
in the intravesicular space. 'Transport' refers to carrier-
mediated (NBTGR-sensitive) passage of permeant across the
vesicle membrane.
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immediately applied to a centrifuged column. After the
sample entered the gel, 20 ul of stopping solution was added
to the syringe column which was then recentrifuged as
described above, and the eluate was collected directly into
a scintillation minivial in the centrifuge bucket.
Radioactivity present in the eluate was measured by liquid
scintillation spectrometry with appropriate quench and
background correction. Blank values for uptake assays were
determined by centrifugal gel column processing of samples
taken immediately after mixing ice-cold NBTGR-treated
vesicles and ice-cold[ 14C]uridine. These blanks were
subtracted from measurements of uridine uptake by
reconstituted vesicles.
3.2.6 Protein Measurements
Protein was determined by the method of-Lowry et al
(1951) as modified by Peterson (1977).
3.2.7 Phospholipid Assay
3.2.7a Phosphate analysis
The phospholipid content of washed asolectin was
measured, by phosphate analysis. The washed asolectin was
diluted 10-fold with chloroform:methanol (4:1). 0.05-0.2 ml
diluted asolectin was then placed in the bottom of 18X150 mm
pyrex test tube and 0.2 ml of Mg(N03)2 (10% (w/v) in
ethanol) was added. Using a wire test tube holder-, the tube
was heated over a bunsen burner with rapid mixing to prevent
thumninp'_ Heating was continued until brown was no'
46
longer released and the sample was white.
The sample was cooled and 0.5 ml 1 N HCl was added.
The tube was covered with a glass marble and heated in a
boiling water bath for 20 min. The sample was cooled again
and 10 ml of color reagent (90 ml water/10 ml ammonium
molybdate solution (10% (w/v) in 10 ml H2SO4)/5 g
FeSO4.7H20) was added. For standards, 0.2-2 umoles
inorganic phosphate was added to 0.5 ml 1 N HCl followed by
10 ml of color reagent. The tubes were allowed to stand for
20 min at room temperature before reading the absorbance at
660 nm.
3.2.7b Diphenylhexatriene fluorescence enhancement method
Phosphate analysis was not sufficiently sensitive to
measure the low phospholipid content of the partially-
purified nucleoside transporter. Therefore, a convenient and
sensitive fluorescence assay for phospholipid using
diphenylhexatriene was empolyed (London and Feigenson,
1978). Diphenylhexatriene exhibits a low background
fluorescence in water and, because of its uncharged
character, is relatively unaffected by the presence of ions
and other-contaminating molecules in the sample.,
Fluorescence measurements were made using a Perkin-
Elmer MPF-3 spectr.of luorimeter. The' protocol was as
follows: 2 ul of 3 mM diphenylhexatriene in tetrahydrofuran.
was added to a solution of 3 ml of water and 1-50 ul of
sample. Tubes were incubated in the dark for-40-60 min at
40°C and then fluorescence was measured after exposing the
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sample to the excitation beam for 5 s. The excitation
wavelength was 365 nm and emission wavelength was 460 nm.
The excitation and emission slits were set at nominal
bandwidths of 5 and 10 nm respectively. Dimyristoyl
phosphatidylcholine was used as standard. Control
experiments established that this method gave essentially
identical asolectin phospholipid values to those obtained by
phosphate analysis.
3.3 RESULTS
3.3.1 Reconstitution Studies With Crude Membrane Extracts
3.3.1a Time course of uridine uptake
Triton X-100 extracts of protein-depleted erythrocyte
membranes, after removal of detergent with SM-2 Bio-Beads,
exhibited substantial NBMPR-binding activity (Jarvis and
Young, 1981). As shown in Fig. 3.1, this crude membrane
extract also catalyzed NBTGR-sensitive uridine transport
when reconstituted into liposomes. Two components of uptake
were apparent as follows: (a) an NBTGR-sensitive component
with a half-time for equilibration of approximately 30 s,
and (b) an NBTGR-insensitive component which was linear with
respect to time. The NBTGR-sensitive entry of uridine into
the vesicles evidently represents transporter-mediated
influx, while the insensitive component of uptake was
considered to be non-specific, probably due to simple
diffusion of the isotopic permeant across the lipid bilayer.
This conclusion was supported by the observation that the
Fig. 3.1 Time course of uridine uptake into vesicles
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Uridine uptake (50 uM) in the presence () and absence (s) of
20 uM NBTGR was measured at 15°C as described under 'METHODS'.
The reconstituted preparation contained 0.53 mg of protein. and
30 umol of phospholipid/ml. The inset shows the time course of
NBTGR-sensitive uridine transport( L is the difference between
uridine uptake in the presence and absence of NBTGR). Error







rate of NBTGR-insensitive uridine uptake by the
reconstituted vesicles was similar to that of liposomes
alone (Table 3.1). The concentration of uridine (50 uM) in
this and subsequent experiments was kept below the half
saturation concentration for uridine transport (as measured
in intact cells) so as to maximise the ratio of mediated-to-
nonspecific uridine uptake.
3.3.1b Effect of sonication time on the reconstitution of
uridine transport activity
The experiment in Fig. 3.2 demonstrates that sonication
was necessary for reconstitution of transport activity. The
sonication volume was 0.4 ml. Little NBTGR-sensitive
transport activity (assayed with 10 s flux intervals) was
apparent in the absence of sonication, and maximum activity
occurred after 5 s of sonication. Longer sonication times
were less effective and the reduction in transport activity
was related to sonication time. Increasing the sonication
volume from 0.4 to 2.4 ml decreased significantly the amount
of transport activity recovered after 5 s sonication,
presumbly, reflecting a decrease in efficiency of sonication
(data not shown). All reconstitution experiments were
therefore carried out with a brief sonication of 5 s in a
volume of 0.4 ml.
3.3.1c 'Effect of exogenous phospholipid concentration on
the reconstitution of uridine transport activity
The influence of lipid concentration on the
Table 3.1 Reconstitution of nucleoside transport activity with a
crude Triton extract of human erythrocyte membranes and









6.63+0.42 0.86+0.15 5.77+0.44Reconstituted vesicles
00.74+0.14 0.78+0.13Lipid only
0.59+0.36 3.66+0.964.25+0.89Protein only
Initial rates of uridine uptake by vesicles (from 50 uM[ 14C]uridine
during 10-s intervals at 15°C) were measured in the presence and
absence of 20 uM NBTGR as detailed under 'METHODS'. In the
preparation of 'reconstituted vesicles', membrane extract and band 4.5
polypeptides (see text) were reconstituted with added soybean
phospholipids. Each transport assay contained 11 ug of protein and
0.6 umol of lipid (membrane extract) or 3.6 ug of protein and 0.2 umol
of exogenous lipid (band 4.5 preparation). For the 'lipid only and
'protein only' controls, reconstitution was performed in the absence
of added protein and lipid, respectively. Values are means+ S.E. for
three independent experiments. L is the difference in uridine
uptake in the presence and absence of NBTGR. The endogenous lipid
content of one of the band 4.5 preparations was determined to be 17.5
umol/mg of protein.
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A mixture of crude Triton membrane extract and sonicated
soybean phospholipids (0.36 mg of protein and 17.3 umol- of
lipid/ml) was frozen, thawed, and sonicated for varying lengths
of time in a volume of 0.4 ml. Initial rates of uridine uptake
(10-s flux, 15°C) were measured in the presence( 0).- and
absence() of NBTGR as described in the text. Error bars






reconstitution of transporter activity is shown in Fig. 3.3.
At low lipid concentrations and a constant protein
concentration of 0.3 mg/ml, rates of uridine transport were
proportional to the exogenous lipid content of the system.
Maximum transport activity was achieved at a
phospholipid:protein ratio of 50:1 (umol/mg) and was not
influenced by further additions of lipid. As expected,
NBTGR-insensitive uridine uptake was proportional to lipid
concentration.
3.3.1d Relationship between protein concentration and
uridine transport in reconstituted vesicles
The relationship between protein concentration and
reconstituted transport activity is shown in Fig. 3.4. At
saturating concentrations of phospholipid (20 umol/ml),
NBTGR-sensitive transport activity was directly proportional
to the amount of protein present during reconstitution,
while NBTGR-insensitive uptake was independent of protein
concentration. These data suggest that either the
incorporation of protein into vesicles was complete or that
a constant fraction of added protein became associated with
the vesicles during the freeze-thaw-sonication step (see
also Chapter 4, Section 4.4). The results further suggest
that membrane protein- does not participate in NBTGR-
insensitive uridine uptake.
Fig. 3.3 Effect of exogenous phospholipid concentration on
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A crude Triton membrane extract at a protein concentration of
0.3 mg/ml was reconstituted with various concentrations of
sonicated soybean phospholipid liposomes (range 0-23 umol/ml).
Initial rates of uridine uptake by'vesicles were measured as.in
Table 1 in the presence (O) and absence(•) of 20 uM NBTGR.
The inset shows rates of NBTGR-sensitive uridine transport as a
function of phospholipid:protein ratio (umol/mg). Error bars







Fig. 3.4 Relationship between protein concentration and
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Reconstitution mixtures were prepared in which the content of
exogenous phospholipid was kept constant (20 umol/ml) and con-
centrations of protein (Triton membrane extract) were varied.in
the range 0-0.36 mg/ml. Initial rates of uridine uptake were
assayed as in Table 1 in the presence (0) and absence(O) of







3.3.le Control Experiments for Lipid and Protein
Requirements on Reconstitution of Nucleoside
Transport Activity with Crude Membrane Extract
As shown in Table 3.1, exogenous lipid was essential
for reconstitution of nucleoside transport activity. The
crude membrane extract alone had.no.uridine uptake activity,
and liposomes alone exhibited only a minimal uptake of
nucleoside which was not affected by NBTGR. Reconstitution
of membrane extract with lipid resulted in a 4-fold
stimulation of uridine uptake compared with liposomes alone,
and uptake was inhibited by NBTGR.
3.3.2 Reconstitution Studies with Partially-Purified Band
4.5 Protein
3.3.2a Time' course of uridine uptake
Band 4.5 polypeptides isolated from the crude Triton
extract were also found to be capable of NBTGR-sensitive
uridine transport when reconstituted into liposomes.
Results from a representative experiment are presented in
Fig. 3.5. NBTGR-sensitive uridine transport (50 uM, 15°C)
by vesicles reconstituted with the partially-purified
material was considerably more rapid than that of vesicles
reconstituted with unfractionated membrane extract. In the
former system, the half-time for equilibration of vesicles
with the [14C] uridine content of the incubation medium,. was
approximately 5 s (Fig. 3.5), whereas the equilibration
half-time of the reconstituted crude fraction was about 30 s
Fig. 3.5 Time course of uridine uptake into vesicles
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Band 4.5 polypeptides were prepared from human erythrocyte
membranes as described under 'METHODS' and reconstituted with
soybean phospholipids at a ratio of 57 umol of phospholipid/mg
of protein. Uridine uptake (50 uM) by the vesicles was also
assayed as described under 'METHODS', and was.. measured in
the presence (o) and absence(O) of 20 uM NBTGR. The
inset shows the time-course of transporter-mediated entry. of
uridine into vesicles, with ordinate values representing the
difference between vesicle content of uridine acquired in the









(Fig. 3.1). The NBTGR-insensitive uptake of uridine by this
preparation (Fig. 3.5) was similar to that of the
reconstituted crude Triton membrane extract (Fig. 3.1) and
lipid vesicles prepared without protein (Table 3.1), again
suggesting that NBTGR-insensitive uptake is due to diffusion
of uridine across the lipid bilayer.
3.3.2b Concentration dependence of uridine uptake
Fig. 3.6 shows the concentration dependence of the
rates of the inward transport of uridine by the
reconstituted 4.5 preparation. Rates of NBTGR-sensitive
uridine transport were saturable with an apparent Km value
of 0.21 mM, a value slightly higher than the published
estimates for uridine transport in intact human
erythrocytes (Young and Jarvis, 1983 Jarvis et al, 1983a
Wohlhueter and Plagemann, 1984b) (see also Chapter 4). The
estimated Vmax was 9 nmol/mg of protein in 5 s. In
contrast, rates of NBTGR-insensitive uridine uptake were
proportional to uridine concentration over the range 0.05-2
mM.
3.3.2c Competition and inhibitor studies
The data of Table 3.2 demonstrate that the NBTGR-
sensitive transport of uridine catalyzed by the band* 4.5
preparation was inhibited by uridine, inosine, and
adenosine. Adenosine was the most effective inhibitor of
the reconstituted transporter, giving 98% inhibition at 2
mM. This result correlates with the known relative
Fig. 3.6 Concentration dependence of uridine uptake of













Uridine uptake from graded concentrations of uridine during 5-s
intervals was measured in the presence (o) and absence(O) of
20 uM NBTGR.in vesicles prepared as described in text (0.087 mg
of protein and 4.6 umol of exogenous lipid/ml). An Eadie-
Hofstee plot of NBTGR-sensitive uridine transport (v/s vs v)
is shown in the inset. Linear regression analysis of the data
(inset) yielded these kinetic constants: Vmax=9 nmol/mg of
protein/5 s apparent Km=0.21 mM. Error bars.are S. E. of
triplicate estimates.
Uridineuptake(nmol/mgpr teinin5s)
Table 3.2 Effects of transported nucleosides and nucleoside transport
inhibitors on uridine transport into vesicles reconstituted
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Rates of NBIXGR-sensitive uridine transport (50 uM) by vesicles (10-s
flux) were determined as in Fig. 3.6. Inhibitors were preincubated
with vesicles for 15 min and at 15°C before addition of permeant.
Values are means of duplicate estimates.
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affinities of these nucleosides for the nucleoside
transporter in intact human erythrocytes(Young and Jarvis,
1983). Specific (NBTGR-sensitive) uridine transport in the
reconstituted vesicles was inhibited by NBMPR, dilazep,
and dipyridamole (Table 3.2), potent inhibitors of the
erythrocyte nucleoside transport system (Young and Jarvis,
1983). Transport was inhibited at concentrations comparable
to those effective in erythrocytes. In contrast, the
inhibitor of glucose transport, cytochalasin B (Wheeler and
Hinkle, 1985) reduced uridine uptake by only 10% when
present at a concentration of 50 uM, a concentration
approximately 300-fold greater than the apparent Ki value
for cytochalasin B inhibition of the glucose transporter
(Widdas, 1980).
Control Experiments for Lipid and Protein3.3.2d
Requirements on Reconstitution of Nucleoside
Transport Activity with Partially-Purified Band
4.5 Polypeptides
In contrast to the crude membrane extract, the
transport activity of the partially-purified band 4.5
preparation was only partially dependent on phospholipids
added during reconstitution (Table 3.1). This preparation
alone exhibited 63% of the NBTGR-sensitive uridine
transport activity of the complete system, unlike that of
the crude Triton membrane extract which depended completely
on added phospholipid. The phospholipid contents of the
crude Triton extract and the purified band 4.5 protein
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preparations were 1.46 and 17.5 umol/mg of protein,
respectively. It appears that the high phospholipid content
of the purified preparation permitted vesicle formation and
partial reconstitution of transport activity even in the
absence of added phospholipid. Indeed, it would be
expected from the lipid dependence for reconstitution of the
crude membrane extract (Fig. 3.3) that 50-60% of the
transport activity would be reconstituted at the
phospholipid-to-protein ratio (17.5 umol/mg of protein) seen
in the partially-purified band 4.5 preparation.
Furthermore, partially delipidated band 4.5 preparations
from pig erythroctye membaranes exhibited a 3.5-fold
stimulation of NBTGR-sensitive uridine transport in the
presence of exogenous phospholipid (see Chapter 5, Section
5.3.3). Partial reconstitution of transp'brt activity
(approximately 10%) without addition of exogenous lipid was
previously reported by Kasahara and Hinkle (1977) during
purification of the erythrocyte glucose transporter by
methods similar to those used here. The glucose transport
activity of the protein fraction was also attributed to the
high phospholipid content of the preparation and partial
reconstitution of the carrier with endogenous phospholipids.
3.3.3 Do. NBMPR Binding Activity and Uridine Transport
Activity Co-purify?
The nucleoside transport activity of representative
band 4.5 and crude membrane preparations were compared using
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5-s assays and a uridine concentration of 50 uM. Protein
fractions were reconstituted with soybean phospholipids at a
ratio of 50-60 umol of phospholipid/mg of protein to insure
maximal transport activity. In 3 separate experiments, mean
values (+S.E.) for'NBTGR-sensitive uridine transport were
1.91+0.19 nmol/mg of protein/5 s for band 4.5 and 0.16+0.01
nmol/mg of protein/5 s for the crude preparation, giving an
apparent purification of nucleoside transport activity of
11-fold. In one of these experiments, I compared the
uridine transport (50 uM) and NBMPR-binding ..activities of
the two preparations (Table 3.3). There was a 9.6-fold
purification of nucleoside transport activity and 6.7-fold
enrichment of ligand-binding activity (see also Jarvis and
Young, 1981), a ratio of 1.4. This discrepancy will be
discussed in Chapter 7.
3.3.4 Stereospecific Glucose Transport by Vesicles
Reconstituted with the Band 4.5 Preparation.
Band 4.5 polypeptides have been implicated in glucose
transport (Kasahara and Hinkle, 1977), and indeed, that
transporter is a major constitutent of the band 4.5
preparation. Therefore, it is predicted that the
reconstituted band 4.5 protein vesicles used here should
also exhibit stereospecific transport of D-glucose. The
stereospecific glucose flux obtained (Table 3.4) (5.47 nmol
of glucose taken up /mg of protein in 10 s at 15-O C from 200
uM D-glucose) is comparable to the flux (9.4 nmol/mg of
protein in 15 s at 21°C) reported previously by Kasahara and
Table 3.3 High-affinity NBMPR-binding and uridine transport
activities of partially-purified band 4.5
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Membranes were depleted of extrinsic proteins, solubilised with
1% (w/v) Triton X-100, and subjected to DEAE-cellulose ion-
exchange chromatography as previously described (Jarvis and
Young, 1981). Samples of void volume fractions from the
column (band,4.5 proteins) were treated with SM-2 Bio-Beads to
remove detergent and assayed for high-affinity NBMPR-binding
activity by equilibrium dialysis. Samples of the two
preparations were reconstituted into phospholipid. vesicles
under identical conditions at a lipid:protein ratio of 60:1
(umol/mg). NBTGR-sensitive uridine transport (50 uM) was.
measured as in Fig_3.6. Values (+S.E) are means of triplicate
estimates.
Table 3.4 Stereospecific glucose transport by vesicles
reconstituted with the band 4.5 preparation
Uptake
D-Glucose L-Glucose
nmol/mg protein in 10 s
0.62+0.166.09+0.26 5.47+0.30Control
0.62+0.090.35+0.06Cytochalasin B (5 uM)
0.84+0.09NBTGR (20 uM) 5.09+0.245.93+0.22
Rates of D- and L-glucose uptake by vesicles reconstituted with
the band 4.5 preparation were determined at 15°C in the
presence and absence of cytochalasin B and NBTGR the assay
measured vesicle uptake of isotope during 10-s intervals from
0.2 mM concentrations of the 14C-labelled glucose isomers. The
phosphplipid:protein ratio of the vesicles was 5.5:1 (3.7 ug of
protein and 0.2 umol of lipid/assay). Values are means (+S.E.)
of triplicate estimates. A represents the stereospecific influx
of glucose.
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Hinkle (1977) in band 4.5 reconstitution studies of the
glucose transporter. Stereospecific glucose transport by
the reconstituted vesicles was' completely blocked by
cytochalasin B (5 uM), but was not affected by 20 uM NBTGR,
a concentration 104- 105 times greater than its apparent Kd
value for binding to the nucleoside transporter.
3.4 DISCUSSION
Using the freeze-thaw-sonication procedure of Kasahara
and Hinkle (1977), I have established that crude Triton X-
100 extracts of human erythrocyte membranes are capable of
catalyzing NBTGR-sensitive uridine transport when
reconstituted into phospholipid vesicles. Optimal
reconstitution of transport activity from the crude Triton
extract occurred after a 5-s sonication interval at a
lipid:protein ratio of 50-80:1 (umol/mg). Under these
conditions, the partially-purified band 4.5 preparation
possessed uridine transport activity 10-fold greater/mg of
protein than that of the crude membrane extract. NBMPR-
binding activity copurified with the uridine transport
activity during preparation of the band 4.5 fraction from
the initial membrane extract.
NBTGR-sensitive uridine transport by the reconstituted
band 4.5 preparation was saturable with an apparent Km value'
for influx of 0.21 mM at 15°C. This estimate is slightly
higher than a value of 0.08 mM measured for uridine influx
into human erythrocytes at 15°C (Wohlhueter and Plagemann,
.1984b) (see also Chapter 4, Section 4.4). The,Vmax-obtained
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in the reconstitution experiment was 9 nmol/mg of protein
in 5 s. This corresponds to an estimated turnover number of
approximately 3.5 molecules of uridine transported/site/s,
calculated from the high-affinity NBMPR-binding activity of
the band 4.5 preparation (Table 3.3) (corrected for the 20%
loss of activity which ocurrs during freeze-thaw-sonication
reconstitution (see Chapter 4, Table 4.1)) and assuming that
each transporter binds one molecule of NBMPR. The
corresponding turnover number for the human erythrocyte
nucleoside transporter in intact cells is 68
molecules/site/s at 15°C (Wohlhueter and Plagemann, 1984b).
The estimated turnover number for the transporter in the
vesicle system is therefore approximately 5% of that in
intact cells. The decreased transport activity in vesicles
may reflect incomplete incorporation of, protein into
liposomes during reconstitution, or perhaps the changed
lipid environment of the transporter (see Chapter 4, Section
4.4). The present experiments also probably underestimate
the initial rate of transport into vesicles reconstituted
with the band 4.5 preparation (Fig. 3.6). The present
estimate of 5% compares favourably with studies. of the
reconstituted erythrocyte glucose carrier (Kasahara and
Hinkle, 1977 Wheeler and Hinkle, 1981) in which it has been
reported. that the activity of the reconstituted system -is
also 5% of that in intact cells, a difference' attributed.
to a reduced rate of carrier function in the reconstituted
state (Baldwin et al, 1981).
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In permeation studies with vesicles, it is important to
differentiate between transport and binding of permeant,
particularly since binding might also be blocked by
inhibitors of transport. The uridine uptake processes here
described evidently represent transport since uridine uptake
by the vesicles was time-dependent, and uptake rates
saturated as uridine concentrations were increased. In
addition, sonication was required for reconstitution (Fig.
3.2). Reconstitution of nucleoside transport activity from
crude membrane extracts also exhibited an absolute
requirement for added phospholipid. Finally, the numbers of
uridine molecules taken up in vesicles that incorporated
either the crude Triton extract or the band 4.5 preparation
greatly exceeded the numbers of available NBMPR-binding
sites in those preparations. This point is discussed further
in Chapter-4.
Finally, the present study showed that vesicles in
which the band 4.5 preparation was reconstituted were
capable of stereospecific glucose transport and that the
latter activity was abolished in the presence of 5 uM
cytochalasin B, but unaffected by 20 uM NBTGR. Conversely,
transport of uridine into vesicles was inhibited by only 10
in the presence of 50 uM cytochalasin B. These. data
support the view that nucleoside transport and glucose
transport are catalyzed by similar but distinct polypeptides
(Wu et al, 1983b Jarvis et al, 1986a). Unlike ..human
erythrocytes, pig erythrocytes lack a functional glucose
transporter (Kim and McManus, .1971a Widdas, 1980 Young et
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al, 1985, 1986). Dialyzed n-octylglucoside extracts of pig
erythrocyte membranes exhibit NBTGR-sensitive uridine
transport when reconstituted into phospholipid vesicles, but
are incapable of stereospecific glucose transport (see
Chapter 5).
CHAPTER 4




Chapter 3 describes experimental conditions which
permit reconstitution of the human erythrocyte nucleoside
transporter. Results obtained in that study demonstrate
that crude detergent extracts from human erythrocyte
membranes and purified band 4.5 polypeptides are capable of
1
carrier-mediated uridine transport when reconstituted into
phospholipid vesicles. The general properties of the
reconstituted system were shown to resemble those of the
nucleoside transporter in intact erythrocytes.. This Chapter
extends these observations by presenting an in depth kinetic
analysis of the reconstituted system under influx, efflux
and equilibrium exchange influx conditions (Section 4.3.2).
Kinetic parameters obtained in these experiments were
analysed by the method of Lieb (1982) and correlated with
data for high-affinity [3H]NBMPR binding to permit detailed
quantitative comparisons with nucleoside transport in
intact human erythrocytes. The ability of the reconstituted
nucleoside transporter to transport inosine and adenosine
was also studied. In a second series of experiments, PCMBS
was used to study the orientation of the reconstituted
nucleoside transporter. As detailed in Chapter 2, this
slowly permeating organomercurial binds asymmetrically to
the transporter, inactivating both uridine transport
activity and NBMPR binding by interacting with, sulphydryl
1 The terms 'transporter' and 'carrier' are used
interchangeably.
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group(s) exposed to the cytoplasmic membrane surface.
Finally, lipid requirements of the nucleoside transporter
were investigated using reconstituted vesicles with
differing phospholipid and cholesterol contents.
4.2 METHODS
4.2.1 Partial Purification of Nucleoside Transporter
Proteins Using n-Octylglucoside as Detergent
Protein-depleted human erythrocyte membranes were
prepared as described previously (Jarvis and Young, 1981
Chapter 3, Section 2.1). Membranes (2 mg/ml) were
solubilised at 4°C by suspension in 46 mM n-octylglucoside,
50 mM Tris/HC1, 2 mM dithiothreitol (pH 7.4 at 4°C) with
stirring for 30 min after which the preparation was
centrifuged at 130,000a for 1 h with retention of
supernatant (Jarvis and Young, 1981 Baldwin et al, 1982
Kwong et al, 1986). An aliquot of the supernatant (crude
membrane extract) was dialysed to remove detergent (see
below). To prepare band 4.5 proteins, the n-octylglucoside
supernatant was applied to a DEAE-cellulose ion-exchange
column equilibrated with 34 mM n-octylglucoside, 50 mM
Tris/HC1, 2 mM dithiothreitol (pH 7.4 at 4°C) (Baldwin et
al, 1982 Kwong et' al, 1986 see also Chapter 3, Section 2.1
for an equivalent procedure using Triton X-100 as
detergent). Protein-containing void volume fractions were
detected by their absorbance at 280 nm and were pooled. The
detergent was then removed by dialysis against four changes,
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each of 2 1 of 10 mM Tris/HC1, 0.2 mM dithiothreitol (pH 7.4
at 4°C) over a period of 48 h. Inclusion of dithiothreitol
in the dialysis buffer was to maintain the integrity of
protein thiols essential for uridine uptake and high-
affinity NBMPR-binding activities (Chapter 2). Partially-
purified preparations of nucleoside transporter were stored
at -70°C. As shown in Fig. 4.1, this material consisted
largely of band 4.5 polypeptides (nomenclature of
Steck(1974)). In the orientation experiments (Section
4.3.2), dithiothreitol was removed from the band 4.5
preparation prior to reconstitution by centrifugal gel
filtration (Penefsky, 1977 Fry et al, 1978). This was
necessary because dithiothreitol interferes with PCMBS
binding to the nucleoside transporter (Jarvis and Young,
1982 Tse et al, 1985a see also Chapter 2).
4.2.2 NBMPR Binding Measurements
Binding of [3H]NBMPR to partially-purified transporter
preparations was measured by centrifugal gel filtration
(Penefsky, 1977 Fry et al, 1978). Briefly, columns of
Sephadex G-50 (fine), which had been pre-equilibrated with
10 mM .Tris/HC1 (pH 7.4 at 4°C), were prepared in 1 ml
(tuberculin) syringes. The columns were centrifuged at
1000 for 2 min, in the swinging bucket rotor of a bench
centrifuge shortly before use. The prepared columns were
kept on ice. Typically, the partially-purified transporter
preparation was diluted 5 times with Tris/HC1 and incubated
for 30 min at room temperature with a saturating
Fig. 4.1 SDS-polyacrylamide gel electrophoresis of human erythrocyte










Partially-purified band 4.5 polypeptides were prepared using n-
octylglucoside as detergent as described in METHODS. Samples of the
starting erythrocyte 'ghost' (52 ug protein, A) and the purified extract
(14 ug of protein, B) were analysed on a 10% SDS-polyacrylamide slab
gel by the method of Thompson and Maddy (1982) using the Laemmli buffer
system (1970) and stained with Coomassie blue and scanned at .633 nm
using an LKB laser densitometer. C shows the background absorbance of





concentration (50 nM) of [3H]NBMPR in the absence and in the
presence of 10 uM NBTGR as competing ligand. The mixtures
were then cooled on ice to minimise subsequent dissociation
of bound ligand from the transporter. A 75 ul sample of the
reaction mixture was then applied to a centrifuged column.
After the sample had entered the Sephadex, the syringe
column was recentrifuged as described above and the eluate
collected directly into a scintillation minivial in the
centrifuge bucket. Radioactivity present in the eluate was
measured by liquid scintillation spectrometry with quench
correction. High-affinity NBMPR binding activity was
defined as the difference in binding activity measured in
the presence and in the absence of 10 uM NBTGR. Control
experiments established that NBMPR binding estimates
determined by centrifugal gel filtration were similar to
those obtained by the equilibrium dialysis method described
by Jarvis and Young (1981)(see also Chapter 3).
4.2.3 Reconstitution of the Nucleoside Transporter
Protein fractions were reconstituted into phospholipid
vesicles by freeze-thaw-sonication exactly as described
previously (Chapter 3, Section 2.4). Control experiments
established that there was 20% loss of high-affinity •NBMPR
binding activity during freeze-thaw-sonication(Table 4.1).
This loss was taken into account when calculating turnover
Table 4.1 Effect of freeze-thaw-sonication on high-affinity










Membranes were depleted of extrinsic proteins, solubilised
with 46 mM n-octylglucoside and subjected to DEAE-cellulose
ion-exchange chromatography as described in METHODS.
Samples of the n-octylglucoside 130,000xf, supernatant (crude
n-octylglucoside extract) and void volume fractions from the
column (partially-purified band 4.5 polypeptides) were
dialysed to remove detergent and assayed for high-affinity
NBMPR-binding activity. Samples of the two preparations
were mixed with phospholipid vesicles at a lipid:protein
ratio of 60:1 (umol/mg), frozen in dry ice/methanol, thawed
slowly at room temperature and then sonicated briefly for 5
s prior to assay of high-affinity NBMPR binding activity.
Values (S.E.) are means of 3 separate experiments. FTS,
freeeze-thaw-sonication.
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time values2 and turnover numbers for the reconstituted
system under various conditions (Tables 4.3 and 4.6).
4.2.4 Transport Assays
All transport measurements were made at 15°C.
4.2.4a Zero-trans influx
Time courses of radioactive nucleoside uptake (+20 uM
NBTGR) into reconstituted vesicles and liposomes were
measured by centrifugal gel filtration as described
previously (Chapter 3, Section 2.5). Uridine uptake from
graded concentrations of [14C] uridine (0.05-2 mM) during 5 s
intervals was also measured in the presence and in the
absence of 20 uM NBTGR as described above.
4.2.4b Zero-trans efflux
Reconstituted vesicles were pre-equilibrated with
varying concentrations of [14C] uridine (0.05-2 mM) (4
UCi/ml) for 2 h at room temperature. To initiate efflux, 20
ui of[ 14C]uridine 'loaded' vesicle suspension was mixed
with 4 'ml of prewarmed 10 mM Tris/HC1 (+20 uM NBTGR) at
15°C. The liposomes were thus diluted 200-fold, such that
the initial external uridine concentration was negligible.
2. Turnover time value (nR) represents the average time it
takes a single transport system to complete a single
transport cycle under the appropriate experimental
situation. nRoo measures the turnover time of empty carrier
and nRoo=nR12+nR21-nRee.
3• Turnover number refers to the number of substrate
molecules transported per site per s.
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Efflux (5 s) was terminated by adding 1 ml ice-cold stopping
solution (20 uM NBTGR in 10 mM Tris/HC1, pH 7.4 at 4°C) and
the proteoliposomes filtered immediately onto a 0.22 um
filter (Millipore type GSWP). The filter was then washed
twice with 5 ml ice-cold stopping solution (Wheeler and
Hinkle, 1981). Filters were presoaked and washed in
stopping solution prior to filtration. Radioactivity
retained on the filter was measured by liquid scintillation
spectrometry with appropriate quench correction.
4.2.4c Equilibrium exchange influx
Reconstituted vesicles were 'loaded' with non-
radioactive uridine (0.05-15 mM) by incubation with uridine-
containing Tris buffer for 2 h at 15°C by which time
equilibration between intravesicular and. extravesicular
uridine had occured (Chapter 3, Section 3.2a). To initiate
equilibrium exchange influx, 45 ul of 'loaded' reconstituted
vesicles were mixed with an equal volume of prewarmed 10 mM
Tris buffer containing the same concentration of radioactive
14[ CJuridine (2 uCi/ml). Uptake was terminated by rapid
addition of 20 ul ice-cold stopping solution containing 20
uM NBTGR in Tris buffer. A 75 ul.sample of the reaction
mixture was immediately applied to a centrifuged Sephadex 1
ml column and processed as described-above for zero-trans
influx..
4.2.5 Extraction of Human Erythrocyte Membrane Lipias
Human erythrocyte membrane lipids were extracted from
washed cells by the method described by-Rose and Oklander
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(1965).
4.2.6 SDS-Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis was carried out
in 1 mm thick slab gels by the method of Thompson and Maddy
(1982) using the Laemmli (1970) buffer system. The gels
were stained with Coomassie blue and scanned at 633 nm using
an LKB laser densitometer.
4.3 RESULTS
As detailed in Chapter 3, I have demonstrated that both
Triton X-100 solubilised extracts and partially purified
band 4.5 protein(s) isolated from human erythrocyte
membranes are capable of NBTGR-sensitive uridine transport
when reconstituted into liposomes. In the present series of
experiments, Triton X-100 was replaced by n-octylglucoside
(Baldwin et al, 1982) so as to facilitate removal of
detergent by dialysis and hence avoid the use of Bio-Beads.
Reconstitution Studies With n-Octylglucoside4.3.1
Solubilised Crude Membrane Extracts
Time courses of adenosine, uridine and inosine4.3.la
uptake into the reconstituted vesicles
In the reconstitution experiments reported in Chapter
3, I used uridine as the nucleoside permeant. Uridine was
chosen because its transport into mammalian cells has been
extensively studied (Cabantchik and Ginsburg, 1977 Jarvis
et al, 1983a; Plagemann and Wohlhueter, 1984bc). In the
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present series of experiments, I also assessed the ability
of adenosine and inosine to serve as permeants in the
reconstituted system..
Fig. 4.2 compares the time courses of uridine, inosine
and adenosine uptake( 20 uM NBTGR) into vesicles
reconstituted with n-octylglucoside solubilised crude
membrane extract. The NBTGR-sensitive components of
transport were 335, 300 236 pmol/mg protein in 10 s for
inosine, uridine and adenosine, respectively. However, it
is striking that the magnitude of the NBTGR-insensitive
component of uptake differs considerably for these three
nucleosides. Initial rates of NBTGR-insensitive nucleoside
uptake into the reconstituted vesicles were 160, 475 and
1925 pmol/mg protein per min for inosine, uridine and
adenosine, respectively. This is equivalent to 3.4, 10.1
and 41.1 pmol/umol phospholipid per min. Thus, the NBTGR-
insensitive component of nucleoside uptake is in the ratio
of 1:3:12 for inosine:uridine:adenosine. It is likely that
this uptake route represents simple diffusion across the
vesicle membrane (see also Chapter 3 and Section 4.4).
Further evidence to support this conclusion is presented in
Fig. 4.3 which shows time courses of uridine, inos.ine and
adenosine uptake measured in vesicles prepared in the
absence of protein. Consistent with the results obtained for.
the reconstituted vesicles, the estimated initial rates of
nucleoside permeation into protein-free liposomes were 3.7,
10.1 and 52.3 pmol/umol phospholipid per min for inosine,
uridine and adenosine, respectively, giving ratios of
Fig. 4.2 Time courses of inosine, uridine and adenosine
uptake into vesicles reconstituted with crude
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Inosine (Panel A), uridine (Panel B) and adenosine (Panel C)
uptake (50 uM) were measured at 15°C in the presence (opened
symbols) and in the absence (closed symbols) of 20 uM NBTGR
as described under 'METHODS'. Each assay contained 11 ug of















Inosine(), uridine ( ) and adenosine(O) uptake (50 uM)
were measured at 15°C by the centrifugal gel filtration
method described. in METHODS'. Liposomes were prepared in
the absence of protein by the standard reconstitution
procedure. Each assay contained 0.52 umol lipid. Values






1:2.7:14.0 with respect to inosine. As expected, exogenous
lipid and membrane extract were both essential for
reconstitution of NBTGR-sensitive inosine and adenosine
transport activity (Table 4.2).
4.3.1b Concentration dependence of zero-trans uridine influx
into reconstituted vesicles-
Fig. 4.4 shows representative concentration dependence
curves for zero-trans influx of uridine(± NBTGR) by
vesicles reconstituted with crude membrane extract. NBTGR-
sensitive zero-trans influx of uridine was saturable and
conformed to simple Michaelis-Menten kinetics. The data, as
analysed by an v/s vs v plot, showed an apparent Km of 0.21
mM and Vmax of 1.08 nmol/mg protein in 10 s. This
preparation exhibited high-affinity NBMPR binding activity
of 80 pmol/mg of protein. Mean apparent Km and Vmax values
from 3 separate experiments are 0.175+0.035 mM and 1.13+0.05
nmol/mg protein in 10 s, respectively.
4.3.2 Transport Studies In Vesicles Reconstituted With
Partially-Purified Band 4.5 Polypeptides
Using n-octylglucoside partially-purified band 4.5
polypeptides, I performed a detailed analysis of the kinetic
parameters of nucleoside transport in the reconstituted
system under conditions of net uptake, net efflux and
equilibrium exchange influx.
Table 4.2 Reconstitution of nucleoside transport activity
















Initial rates of uridine uptake by vesicles (from 50 uM
14[ C]uridine during 10-s intervals at 15°C) were measured in
the presence and in the absence of 20 uM NBTGR as detailed.
under 'METHODS'. In the preparation of 'reconstituted
vesicles', membrane extract was reconstituted' with added
soybean phospholipids. Each transport assay contained .11 ug
of protein and 0.52 umol of lipid. For the 'lipid only' and
'protein only' controls, reconstitution was performed in the
absence of added protein and lipid, respectively. -Values
are means of duplicate estimates. is the difference in
uridine uptake in the presence and in the absence of NBTGR.
Fig. 4.4. Concentration dependence of zero-trans uridine












Apparent initial rates (10 s-assay) of zero-trans influx of
Uridine (0.05-2 mM) by the reconsituted vesicles were
measured in the presence and in the absence of 20 uM NBTGR
as described in 'METHODS'. Apparent Km and Vmax values
were 0.21 mM and 1.08 nmol/mg of protein in 10 s,
respectively, as determined by linear regression analysis of
the v/s vs v plot shown in the inset. This preparation of
crude membrane extract exhibited- a high-affinity NBMPR












As predicted from experiments described in Chapter 3,
n-octylglucoside purified band 4.5 protein(s) were capable
of rapid uridine transport when reconstituted into
proteoliposomes (Fig.4.5). Influx was measured both in the
absence and in the presence of 20 uM NBTGR. The carrier-
mediated, NBTGR-sensitive component of uptake exhibited a
half-time for equilibration of approximately 10 s whereas
the NBTGR-insensitive component of uptake was linear with
respect to incubation time. Fig. 4.6 shows representative
concentration dependence curves for zero-trans influx of
uridine(+ NBTGR) by the reconstituted band 4.5 preparation.
NBTGR-sensitive zero-trans influx of uridine was saturable
and conformed to simple Michaelis-Menten kinetics with an
apparent Km of 0.26 mM and an estimated Vmax of 7.6 nmol/mg
protein (5 s flux). The high-affinity NBMPR binding
activity of the band 4.5 preparation used in this experiment
was 532 pmol/mg protein. These values compare favourably
with estimates of 0.21 mM and 9 nmol/mg protein (5 s flux),
respectively, for the apparent Km and Vmax of zero-trans
influx of uridine by Triton X-100 partially-purified band
4.5 polypeptides (high-affinity NBMPR binding- activity of
632 pmol/mg protein) (Chapter 3, Section 3.2b). Mean
apparent Km and Vmax values from 3 separate n-octylglucoside
experiments are presented in Table 4.3.
4.3.2b Zero-trans efflux
For efflux experiments, reconstituted vesicles were
Fig. 4.5 Time course of zero-trans uridine uptake into
vesicles reconstituted with n-octylglucoside-
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Band 4.5 polypeptides were prepared as described in METHODS
and reconstituted with soybean phospholipids at a ratio of
60 umol of phospholipid/mg protein. Uridine uptake (50 uM)
by the vesicles was measured in the presence( 0) and in the
absence of 20 uM NBTGR(O). Each assay contained 2.4 ug of
protein and 0.15 umol of exogenous lipid. The inset, shows
the time course of transporter-mediated entry of uridine
into vesicles, with ordinate values representing the
difference between vesicle content of uridine acquired in
the presence and in the absence of NBTGR. Values are





Fig. 4.6 Concentration dependence of zero-trans uridine
influx into vesicles reconstituted with













Apparent initial rates of zero-trans influx of uridine
(0.05-2 mM) by reconstituted vesicles were measured in the
presence( O) and in the absence of 20 uM NBTGR(O) as
described in text. The inset shows an Eadie-Hofstee' plot of
NBTGR-sensitive uridine transport (v/s vs v). Apparent Km
and Vmax values, as estimated from the plot by linear
regression analysis, were 0.26 mM and 7.6 nmol/mg of protein
in 5 s, respectively. Error bars are S.E. of triplicate
estimates.
Uridineuptakea e(nmol/mgprotein5s)
Table 4.3 Kinetic parameters for uridine equilibrium exchange influx,
zero-trans influx and zero-trans efflux in vesicles




in 5 s)(mM)in5 s)Condition
0.25+0.04 35+78.6+1.4Zero-trans influx 21
65+330.18+0.07Zero-trans efflux 12 9.7+1.1
2.84+0.37 34+5Equilibrium exchange influx 97+18
Simple carrier resistance parameters
ReconstitutedFreshReconstituted
vesicleserythrocytesvesicles




















Bounds for the rate constants of the simple carrier
Fresh erythrocytes Reconstituted vesicles
68kl92s-1 4.52 kl 5.03s-1
4.00 k2 4.39 s-168 k292s-1
261 s-1 45.5 s-1b1, b2, g1, g2
6
1.4x10 M-1 s-1f1 3.7x104 M-s-1
6 4
1.4x106 M-1 s-l 3.3x104 M-1s-l
Experimental details are described under 'METHODS' and in other
sections of the text. The data presented include results from
experiments illustrated in Figs 4.6, 4.8 and 4.10. Values are
mean+S.E. (3 observations). Solution 1 has been arbitrarily chosen to
be the intravesicular solution. Resistance and affinity parameters
and bounds for the rate constants of the simple carrier were
calculated according to the method of Lieb (1982) (see also Chapter 1
Fig. 1.1).
@1. The experimental values for fresh erythrocytes at 15°C were
taken directly from Plagemann and Wohlhueter (1984b). Solution 1
is arbitrarily chosen to be the cytoplasm. The value for n was
obtained from the average cellular density of NBMPR.,high-affinity
binding sites (11,000 sites per cell) (Jarvis et al, 1982a),
assuming one binding site per nucleoside carrier. The average
erythrocyte volume was taken as 87 fl. (Whittam, 1964) and the
average water content as 71.7% (v/v) (Savitz et al, 1964).
@2. The high-affinity NBMPR binding capacity of the reconstituted.
band 4.5 preparation (530 pmol NBMPR bound/mg protein) used in
this series of experiments was determined as described in
METHODS. There is a 20% loss of high-affinity NBMPR binding
activity during reconstitution (see Table 4.1). This loss was
taken into account when estimating of the density of high-






preloaded with varying concentrations of radioactive
[ 14C]uridine (0.05-2 mM) for 2 h at 15°C. However,
extravesicular uridine could not simply be removed by
washing. Therefore, efflux was initiated by dilution of
preloaded vesicle suspensions by 200-fold such that
extravesicular uridine concentrations were negligible
(Wheeler and Hinkle, 1981).
Efflux was measured in the presence and in-the absence
of 20 uM NBTGR. As predicted, NBTGR inhibited uridine
efflux from preloaded vesicles. Fig. 4.7 shows the time
course of NBTGR-sensitive uridine efflux from the
reconstituted vesicles preloaded with 50 uM radioactive
14[ C]uridine. Efflux was rapid with an initial efflux rate
corresponding to 2.0 nmol/mg protein in 5 s, a value which
is similar to the initial influx rate of 1.7 nmol/mg protein
in 5 s shown in Fig. 4.5 for the same preparation of band
4.5 polypeptides (532 pmol NBMPR bound/mg protein).
Fig. 4.8 shows the concentration dependence of NBTGR-
sensitive uridine efflux from reconstituted vesicles
preloaded with varying concentrations of radioactive
14[ C]uridine (range 0.05-2 mM). Uridine efflux was
saturable with estimated apparent Km and Vmax values of
0.17 mM and 8.3 nmol/mg protein (5 s flux), respectively.
Mean data for 3 such experiments are given in Table 4.3.
The values are similar to those for zero-trans influx into
the reconstituted vesicles (see also Table 4.3).
Fig. 4.7 Time course of NBTGR-sensitive uridine efflux from
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Reconstituted vesicles were pre-equilibrated with 50 uM
radioactive[ 14C] uridine (4 uCi/ml) for 2 h. Efflux was
initiated by mixing 20 ul of[ 14 C]uridine loaded vesicles
with 4 ml of 10 mM Tris/HC1. NBTGR-sensitive uridine efflux
was determined as the difference in efflux measured in the
presence and in the absence of 20 uM NBTGR. Values are






Fig. 4.8 Concentration dependence of zero-trans uridine
efflux from vesicles reconstituted with











Reconstituted vesicles were preloaded with varying
concentrations of radioactive [14C]uridine (0.05-2 mM) (4
uCi/ml)for 2 h. NBTGR-sensitive uridine efflux rates (5 s)
were determined as described in the text. Each assay
contained 1.2 ug. of protein and 0.07 umol of exogenous
lipid. The inset shows the v/s vs v plot of the data.
Linear least square analysis of the data yielded.an apparent
Km of 0.17 mM and a Vmax of 8.3 nmol/mg of protein in 5 s.





4.3.2c Equilibrium exchange influx
In equilibrium exchange experiments, substrate
concentrations are identical on both sides of the membrane.
Reconstituted vesicles were therefore pre-equilibrated with
varying concentrations of non-radioactive uridine.
Equilibrium exchange influx was initiated by adding
14
[ C]uridine, at the same concentration, to the preloaded
vesicles. Representative time courses for equilibrium
exchange influx of uridine (50 uM) measured in the presence
and in the absence of 20 uM NBTGR are shown in Fig. 4.9.
Two components of uptake are apparent. NBTGR-sensitive
uptake of[ 14C]uridine rapidly equilibrated, with a half
time for equilibration of approximately 10 s. In contrast,
NBTGR-insensitive uptake of tracer was linear with time. By
analogy with zero-trans experiments, NBTGR-sensitive
'14
[ ,]uridine uptake was considered to represent
transporter-mediated equilibrium exchange influx while the
NBTGR-insensitive component of uptake was attributed to non-
spe-cific diffusion of radioactive permeant across the lipid
bilayer. This conclusion is supported by the observation
that NBTGR-sensitive equilibrium exchange influx of uridine
was saturable and conformed to simple Michaelis-Menten
kinetics (Fig. 4.10). Estimated apparent Km and Vmax values
from this experiment were 3.1 mM and 94 nmol/mg protein in 5
s, respectively, as'determined from the inset v/s vs _v plot
shown in Fig. 4.10. In contrast, the NBTGR-insensitive
component of uridine equilibrium exchange exhibited a*linear
concentration dependence. Mean results for 3 separate
Fig. 4.9 Time course of uridine equilibrium exchange influx
into vesicles reconstituted with partially-












Reconstituted vesicles were pre-equilibrated with non-
radioactive uridine (50 uM) by incubation with uridine-
containing Tris buffer for 2 h. To initiate equilibrium
exchange influx, equal volumes of 'loaded' reconstituted
vesicles and 10 mM Tris buffer containing the same
concentration of radioactive [14C]uridine (2 uCi/ml) were
mixed. Equilirium. exchange influx was measured in the
presence( 0) and in the absence of 20 uM NBTGR(O). The.
inset shows the time course of NBTGR-sensitive- uridine
transport into vesicles. Values are meanS.E. of triplicate
estimates.
Urldineequlllbriumexchangelnflux(nmpl/ gprotein)
Fig. 4.10 Concentration dependence of uridine equilibrium
exchange influx by vesicles reconstituted with
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Reconstituted vesicles were pre-equilibrated with varying
concentrations (0.05-15 mM) of non-radioactive uridine as
described in METHODS. Apparent initial rates (5 s-assay) of
uridine- equilibrium exchange influx were measured in the
presence( O) and in the absence of 20 uM NBTGR(O). The
inset shows an v/s vs v plot of initial rates of NBTGR-
sensitive uridine equilibrium exchange influx. Estimated
apparent Km and Vmax values were 3.1 mM and 94 nnnol/ mg of












experiments are again presented in Table 4.3. The mean Vmax
of equilibrium exchange influx was 12-fold greater than the
Vmax observed for either zero-trans influx or efflux
measured at the same temperature and with the same band 4.5
preparation. The increase in Vmax was paralleled by a
corresponding increase in apparent Km. Thus, there was no
significant difference in the Vmax/Km ratio for transport
under zero-trans and equilibrium exchange influx conditions.
A full analysis of these kinetic data is presented in next
section.
4.3.2d Characterisation of the reconstituted nucleoside
transporter in terms of the simple carrier model
Kinetic parameters for zero-trans influx, zero-trans
efflux and equilibrium exchange influx of ..uridine are
zt zt zt zt
summarised in Table 4.3. Since V12=V21 and K12=K21, the
transporter exhibited directional symmetry in the
reconstituted state.
Trans-acceleration of uridine influx was observed in
ee
the reconstituted system, V being approximately 10-fold
zt zt
greater than V12 and V21 (Table 4.3). Therefore, a simple
pore model (Lieb, 1982, Stein, 1986) cannot be applied to
the reconstituted nucleoside transport system, a finding
consistent with previous kinetic studies of nucleoside
transport in intact erythrocyte- (Cabantchik and Ginsburg,
1977 Jarvis et al, 1983a). For a carrier-mediated system
to be compatible with the simple carrier model, Vmax/Km
ratios for all experimentally determined flux measurements
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must be equal (Lieb, 1982 Stein, 1986). As shown in Table
4.3, the Vmax/Km ratios for uridine influx, efflux and
equilibrium exchange influx in reconstituted proteoliposomes
were, within experimental error, equal. Using the Vmax
4
values, simple carrier resistance parameters were
calculated for the reconstituted system (Table 4.3).
Consistent with kinetic symmetry, R12= R21. The analysis
also clearly demonstrates that the loaded carrier moves at a
5
much faster rate than the empty carrier, the mobilities of
the loaded and empty carriers differing by 21-fold
(Roo/Ree=21).
Turnover time values (nR), n being derived from
assays of high-affinity NBMPR binding activity (Lieb, 1982;
Stein, 1986), were also calculated for the reconstituted
system. The estimated nR21, nR12, nRee and, nRoo values are
17.0, 15.0, 5.7 and 17.5 fold greater, respectively, than
the corresponding values in fresh erythrocytes,
demonstrating that there is a preferential impairment of the
mobility of the empty vs loaded carrier in the reconstituted
state.
4. Simple carrier resistance parameters were calculated
from the reciprocals of the Vmax values for zero-trans
influx, zero-trans efflux and equilibrium exchange and Roo=
R12+R21-Ree.
5. Carrier 'mobility' implies macromolecular movement, e. g.
a conformational shift, and does not denote actual
translocation of the carrier.
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In intact erythrocytes, apparent Km values are 0.08 mM
for both zero-trans influx and efflux and 0.56 mM for
equilibrium exchange influx at 15°C (Plagemann and
Wohlhueter, 1984b). Corresponding values for zero-trans
influx, efflux and equilibrium exchange influx in the
reconstituted system were numerically higher (0.25, 0.18 and
2.84 mM, respectively). From these apparent Km values, it
was possible to calculate the simple carrier affinity
constant (K), which is proportional to the dissociation
constant between substrate and empty carrier (Table 4.3).
The three independent estimates of K value were similar and
not significantly different from each other as determined by
Student's t-test. The mean K value was 120+28 uM measured
at 15°C and compares with 48 uM for intact cells (Plagemann
and Wohlhueter, 1984b).
Bounds for the rate constants of the simple carrier
were also calculated according to Lieb (1982) for the
reconstituted system (Table 4.3) (Chapter 1, Fig.1.1; Lieb,
1982). Again, kinetic symmetry is apparent with k1 = k2,
while g1 and g2 are at least 10 fold greater than k1 and k2.
In other words, the interconversion rate of loaded carriers
is at least a order of magnitude greater than that for
unloaded carriers.
4.3.3 Orientation Studies
The finding that PCMBS binds to the. erythrocyte
nucleoside transporter asymmetrically (Chapter 2) suggested
that it could be used as a probe to determine the
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orientation of the reconstituted system. For these
experiments, PCMBS (0.1 mM) was incubated with reconstituted
vesicles, prepared from dithiothreitol-free crude membrane
extract and partially-purified band 4.5 polypeptides, for
30 min. Incubation was at 0°C so as to minimise diffusion
of the organomercurial though the lipid bilayer. Excess
PCMBS was removed by centrifugal gel filtration as described
in METHODS (Section 4.2.2). PCMBS-treated and control
vesicles processed in an identical manner in the absence of
inhibitor were then subjected to uridine uptake and high-
affinity NBMPR binding measurements. The results summarised
in Table 4.4 demonstrate that PCMBS treatment of the two
reconstituted preparations resulted in a 40% decrease in
NBTGR-sensitive uridine transport activity with a parallel
loss of high-affinity NBMPR-binding activity. This
inhibition' was reversed by subsequent incubation of PCMBS-
treated vesicles with 2 mM dithiothreitol, confirming the
previous observation (Chapter 2) that PCMBS inhibits
transporter function by binding to membrane thiol(s). In
contrast, the presence of PCMBS during and subsequent to
freeze-thaw-sonication caused total inhibition of both
activities. As also shown in Table 4.4, PCMBS treatment
prior to reconstitution totally inactivated the crude
membrane extract, but only caused 70-75% inhibition. of
transporter activity in the partially-purified band 4.5
prepartaion. This protection presumbly reflects partial
transporter reconstitution even in the absence of exogenous
lipid (see Chapter 3, Section'3.4).
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4.3.4 Lipid Modification Experiments
The Asolectin soybean phospholipid used in the present
series of reconstitution experiments consisted mainly of
phosphatidylcholine (PC) and phosphatidylethanolamine (PE)
with some minor lipids (Miller and Racker, 1976). As
detailed in Chapter 3 and also in the DISCUSSION to the
present Chapter, the transport activity of the nucleoside
transporter is diminished upon reconstitution. The
Possibility that the change of lipid environment might
contribute towards this decrease was investigated.
My initial reconstitution experiments presented in
Chapter 3 showed that the transport activity of purified
band 4.5 polypeptides was only partially dependent upon
exogenous phospholipids while the crude extract depended
completely on added lipids for activity (Chapter 3, Section
3.1e, 3.2d see also Section 4.3.1 of the present Chapter).
Therefore, proteoliposomes reconstituted with crude membrane
extract were employed to investigate the effect of lipid
modification on transport activity. Asolectin vesicles were
employed'as control.
Initial rates of NBTGR-sensitive uridine zero-trans
uptake (10 s flux) measured using vesicles with differing
lipid compositions are summarised in Table 4.5. It was
demonstrated that vesicles reconstituted with pure PE•failed
to transport uridine while pure PC vesicles only substained
transport activity at one third of the control rate. PC and
PE mixed vesicles (PC:PE=55:44(mol%)) in the same molar
Table 4.5 Effects of phospholipids, cholesterol and extracted human
erythrocyte lipids on the activity of the reconstituted
human erythrocyte nucleoside transporter.
Uridine transpor7
pmol/mg protein




100+8PC+PE (55:45 mol%) 306+23
Human erythrocyte lipids 125+2384+4
Asolectin+ 20 mol% PS 26+12 8+4
+ 20 mol% Cholesterol 289+16 94+6
263+18+ 20 mol% Sphingomyelin 85+6
Liposomes were prepared from extracted human erythrocyte lipids, pure
PC, pure PE, or a mixture of PC and PE, asolectin or asolectin in
combination with 20 mol% PS, cholesterol or sphingomyelin. Crude n-
octylglucoside solubilised human erythrocyte membrane extract was
mixed with the liposomes and reconstituted by freeze-thaw-sonication
as described in METHODS. Each assay contained 15.3 ug protein and 0.9
umol phospholipid. Rates of NBTGR-sensitive uridine transport (50 uM,
10 s flux at 15°C) were determined as detailed in the text.
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ratio as asolectin (Miller and Racker, 1976) gave the
control uptake rate. Addition of phosphatidylserine (PS) at
20 mol% to asolectin vesicles resulted in an 90% loss of
activity, whereas sphingomyelin-containing vesicles only
exhibited a slight decrease in transport activity (15%
inhibition). In contrast, inclusion of 20 mol% cholesterol
in asolectin vesicles did not affect transport activity.
Replacement of asolectin by extracted human erythrocyte
lipids resulted in a modest 25% stimulation of transport
activity. Control experiments established that the
different phospholipid vesicles had similar uridine trapping
spaces as estimated after 24 h incubation at room
temperature with 50 uM[ 14C] uridine (1.7 ul-2.2 ul/umol
phospholipid). Decreased transport activity, therefore, was
not related to a failure in vesicle formation.
As best transport activity was.observed in PC and PE
mixed vesicles, a titration curve with these two
phospholipids is shown in Fig. 4.11. Consistent with the
results presented in Table 4.5, the initial rate of NBTGR-
sensitive uridine transport in pure PC vesicles was 98
pmol/mg protein in 10 s. Introducing PE to the
reconstituted vesicles resulted in a progressive stimulation
of NBTGR-sensitive uridine transport activity. Optimal
transport activity was observed at a PC:PE ratio of 1:1.
Under this condition, NBTGR-sensitive uridine transport
activity was 320 pmol/mg protein in 10 s, a 3.3. fold
increase in activity compared to pure PC vesicles. Further
increases in the PE content of the vesicles resulted in
Fig. 4.11 Apparent initial rates of NBTGR-sensitive uridine
transport into reconstituted vesicles composed of
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Crude n-octylglucoside membrane extract was, reconstituted
(at a lipid to protein ratio of 55:1) into liposomes
composed of varying ratios of PC and PE as indicated.
Apparent initial rates of NBTGR-sensitive zero-trans
uptake of uridine (50 uM at 15°C, 10 s flux) were measured-












diminished transport activity, and pure PE vesicles only
exhibited a transport activity of 25 pmol/mg protein in 10
s, 13% of the optimum activity.
4.4 DISCUSSION
The present results show that the erythrocyte
nucleoside transporter exhibits NBTGR-sensitive uridine,
adenosine and inosine transport activity when reconstituted
into the vesicles. The striking difference in the
magnitude of the NBTGR-insensitive component of uptake of
these three nucleosides (Fig. 4.1) represents differences in
diffusion velocity across the lipid bilayer. This
conclusion is based on the similar nucleoside permeation
rates observed in vesicles reconstituted with crude membrane
extract measured in the presence of 20 uM.NBTGR and those
given by liposomes reconstituted in the absence of protein
(Fig. 4.2, Table 4.2). The magnitude of this flux for the
different nucleosides correlates well with their respective
octanol/water partition coefficients (adenosine 0.10;
uridine 0.037; inosine 0.0087) (Jarvis and Young, 1982) and
also with the relative permeabilities of these three
nucleosides in nucleoside transport-deficient sheep
erythrocytes (Young, 1978). Thus, the present experiments
provide direct evidence that the relatively high
permeability of these cells to adenosine reflects non-.
mediated diffusion across the lipid bilayer.
Physiologically, this means that cells are permeable to
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adenosine, even in the absence of a nucleoside carrier.
The kinetic studies presented in this Chapter
demonstrate that the simple carrier model of Lieb (1982) can
be applied to uridine transport in the reconstituted system.
Furthermore, the number of uridine molecules taken up per s
in reconstituted vesicles assayed under equilibrium
exchange influx conditions is 49 times the number of
available high-affinity NBMPR binding sites (Table 4.5),
calculated assuming that each transporter binds one molecule
of NBMPR. Therefore, NBTGR-sensitive uridine transport as
measured in the present experiments reflects carrier-
mediated nucleoside permeation into the reconstituted
vesicles rather than binding (see also Chapter 3).
As shown in Table 4.3, the transporter exhibited
directional symmetry in the reconstituted state. In fresh
erythrocytes, the transporter also exhibits directional
symmetry (Jarvis and Young,1983, Jarvis et al, 1983a;
Plagemann and Wohlhueter, 1984b). In contrast, nucleoside
transport in erythrocytes from out-dated blood is asymmetric
with respect to flux kinetics (Cabantchik and Ginsburg,
1977; Jarvis et al, 1983a). PCMBS-treated proteoliposomes
(reconstituted with either crude membrane extract or
partially-purified band 4.5 polypeptides) exhibited 60% of
control high-affinity NBMPR binding and uridine transport
activities, suggesting that this fraction of transporter is
reconstituted in an inside orientation with respect to
PCMBS-sensitive site(s). The finding that PCMBS treatment
caused a similar inhibition of both NBMPR binding and
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uridine transport provides strong evidence that the majority
of available transporters were incorporated into liposomes.
Consistent with this result, it was reported in Chapter 3
(Fig. 3.4) that reconstituted NBTGR-sensitive uridine
transport is directly proportional to the amount of protein
present during reconstitution.- The 40% loss of ligand
binding and transport activity following exposure to PCMBS
therefore represents that fraction of transporters which
are reconstituted with an outside orientation. Thus the
nucleoside transporter is reconstituted with high efficiency
and distributed in an 40:60 outside:inside orientation in
the reconstituted proteoliposomes. The reconstituted human
erythrocyte glucose transporter exhibits a similar
orientation in the reconstituted state as judged by
asymmetric trypsin cleavage of the transporter (Baldwin et
al, 1980; Wheeler and Hinkle, 1981 Sase et al, 1982).
Therefore, the observed kinetic symmetry of the
reconstituted nucleoside transport system is imposed by the
almost random orientation of transporters in proteoliposomes
and provides no information on possible intrinsic
directional asymmetry of the reconstituted transport
protein.
The difference in mobilities of the loaded and. empty
carriers was 21-fold (Roo/Ree=21) (Table 4.3). This implies
that the movement of the empty carrier is the rate
determining step of uridine transport in reconstituted
vesicles. This is also the case in erythrocytes. However,
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the difference in mobility of loaded and empty carriers in
fresh erythrocytes is less marked (5-10 fold at 15-
30°C)(Jarvis et al, 1983a), but much enhanced at lower
temperature and in out-dated blood (Plagemann and
Wohlhueter, 1984b,c). As shown in Table 4.5, the
reconstituted transporter exhibited 6-7% activity relative
to intact erythrocytes, when assayed under zero-trans efflux
and influx conditions, but 18% when assayed under
equilibrium exchange influx conditions. This is because the
empty carrier is more effectively slowed down in the
reconstituted state than the loaded carrier. Under
equilibrium exchange conditions, both inward and outward
bound movements of the carrier occur in the loaded form,
thus by-passing the empty carrier step and accounting for
the higher transport activity observed under equilibrium
exchange conditions.
The estimated mean K value (Table 4.3) was 120+28 uM
measured at 15°C for. the reconstituted nucleoside
transporter. The K value in fresh erythrocytes is 2.5-fold
lower at the same temperature (48 uM) (Plagemann and
Wohlhueter, 1984b). Since the mobility rate constants k1,
k2 and g1 appear in the carrier affinity parameter,K (k1 /f1
+ k2/f2+ b1k1 /f1g1), changes in K value do not necessarily
reflect altered rates of substrate association* and
dissociation (i.e f1, f2 and b1). In contrast to the present
results, values of K are not significantly different between'
out-dated and fresh blood (Plagemann and Wohlhueter, 1984c
Stein, 1986).
Table 4.6 Activity of the reconstituted human erythrocyte nucleoside
transporter assayed under zero-trans influx, zero-trans





68Zero-trans influx 4.00+0.7 5.9+1
68 6.6+1Zero-trans efflux 4.52+0.6
261 17.4+4Equilibrium exchange influx 45.45+10
Data for erythrocytes were taken from Plagemann and Wohlhueter
(1984b). Vmax values at 15°C in reconstituted vesicles were taken
from Table 4.3 and high affinity NBMPR binding activities were
measured as described in METHODS and corrected for the 20% loss of
activity during reconstitution (Table 4.1). Turnover numbers were
calculated assuming that each transporter binds one molecule of NBMPR.
Values are mean+S.E.(3).
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The altered kinetic properties of the reconstituted
nucleoside transport system are likely to reflect the change
of transporter lipid environment. This view is supported by
the 2.2-fold lower turnover number observed for the
reconstituted crude membrane extract (1.8 molecules per
site per s at 15°C for zero-trans influx) (Fig. 4.4 and
Section 4.3.1b) compared with that for the partially-
purified transporter preparation (4.0 molecules per site per
s) (Fig. 4.6 and Table 4.6), partially-purified band 4.5
proteins depending only partly on exogenous lipids for
transport activity. Lipid requirements of the nucleoside
transporter were investigated directly using crude membrane
extract reconstituted with vesicles of differing
phospholipid and cholesterol contents. The results
demonstrated that neither pure PC nor PE.. vesicles could
support transport activity (Table 4.5 and Fig 4.11).
Similar observations have been reported by Wheeler and
Hinkle (1985) for the reconstituted human erythrocyte
glucose transporter, a protein that co-purifies with the
erythrocyte nucleoside transporter during ion-exchange
chromatography, and also by Sandra et al, (1984). for the
reconstituted glucose transporter from rat adipocytes. The
reason why a combination of PC and'PE are required for
transporter activity remains to be determined (Kagawa an
Racker, 1973). Addition of PS, which has a negatively
charged headgroup, to asolectin drastically decreased
nucleoside transport activity by 90 %. In contrast, the
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presence of sphingomyelin, where the glyceride backbone is
replaced by ceramide, only had a small effect on transport
function. Increasing liposomal fluidity by addition of
cholesterol (Connolly et al, 1985 Tefft et al, 1986) had no
effect on transport activity. It therefore appears that the
nature of the polar phospholipid headgroup plays a key role
in determining transporter activity, while other factors
(phospholipid backbone modification, and liposomal fluidity)
are of less importance. Of course, more detailed and
systematic modifications of liposomal lipid.. composition
would give a better understanding of lipi--1 requirements o1''
the nucleoside transporter. Replacement of asolectin by
extracted human erythrocyte lipids resulted in modest (25%)
stimulation of reconstituted transporter activity. A larger
increase in transport activity might have been expected.
However, liposomes cannot mimic the asymmetric distribution
of lipids between the two halves of the erythrocyte membrane
bilayer (Singer and Nicolson, 1972 Racker and Miller,
1980). Also, some important minor membrane lipids may have
been absent from the erythrocyte lipid extract.
In conclusion, a simple carrier model is sufficient to
describe the characteristics of uridine transport in
reconstituted vesicles. The transport protein was
reconstituted with high efficiency but with reduced
mobilities for both the loaded and empty carriers, the
mobility of the empty transporter being more severely
impaired. The results suggest that the observed decrease in
transport activity in the reconstituted system is a
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consequence of the transporters functioning at a lower rate
rather than a few transporters functioning at the in vivo
rate (see also Baldwin et al, 1981). Decreased transporter
activity is probably related to modification of the
transporter's lipid environment. Lipid effects may also
explain the carrier mobility- changes observed in
erythrocytes from out-dated blood (Jarvis et al, 1983a) and
at low temperature (15°C) (Plagemann and Wohlhueter,
1984b). Variation in membrane lipid composition between
erythrocytes and other cell types may also offer a potential
explanation of why there is no difference in the mobilities
of loaded and empty carriers in cultured mammalian cells
(Wohlhueter et al, 1979a Plagemann and Wohlhueter, 1980).
Interestingly, the mobility of the loaded erythrocyte
carrier varies with different substrates (Jarvis, 1986b).
Taken together, these observations emphasis that the
nucleoside transporter is highly responsive to changes in
its, environment. Modulation of the relative mobilities of
loaded and empty carriers is a potential mechanism of in
vivo control.
CHAPTER 5




Photoaffinity labelling experiments with [3H]NBMPR and
reconstitution studies using uridine transport activity as
an assay of transporter function have implicated band 4.5
polypeptides in erythrocyte nucleoside transport (Wu et al,
1983a,b; Tse et al, 1985b; see also Chapter 3). The glucose
transporter has also been shown to be a band 4.5
polypeptide and is the major constitutent( 95 %) present
in partially-purified band 4.5 polypeptides from human
erythrocytes. In contrast, the nucleoside transporter
exists as a minor component( 5 %) in the preparation
(Jarvis and Young, 1981; Baldwin et al, 1982).
Further purification of the erythrocyte nucleoside
transporter requires its separation from the glucose
transport protein. One possible experimental strategy is to
attempt purification of the nucleoside transporter from pig
erythrocytes. These cells possess approximately 5000
nucleoside transport sites per cell but are totally devoid
of cytochalasin B-sensitive glucose transport activity-(Kim
and McManus, 1971; Zeidler et al, 1976; Young et al, 1985,
1986).. Pig erythrocytes are therefore anticipated to be
deficient with respect to the major band 4.5 polypeptide
present in human erythrocytes (Young and Jarvis, 1982
Wagner et al, 1984). Physiologically, pig erythrocytes
utilise plasma inosine as their energy source (Kim et al,
1980 Zeidler et al, 1985; Young et al, 1985, 1986).
Recently, Mr. F.Y.P. Kwong of this laboratory has
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developed a gradient-elution DEAE-cellulose ion-exchange
chromatography procedure for the isolation of the
erythrocyte nucleoside transporter from this species. The
degree of purification achieved was 60-65-fold based on
assays of reversible high-affinity NBMPR binding activity or
140-fold based on determinations of the specific activity of
NBMPR covalent labelling (Kwong et al, 1986; 1987). This
preparation exhibits 1500 pmol NBMPR bound/mg protein. In
order to establish that this band 4.5 membrane fraction does
in fact contain functional nucleoside transporter, it is
necessary to demonstrate its ability to catalyse carrier-
mediated nucleoside transport activity following
reconstitution into phospholipid vesicles. This was the
objective of the studies described in the present Chapter.
Conditions for reconstitution and assays of uridine
transport, were based on previous reconstitution studies of
the human erythrocyte nucleoside transporter (see Chapter
3). The results presented here show that dialysed crude
octylglucoside extracts and partially-purified band 4.5
polypeptides from pig erythrocyte membranes exhibit NBTGR-
sensitive uridine transport when reconstituted into
asolectin liposomes. Unlike the equivalent human
erythrocyte preparation, the crude pig membrane extract was




5.2.1 Cell and Membrane Preparation
Fresh blood was collected into heparin and the
erythrocytes washed 3 times with a medium containing 140 mM
NaCl, 5 mM KC1, 20 mM Tris-HCl (pH 7.4 at 22°C), 2 mM MgCl2
and 0.1 mM EDTA (disodium salt). The buffy coat was
discarded. Haemoglobin-free erythrocyte 'ghosts' depleted
of extrinsic proteins were prepared as described previously
(Jarvis and Young, 1981) (see also Chapter 3, Section
3.2.1) except that the initial haemolysis medium contained
0.1 mM PMSF to minimise proteolysis. Control experiments
established that this concentration of PMSF did not inhibit
nucleoside transporter function. Membranes were resuspended
in 5 mM Tris-HC1 (pH 7.4 at 4°C) and stored at -70°C for a
maximum of one week before use. All subsequent procedures
were carried out at 4°C unless noted otherwise.
5.2.2 Purification of Band 4.5 Polypeptides
Pig erythrocyte protein-depleted membranes (1.5 mg
protein/ml) in 5 mM Tris-HC1 were solubilised in 46 mM n-
octylglucoside,5 mM Tris-HC1,2 mM dithiothreitol (pH 7.4 at
4°C), with stirring for 30 min after which the preparation
was centrifuged.at 130,000g, for 1 h with retention of the
supernatant. An aliquot of the supernatant (crude membrane
extract) was dialysed to remove detergent (see-below).
To purify the nucleoside transporter, 60 ml of the
130,000g supernatant was applied at a flow rate of 150 ml/h
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to a DEAE-cellulose ion-exchange column (typically 30 ml)
equilibrated with the same detergent buffer containing 34 mM
n-octylglucoside. Where appropriate, void-volume fractions
were collected and the detergent was removed by dialysis
(see below). As the pig erythrocyte nucleoside
transporter is adsorbed by DEAE-cellulose (Kwong et al,
1985 1986 1987), the column was eluted with 800 ml of a
linear salt gradient (0-0.20 M NaCl 34 mM n-octylglucoside,
2 mM dithiothreitol, 5 mM Tris-HC1). To monitor elution and
purification of the nucleoside transporter, 5% of the
starting protein-depleted membranes were covalently
radiolabelled with [3H]NBMPR prior to solubilisation (see.
next section). Column fractions containing nucleoside
transporter protein (0.08-0.11 M NaCl) were pooled and
dialysed free of detergent against 4 changes, each of 2 1 of
10 mM Tris-HC1, 0.2 mM dithiothreitol (pH 7.4 at 4°C). In
some experiments, the residual adsorbed protein was eluted
with buffer containing 1 M NaCl in addition to detergent and
dithiothreitol. Appropriate fractions were collected and
detergent was removed as described above. The specific
activity of reversible high-affinity NBMPR binding to the
final preparation was in the range 1200-1500 pmol of NBMPR
bound/mg of protein compared with 24 pmol NBMPR bound/mg of
protein for the starting pig erythrocyte ghosts, a
purification of 50-65-fold.' Purification based on the
specific activity.of [3H]NBMPR covalent labelling was 120-
150-fold. The discrepancy between the two purification
estimates results from a 60% loss of reversible NBMPR
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binding activity during column chromatography (Kwong et al,
1987).
Fig. 5.1 shows a representative SDS-polyacrylamide gel
electrophoresis profile of the partially-purified pig
erythrocyte nucleoside transporter preparation. The
preparation exhibits two regions of Coomassie blue staining.
The upper high molecular weight band [Mr(average) 64,000]
corresponds to the 3 H-labelled pig transporter (Wu et al,
1983a). The other, with a lower apparent molecular weight
of 43,000, was not radiolabelled with [3H]NBMPR (Kwong et
al, 1986) and contributed an average 60% of the protein
present in the preparation as judged by absorbance scans.
The identity of this low molecular species remains to be
resolved, but is likely to represent a degradation product
of band 3 (Good et al, 1986; Kwong et al, 1987)
5.2.3 Photoaffinity Labelling with NBMPR
NBMPR-binding to the nucleoside transporter is normally
reversible. However, specific covalent radiolabelling of
transport protein occurs when site-bound [3H]NBMPR is
exposed to high-intensity UV light (Wu et al, 1983a; b
Young et al, 1983). Protein-depleted membranes (2 mg
protein/ml) were equilibrated at room temperature for 30 min
with a saturating concentration of [3H]NBMPR (50- nM).
Samples were then cooled to 4oC and supplemented with 50 mM
dithiothreitol added as a free-radical scavenger.
Photolysis was carried out in conventional 3 ml
spectrophotometer quartz cuvettes (1 cm light path) using a
Fig. 5.1 SDS-polyacrylamide gel electrophoresis of pig
erythrocyte 'ghosts' and partially-purified band
4.5 polypeptides.
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Samples of the starting erythrocyte 'ghosts' (75 ug protein,
A) and the purified extract (30 ug protein, B) were analysed
on a 12% SDS-polyacrylamide slab gel, stained with
Coomassie blue and scanned at 633 nm using an LKB. laser
densitometer. The positions of the stacking gel-running gel
interface and the tracking dye are indicated by a and b,












450-watt mercury arc lamp (Conrad-Hanovia Inc., Newark NJ).
UV exposure was for 45 s at a distance of 6.5 cm from the
lamp's silica cooling sleeve. Samples were then diluted 20-
fold with Tris-HC1 and allowed to stand at room temperature
for 10 min before recovery of the radiolabelled membranes by
centrifugation. This washing procedure was repeated two
more times to remove any residual unreacted ligand.
5.2.4 Reversible NBMPR Binding
High-affinity binding of [3H]NBMPR (saturating
concentration, 100 nM) to membranes and detergent-free
membrane extracts was determined in the absence and in the
presence of 20 uM NBTGR as competing nonradioactive ligand
as described in Chapter 4, Section 4.2.2).
5.2.5 Reconstitution Experiments
Protein fractions were reconstituted into phospholipid
vesicles using the method described previously by Kasahara
and Hinkle (1977) as modified and described in Chapter 3.
Acetone-washed soybean phospholipids (Kagawa and Racker,
1971) (20-40 umol in 0.5 ml of 10 mM Tris-HC1) were
sonicated to clarity (20 min at 20-30°C) in a bath-type
sonicator containing 0.02% (w/v) Triton X-100 in distilled
water (Kasahara and Hinkle, 1977). Samples (0.018-0-.15 mg
of protein) were added to the,sonicated vesicles (4-8 umol)
in a final volume of 0.4 ml. The phospholipid:protein ratio-
(umol/mg) was kept in the range 50-240:1. The mixture.was
rapidly frozen in dry ice/ethanol, slowly thawed at room
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temperature, and then sonicated briefly (5 s). These
preparations were then used for uridine and glucose uptake
studies.
5.2.6 Transport Assays
Uptake of[ 14C] uridine (50 uM) by liposomes and
reconstituted vesicles was measured at 25°C by a centrifugal
gel filtration method (Penefsky, 1977 Fry et al, 1978) as
described in Chapter 3 (Tse et al, 1985b). D-[ 14C] and L-
[14 C]Glucose uptake (0.2 mM) was determined by an identical
procedure except that cytochalasin B (10 uM) replaced NBTGR
as transport inhibitor.
5.2.7 Protein and Lipid Determinations
Protein was assayed by the method of Peterson (1977)
and phospholipid was assayed by the diphenylhexa triene
fluorescence enhancement method described by London and
Feigenson (1978) (see Chapter 3, Section 3.2.7).
5.2.8 SDS-Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis was carried out
in 1 mm thick slab gels by the method of Thompson and Maddy
(1982) using the Laemmli (1970) buffer system. The gels
were stained with Coomassie blue and scanned at 633 nm using
an LKB laser densitometer.
5.3 RESULTS
The partially-purified band 4.5 preparation eluted by
the linear salt gradient was substantially enriched with
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respect to high-affinity NBMPR binding activity (see
METHODS). Subsequent experiments were undertaken to
investigate whether this pig erythrocyte membrane extract
was also capable of nucleoside transport when reconstituted
into phospholipid vesicles.
5.3.1 Time Course of Uridine Uptake Into Vesicles
Reconstituted with Crude n-Octylglucoside Extract and
Partially-Purified Band 4.5 Polypeptides from Pig
Erythrocyte Membranes.
Representative time courses of uridine uptake(+ 20 uM
NBTGR) into vesicles reconstituted with crude n-
octylglucoside membrane extract and the isolated band 4.5
preparation are shown in Figs. 5.2 and 5.3. Both
reconstituted preparations were capable of NBTGR-sensitive
uridine uptake (50 uM, 25°C), the latter exhibiting a 31-
fold higher transport activity per mg protein (Table 5.1).
The corresponding increase in the specific activity of
reversible NBMPR binding was 20-fold, a ratio of 1.5 (Table
5.1) (see also General Discussion). From the data presented
in Table 5.1, and assuming that there is a 20 % loss of
high-affinity. NBMPR binding activity during reconstitution
(see Chapter 4, Table 4.1), it can be calculated that.the
purified pig preparation catalysed the transport of 11.2
molecules of uridine/NBMPR binding site per 5 s (50 uM
Permeant, 25°C). This turnover number corresponds to 3.7
molecules of uridine transported/NBMPR binding site per 5 s
at 15°C (Q10 for the reconstituted pig nucleoside
Fig. 5.2 Time course of uridine uptake into vesicles
reconstituted with crude n-octylglucoside extract
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The 130,000 g, supernatant from n-octylglucoside solubilised
protein-depleted membranes (crude n-octylglucoside extract)
was dialysed free of detergent and reconstituted into
phospholipid vesicles as described-in METHODS. Uptake of
14
[ C]uridine (50 uM) in the presence (○) and in the
absence of 20 uM NBTGR() was measured at 25°C. The inset
shows the time course of NBTGR-sensitive uridine transport
(△ is the difference between uridine uptake in the









Fig. 5.3 Time course of uridine uptake into vesicles
reconstituted with partially-purified band 4.5
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Partially-purified band 4.5 polypeptides (see METHODS) were
reconstituted into phospholipid vesicles and assayed for
uridine uptake (50 uM, 25°C) in the absence() and in the
presence of 20 uM NBTGR (○). The inset shows the time
course of NBTGR-sensitive uridine transport( △ is the
difference between uridine uptake in the absence and in the
presence of NBTGR). Values are means of triplicate
determinations.
Uridineuptake(nmoles/mgprotein)
Table 5.1 High-affinity NBMPR binding and uridine transport
activities of partially-purified band 4.5 polypeptides











Membranes were depleted of extrinsic proteins, solubilised with n-
octylgiucoside and subjected to gradient-elution DEAE-cellulose
ion-exchange column chromatography as described in METHODS.
Samples of the n-octylglucoside 130,000 g supernatant (crude n-
octylglucoside extract) and partially-purified band 4.5
polypeptides were dialysed free of detergent and assayed for high-
affinity NBMPR binding activity at a saturating concentration of
ligand (50 uM). Samples of the two preparations were also
reconstituted into phospholipid vesicles and assayed for NBTGR-
sensitive uridine transport activity (50 uM 14[ C]uridine (+'20 uM
NBTGR), 250C) as detailed in the text. Values are means (+S.E.) of
triplicate estimates from a single experiment.
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transporter, 3.0 (data not shown)), and compares favourably
with a value of 3.2 molecules/site per 5 s (15°C) calculated
for the reconstituted human erythrocyte nucleoside
transporter (see Chapter 3, Table 3.2).
5.3.2 Effects of Transported Nucleosides and Nucleoside
Transport Inhibitors on Uridine Transport into
Vesicles Reconstituted with Crude n-Octylglucoside
Extract from Pig Erythrocyte Membranes
Results presented in Table 5.2 confirm that NBTGR-
sensitive uridine uptake by the reconstituted crude membrane
extract was inhibited by the nucleoside permeants inosine
and adenosine. Adenosine was a more effective inhibitor of
the reconstituted transporter than inosine, in agreement
with their known relative affinities of these two
nucleosides 'for the nucleoside transporter in intact pig
erythrocytes (Jarvis et al, 1980a). The apparent inhibition
of NBTGR-sensitive [14C]uridine uptake by non-radioactive
uridine indicates that transport was saturable. As also
shown in Table 5.2, specific (NBTGR-sensitive) uridine
transport in the reconstituted vesicles was inhibited by
NBMPR, dipyridamole and dilazep, potent inhibitors of the
erythrocyte nucleoside transport system (Young and Jarvis,
1983).
5.3.3 Control Experiments for Lipid and Protein Requirements
on Reconstitution of Nucleoside Transport Activity-
Results presented in Table.5.3 demonstrate that the
Table 5.2 Effects of transported nucleosides and nucleoside transport
inhibitors on uridine transport into vesicles reconstituted











Rates of NBTGR-sensitive uridine transport (5O uM) by vesicles kw-s
flux, 25°C) were determined as described in METHODS. Inhibitors were
preincubated with reconstituted vesicles for 15 min at 25°C before
addition of permeant. Values are means (+S.E.) of triplicate
estimates.
Reconstitution of nucleoside transport activity with aTable 5.3
crude n-octylglucoside extract from pig erythrocyte










18.8+1.1 2.6+0.3 16.2+1.1Reconstituted vesicles
02.4+0.6 2.5+0.3Lipid only
6.1+0.7 1.5+0.1Protein only 4.6+0.7
Uridine uptake by vesicles (50 uM, 10-s flux at 25°C) was measured as
described in METHODS. In the preparation of 'reconstituted vesicles',
crude n-octylglucoside extract and partially-purified band 4.5
polypeptides were reconstituted with added soybean phospholipids.
Each transport assay contained 10 ug of protein and 0.3 umol of lipid
(membrane extract) or 1.2 ug of protein and 0.3 umol of lipid (band
4.5 preparation). For the 'lipid only' and 'protein only' controls,
reconstitution was performed in the absence of added protein and
lipid, respectively. △ is the difference in uridine uptake in the
absence and in the presence of 20 uM NBTGR. Values are means (.+S.E.)
of triplicate determinations.
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NBTGR-sensitive uridine transport activity of the crude
membrane preparation was strongly dependent upon the
presence of added phospholipid, membrane extract alone
exhibiting 2% of the NBTGR-sensitive uptake of the
reconstituted system. The higher basal NBTGR-sensitive
uridine transport activity of the partially-purified band
4.5 preparation (23%) (Table 5.3) is a consequence of its
higher p hospholipid:protein ratio, permitting vesicle
formation and partial reconstitution of transport activity
even in the absence of added lipid (see Chapter 3, Section
3.3.2d). The measured phospholipid:protein ratio of one
preparation was 23.2 umol/mg compared with 1.64 umol/mg for
the crude n-octylglucoside membrane extract. Rates of
NBTGR-insensitive uridine uptake by the two reconstituted
preparations were similar to those given by liposomes alone
(Table 5.3), indicating that this component of uptake
reflects simple diffusion of isotopic permeant across the
lipid bilayer (see also Chapters 3 and 4).
5.3.4 Reconstitution Studies of DEAE-Cellulose Fractions.
Dialysed DEAE-cellulose fractions (void volume,
gradient and 1 M NaCl) (see METHODS) were reconstituted into
phospholipid liposomes at a ratio of lipid to protein in the
range of 15-400:1* and assayed for uridine transport activity
(50 uM, -25°C). Consistent with Fig. 5.3, reconstituted
gradient fraction proteins (essentially band 4.5'
polypeptides (Kwong et al, 1986 see also Fig. 5.1))
exhibited an NBTGR-sensitive uptake rate of 15.3 nmol/mg of








0.51+0.06 0.58+0.041 M NaC l
Uridine uptake by reconstituted vesicles (50 uM, 10-s flux at
25°C) was measured as described in METHODS. Each transport
assay contained 0.11 umol of lipid and 0.54 u,g (void-volume),
0.27 ug (gradient) or 7.5 ug (1 M NaCl) of protein. is the
difference in uridine uptake in the absence and in the presence
of 20 uM NBTGR. Values are means (S.E.) of triplicate
determinations.
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protein in 10 s (Table 5.4). In contrast, neither the
pooled void volume nor 1 M NaCl fractions exhibited
detectable NBTGR-sensitive uridine transport activity.
These fractions have been shown to exhibit low NBMPR-binding
activities (Kwong et al, 1987).
5.3.5 Reconstitution Studies_ of Glucose Transport
Activities in Crude Membrane Extracts from Human and
Pig Erythrocytes
In a final series of control reconstitution
experiments, I tested the crude n-octylglucoside extract
from human and pig erythrocytes for stereospecific glucose
transport activity. In contrast to the equivalent human
erythrocyte preparation, no transporter-mediated uptake of
glucose was detected in the pig preparation (Fig., 5.4), the
two glucose isomers exhibiting the same uptake rate (1
nmol/mg of protein in 1 min). This result confirms the
absence of glucose transporter from detergent extracts of
pig erythrocyte membranes.
5.4 DISCUSSION
The human and pig erythrocyte nucleoside transporters
exhibit substantial molecular differences: a) the
radiolabelled pig-erythrocyte NBMPR-binding protein migrates
on SDS-polyacrylamide gels with a significantly higher
apparent Mr than the human erythrocyte nucleoside transport.
protein (64,000 vs 55,000) (Wu et al, 1983a Kwong.et al,
1986), b) they behave differently during DEAE-cellulose
Fig. 5.4 Time courses of D- and L- glucose uptake into
vesicles reconstituted with crude n-octylglucoside
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The 130,000 supernatant from n-octylglucoside sol.ubilised
protein-depleted human (A) and pig erythrocyte membranes (B)
were dialysed free of detergent and reconstituted- into
phospholipid vesicles under identical conditions. Uptake of
0.2 mM D-[ 14 C]glucose() and L-[ 14 C]glucose (○ ) were







ion-exchange column chromatography '(Kwong et al, 1985
1986), c) endo-q-galactosidase had no effect on the
electrophoretic mobility of the isolated pig erythrocyte
nucleoside transporter, but reduces the apparent Mr
(average) of the human protein from 56,000 to 47,000 (Kwong,
et al, 1986), d) endoglycosidase-F treatment decreases
the apparent Mr(average) of the pig and human erythrocyte
nucleoside transporters from 64,000 to 57,000 and 55,000 to
44,000, respectively (Kwong et al, 1986). These observations
provide evidence of both carbohydrate and polypeptide
differences between the human and pig erythrocyte nucleoside
transporters. Functionally, however, the pig and human
erythrocyte nucleoside transporters are indistinguishable.
For example, in intact erythrocytes, the two transporters
have similar affinities for NBMPR and nucleoside permeants
as well as equivalent turnover rates for nucleoside
translocation (Young and Jarvis, 1983). Transport in both
cell types is inhibited by nanomolar concentrations of NBMPR
and its analogues (Young and Jarvis, 1983). Thus, the
molecular differences between the two transporters have no
obvious functional significance.
Using the gradient-elution procedure described in
METHODS, the high-affinity [3H]NBMPR binding component from
pig erythrocytes can be enriched approximately 60-fold with-
respect to the starting membrane ghosts (Kwong et a1, 1986
1987). The present series of experiments demonstrate that
this partially-purified band 4.5 preparation is capable of
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rapid NBTGR-sensitive uridine transport when reconstituted
into phospholipid liposomes, providing further evidence to
implicate band 4.5 polypeptides in nucleoside permeation
(see also Chapter 3). Uridine transport activity, as assayed
in reconstituted phospholipid vesicles, co-purified with
reversible NBMPR-binding activity (Table 5.1), providing
evidence that the transport system was isolated in its
entirety. It is anticipated that the availability of a
highly-enriched pig nucleoside transporter preparation will
prove useful in molecular studies of nucleoside transporter
function and provide a convenient starting point for further
isolation studies. One immediate application of the
preparation has been as immunogen for the production of
monoclonal antibodies directed against the pig erythrocyte
nucleoside transporter (Good et al, 1986).
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CHAPTER 6
SOLUBILISATION AND RECONSTITUTION STUDIES OF THE NUCLEOSIDE
TRANSPORTER FROM GUINEA PIG LUNG PLASMA MEMBRANES
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6.1 INTRODUCTION
As detailed in the General Introduction to this Thesis,
NBMPR has been shown to interact specifically with
functional elements of the erythrocyte nucleoside
transporter and reversible ligand binding has been used as a
specific quantitative assay for the transporter
polypeptide(s) (Jarvis and Young, 1982 Young and Jarvis,
1983). Photolysis experiments with [3H]NBMPR have
identified a membrane glycoprotein component of Mr 45,000-
65,000 to be the nucleoside transporter in erythrocytes and
in a number of other cell types and tissues, including lung
which has a particularly high density of NBMPR binding sites
(Vlu et al, 1983a b Kwan and Jarvis, 1984; Shi et al, 1984
Young et al, 1983 1984 Jarvis and Ng, 1985 Jarvis and
Young, 1986b). Physiologically, lung is.a major site for
the removal of circulating adenosine, a potent endogenous
vasodilator (Berne et al, 1983 Bakhle and Chelliah, 1983
Hellewell and Pearson, 1983). Despite its physiological and
clinical importance, the functional properties of the lung
nucleoside transporter are poorly understood and largely
limited to indirect studies of NBMPR binding (see
Discussion). Transport experiments have been limited to
whole tissue perfusion studies (Hellewell and Pearson,
1983). In the series of experiments described in this
Chapter, n-octylglucoside was used to solubilise the
nucleoside transporter from lung plasma membranes. After
removal of detergent, the carrier was reconstituted into
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proteoliposomes and its kinetic properties characterised in
detail. As far as I am aware, these experiments represent
the first successful attempt to reconstitute a nucleoside
transporter from a non-erythroid cell type or tissue.
6.2 METHODS
6.2.1 Tissue and Plasma Membrane Preparation
Plasma membranes from guinea pig lung was prepared
according to Casale et al (1984) as modified by M.M. Shi in
our laboratory. Fig. 6.1 outlines the -procedure used.
Unless stated otherwise, all steps were performed at 0-4°C.
Briefly, Dunkin-Hartley guinea pigs (700-800g) were'
anaesthetised with ether and the lungs perfused in situ with
heparinized saline to remove trapped erythrocytes. Lung
tissue was then removed from the animals, .,washed twice in
ice-cold saline and homogenised in 10 vol. (w/v) of ice-
cold 50 mM Tris-HC1 (pH 7.4 at 22° C) using a Brinkman
Polytron PT-10 (setting 7, 1 min). Samples were centrifuged
at 30,000g for 10 min and the pellets washed twice with 10
vol of Tris-HC1 before suspension in the same volume of
buffer. This crude lung homogenate.(H) was filtered through
double layered cheese cloth and then centrifuged at 900 for
10 min to remove residual tissue, nuclei and cellular debris
(P1). The supernatant (S1) was sequentially centrifuged- at
6000, 9000 and 20,0008, each for 10 min,, subsequent
supernatants being designated S2, S3 and S4, respectively.
MgC12 was added to the final supernatant (S4) to a
Fig. 6.1 Outline of isolation procedures for the
preparation of guinea-pig lung plasma membranes
Crude lung homogenate (H)
900y x 10 min x 2
Supernatant (Si)Pellet (P1)
16,0008 x 10 min
Supernatant (S2)Pellet (P2)
19,000g x 10 min
IN
Supernatant (S3)Pellet (P3)
I20,000f x 10 min
f
Supernatant (S4)Pellet (P4)















concentration of 1 mM so as to enhance the final sucrose
density gradient separation of ribosomes and smooth
endoplasmic reticulum membranes from plasma membranes
(Nijjar and Ho, 1980). 8 ml of Mg2+ -supplemented S4 were
applied to the top of a discontinuous sucrose gradient which
was composed of 10 ml each of 7.5 and 15% (w/v) surcose in
water and 5 ml of 50% (w/v) sucrose. The tube was
centrifuged at 35,000a for 1 h in a SW 25.1 Beckman
ultracentrifuge swing-out rotor. Four distinct fractions
were identified (Fig. 6.1), but only B1.. and F2 were
collected and diluted 1:1 with 0.1 M Tris-HC1. These two
fractions were pooled and centrifuged at 40,000g for 2 h.
The supernatant was discarded and the pellet (which
contained lung plasma membranes) resuspended at 2 mg
protein/ml in 50 mM Tris/HC1 (pH at 4°C) and stored at -70°C
until required. The purity of this plasma membrane fraction
was assessed by measurements of the specific activity of the
plasma membrane marker, .5'-nucleotidase. The procedure
described above typically resulted in a parallel 3-5 fold
enrichment of both 5'-nucleotidase and NBMPR binding
activities compared with the starting crude lung homogenate
(M.M.Shi, unpublished data).
6.2.2 Solubilisation of Lung Plasma Membranes
Lung plasma membranes at a final protein concentration
of 1.5 mg/ml were solubilised at 4°C by suspension in 46 mM-
n-octylglucoside, 2 mM dithiothreitol and 50 mM Tris-HCl (pH
7.4 at 4°C) with stirring for 30. min. The
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membrane/detergent suspension was then centrifuged at
130,000.g for 1 h and the supernatant was retained.
Detergent was removed by dialysis against four changes, each
of 2 1, of 10 mM Tris-HC1, 0.2 mM dithiothreitol (pH 7.4 at
4°C) over a period of 48 h. This solubilised crude lung
membrane extract was stored at -70°C.
6.2.3 NBMPR Binding Measurements
6.2.3a Filtration method
High-affinity binding of NBMPR to guinea pig lung
membranes was assayed by a filtration method (Shi et al,
1984). Membranes in 50 mM Tris-HC1 (0.05 mg protein) were
incubated with a saturating concentration (10 nM) of
[ 3 H]NBMPR in a total volume of 1 ml for 30 min at room
temperature (22°C) in the presence and in the absence of 20
uM NBTGR as competing non-radioactive ligand. Incubation
was terminated by filtration on glass fibre filters (Whatman
GF/B, which were washed with ice-cold buffer before sample
filtration) under vacuum. The filters were washed four
times with 3 ml aliquots of ice-cold buffer to remove
unbound 3H. The entire procedure was completed within 15 s
so that any dissociation of site-bound [3H]NBMPR was
minimised. The filters were dried, added to 10 *ml of
scintillation fluid and shaken overnight before counting.
Specific binding of 3[ H]NBMPR was calculated as the
difference in binding measured in the presence and in the
absence of NBTGR.
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6.2.3b Centrifugal gel filtration method
High-affinity binding of NBMPR to solubilised lung
membrane extract was measured by a centrifugal gel
filtration method (see Chapter 4, Section 4.2.2 for
details). Solubilised extract in 10 mM Tris-HC1 was diluted
3-fold in the same buffer and incubated at room temperature
(+ 20 uM NBTGR) for 30 min with graded concentrations of
[ 3 H]NBMPR (final equilibrium concentrations 0.25-45 nM) at a
final protein concentration of 0.13 mg/ml. After incubation,
samples were cooled on ice before separation of bound and
free radioligand by the method described previously (Chapter
4, Section 4.2.2).
6.2.4 Reconstitution of the Solubilised Lung Membrane
Extract
Solubilised lung membrane extract was reconstituted
into phospholipid vesicles by freeze-thaw-sonication as
described previously (Chapter 3).. Acetone-washed soybean
phospholipids (40 umol in 0.5 ml 10 mM Tris-HC1) were
sonicated to clarity in a 13x100 mm pyrex tube. Solubilised
lung membrane extract (0.2 mg protein) was added to
sonicated vesicles (10 umol) in a final volume of 0.4 ml.
The mixture was rapidly frozen in dry ice/ethanol, slowly
thawed at room temperature and then sonicated briefly (5 s).
These reconstituted proteoliposomes were used for uridine
uptake studies.
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6.2.5 Transport Assays in Reconstituted Proteoliposomes.
Both zero-trans influx and equilibrium exchange influx
of uridine were measured as described in Chapter 4, Section
4.2.4, except that a 20 s incubation period at 25°C was used
to measure apparent initial rates of uptake.
6.3 RESULTS
6.3.1 Lung Membrane Solubilisation Procedure
n-Octylgluoside has been used successfully to
extract high-affinity NBMPR binding component(s) from human
and pig erythrocyte 'ghosts' (Kwong et al, 1986 see also
Chapters 4 and 5). The same detergent was used to solubilise
lung membranes in the present study.
In contrast to erythrocyte membranes (Kwong et al,
1986), solubilisation of lung membranes with n-
octylglucoside did not lead to an increase in the specific
activity of NBMPR binding i.e. there is no selective
solubilisation of the nucleoside transporter under the
conditions used. Thus, extraction of lung plasma membrane
protein by n-octylglucoside (46 mM) resulted in
solubilisation of 70-80% of the total plasma membrane
protein and a parallel percentage of NBMPR binding activity
(Table 6.1). As expected, the remainder of the protein and
NBMPR binding activity was recovered in the insoluble' n-
octylglucoside residue. The average specific activity of.
reversible high-affinity NBMPR binding to crude. lung
membrane extracts, measured after detergent removal, was




(Pmol) (pmol/mg of protein)(mg)
38+4Guinea-pig lung plasma membranes 348+459.11+2.02
247+33 35+4Solubilised membrane extract 7.21+1.13
71+10,79.1+13% Solubilised
Lung plasma membranes were solubilised with 46 mM n-octylglucoside, 50 mM
Tris/HC1 (pH 7.4 at 4°C) and 2 mM dithiothreitol. The 130,000A supernatant
was then dialysed free of detergent and assayed for protein and high-
affinity NBMPR-binding activity (at a saturating concentration of
radioactive ligand, 25 nM) as described in METHODS. Values are means (+S.E.)
of four separate experiments.
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35+4 pmol/mg of protein (mean of 4 experiments), a value
similar to that of the starting plasma membranes.
6.3.2 Characterisation of the Solubilised Lung Membrane
Extract
Fig. 6.2 shows concentration-dependence curves of
3
[ 3H]NBMPR binding to solubilised lung membrane extract
measured at equilibrium (30 min incubation) in the presence
and in the absence of 20 uM NBTGR. Binding activity is
plotted against the calculated free concentrations of
unbound ligand- in the medium. NBTGR-sensitive [ 3H]NBMPR
binding to the membrane extract was saturable with an
apparent Kd of 1.1 nM as determined by Scatchard analysis.
This affinity constant compares with an apparent Kd of 0.2
nM for[ 3 H]NBMPR binding to guinea pig lung plasma membranes
(Shi and Young, 1986a b). The Bmax value for NBTGR-
3
sensitive[ 3H]NBMPR binding in the experiment shown in Fig.
6.2 was 33 pmol/mg of protein.
High-affinity NBMPR binding activity in solubilised
lung membrane extracts was inhibited by the physiological
nucleosides, adenosine and uridine (Table 6.2). Adenosine
was more effective than uridine (IC50 2 and 8 mm
respectively, 5 nM [ 3H]NBMPR), in agreement with. their
relative affinities for the nucleoside transporter in a
variety of cell types (Young and Jarvis, 1983). These IC50
concentrations were used to determine apparent Ki values
from the relationship
Fig. 6.2 Concentration dependence of NBMPR binding to
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The amounts of [ 3H]NBMPR bound reversibly to crude lung
membrane extract were measured by centrifugal gel filtration
in the presence (○) and in the absence of 20 uM NBTGR()
and are plotted against the equilibrium concentrations of
free NBMPR. The inset shows a Scatchard plot of the data
(corrected for the NBTGR-insensitive component of binding).
Maximum binding (33 pmol/mg of protein) and apparent Kd (1.1






Table 6.2 Effects of nucleosides on high-affinity binding of










Binding of [3H]NBMPR (initial concentration 5 nM) was measured
at room temperature (30 min incubation) in the absence and in
the presence of various concentrations of competing nucleoside
(+ 20 uM NBTGR to correct for non-specific binding). High-
affinity binding activity in the absence of tested nucleosides
was 15 pmol/mg of protein. Values are mean+S.E. of triplicate
estimates.
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where [L] is the radioligand concentration and Kd- its
binding affinity. Calculated inhibitor constants were 0.5
and 2 mM for adenosine and uridine, respectively. The
calculated apparent Ki value for uridine compares well with
its apparent Km of equilibrium exchange influx in
reconstituted lung proteoliposomes (see below).
6.3.3 Reconstitution Studies of the Crude Lung Membrane
Extract
Solubilised lung membrane extract was reconstituted
into proteoliposomes using the experimental conditions
described previously (see Chapter 3). The lipid:protein
ratio was maintained at 50-80.1 (umol/mg).
6.3.3a Zero-trans influx
Representative time courses of uridine.- uptake (50 uM,
25°C), measured in the presence and in the absence of 20 uM
NBMPR, are shown in Fig. 6.3. Uptake was inhibited by
NBMPR. The NBMPR-sensitive component of transport exhibited
a half time for equilibration of approximately 50 s (Fig.
6.3 inset) while the NBMPR-insensitive component of uptake
was linear with respect to time. Fig.,, 6.4 shows
concentration dependence curves(+ 20 uM NBMPR) for zero-
trans uridine influx into vesicles reconstituted with. crude
lung membrane extract over the concentration range 0.05-2
mM. Rates of NBMPR-sensitive uridine transport were.
saturable and conformed to simple Michaelis-Menten kinetics
(apparent Km 0.14 mM and Vmax 0.97 nmol/mg of protein in 20
Fig. 6.3 Time course of uridine uptake into vesicles
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Crude lung membrane extract was reconstituted into
phospholipid vesicles as described in METHODS and assayed
for uridine uptake (50 uM, 25°C) in the absence() and in
the presence of 20 uM NBMPR (○). The inset shows the time
course of NBMPR-sensitive uridine transport (△ is the
difference between uridine uptake in the absence and in the







Fig. 6.4 Concentration dependence of zero-trans uridine
influx into vesicles reconstituted with crude









Apparent initial rates of zero-trans influx of uridine by
the reconstituted vesicles were measured in the presence
(○) and in the absence() of 20 uM NBMPR as described
in METHODS. The inset shows an Eadie-Hofstee plot of NBMPR-
sensitive uridin.e transport (v/s vs v). Apparent Km and
Vmax values, as estimated by linear regression' analysis,
were 0.14 mM and 0.97 nmol/mg in 20 s, respectively. Error.










s) (Table 6.3). In contrast, rates of NBMPR-insensitive
uridine uptake were linear with respect to uridine
concentration over the same range.
6.3.3b Equilibrium exchange influx
Representative concentration-dependence curves for
equilibrium exchange influx of uridine are shown in Fig.
6.5. NBMPR-sensitive equilibrium exchange influx of uridine
was saturable and conformed to simple Michaelis-Menten
kinetics. Estimated apparent Km and Vmax values were 1.1 mM
and 7.1 nmol/mg of protein in 20 s, respectively, as
determined from the inset v/s vs v plot (see also Table
6.3). The Vmax of NBMPR-sensitive equilibrium exchange
uridine influx was 7.3-fold greater than the Vmax observed
for zero-trans influx measured at the same temperature and
was paralleled by a corresponding increase in apparent Km.
Thus, there was no significant difference in the Vmax/Km
ratio under these two experimental conditions (Table 6.3).
6.3.3c Inhibition studies
In a series of inhibition experiments, the transported
nucleosides uridine, adenosine and inosine, and the
vasodilators, dilazep and dipyridamole, were tested for
their ability to inhibit NBMPR-sensitive uridine uptake by
the reconstituted vesicles. Results presented in Table*6.4
confirmed that NBMPR-sensitive uridine uptake by the
reconstituted vesicles was inhibited by the nucleoside
permeants, inosine and adenosine. Adenosine was a more
effective inhibitor of the reconstituted transporter than
Table 6.3 Kinetic parameters for uridine equilibrium exchange
and zero-trans influx in vesicles reconstituted with




(pmol/mg (ul/mg protein(nmol/nig protein
Condition in 20 s in20s) /site/s(MM) protein)
0.97 0.14 28 6.93 2.2Zero-trans influx 2-1
Equilibrium exchange
7.1 1.1 28 6.45 15.9inf lux
Simple carrier resistance parameters
-1
(nmol/mg protein in 20 s) (ms)
zt -1




Independent estimates of simple carrier affinity parameter K






Data from experiments illustrated in Figs 6.3 and 6.4 are summarised in this
Table. Solution 1 has been arbitrarily chosen to be the intravesicular
solution. Resistance and affinity parameters according the simple carrier
model were calculated according to the method of Lieb (1982) (see also
Chapter 4). When calculating the turnover numbers, it was assumed that
there was a 20% loss of high-affinity NBMPR binding during freeze-thaw-
sonication as occurs with erythrocyte membrane extracts (see Chapter 4).
Fig. 6.5 Concentration dependence of uridine equilibrium
exchange influx by vesicles reconstituted with
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Reconstituted vesicles were pre-equilibrated with varying
concentrations (0.05-15 mM) of non-radioactive uridine as
described in METHODS. Apparent initial rates of uridine
equilibrium exchange influx (20 s flux) were measured in the
presence() and in the absence() of 20 uM NBMPR. The
inset shows an v/s vs v plot of apparent initial rates of
NBMPR-sensitive uridine equilibrium exchange influx.
Estimated apparent Km and Vmax values were 1.1 mM and 7.1
nmol/mg of protein in 20 s, respectively. Error bars are.












Table 6.4 Effects of transported nucleosides and nucleoside
transport inhibitors on uridine transport into
vesicles reconstituted with crude n-octylglucoside
















Rates of NBMPR-sensitive uridine transport (50 uM) by vesicles
(20 s flux, 25°C) were determined as described in METHODS.
Inhibitors were pre-incubated with reconstituted vesicles for 15
min at 25°C before addition of permeant. Values are
means(+S.E.) of triplicate estimates.
% %
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inosine (IC50 0.07 and 0.10 mM respectively, 50 uM
[ 14C]uridine), in agreement with their relative affinities
for the nucleoside transporter in other cell types (Young
and Jarvis, 1983) and their ability to inhibit high-affinity
[ 3 H]NBMPR binding to guinea pig lung membranes (Shi et al,
1984). NBMPR-sensitive uridine transport in the
reconstituted vesicles was also inhibited by NBTGR, dilazep
and dipyridamole (Shi et al, 1984). IC50 values were 10 and
15 nM for dilazep and dipyridamole, respectively. These
values were found to correspond well with apparent Ki values
determined for inhibition of high-affinity [3H]NBMPR binding
to guinea-pig lung membranes (2 and 18 nM for dilazep and
dipyridamole, respectively) (Shi and Young., 1986b). My
results therefore suggest that high-affinity binding of
NBMPR to lung membranes represents a specific interaction
with element(s) of the nucleoside transporter. This
conclusion is consistent with previous findings in
erythrocytes (see e. g. Young and Jarvis, 1983 Chapter 1).
6.3.3d Control experiments
Results presented in Table 6.5 demonstrate that the
NBMPR-sensitive uridine transport activity of the crude lung
membrane preparation was dependent upon the presence of
added phospholipid, membrane extract alone having no
detectable uridine uptake activity. Liposomes alone only
exhibited NBMPR-insensitive uptake of nucleoside, reflecting
simple diffusion of isotopic permeant across the lipid
bilayer.
Table 6.5 Reconstitution of nucleoside transport activity with








Uridine uptake by vesicles (50 uM, 20 s flux at 25°C) was
measured as described in METHODS. In the preparation of
reconstituted vesicles', crude n-octylglucosid.e extract was
reconstituted with added soybean phospholipids. For the 'lipid
Only' and 'protein only' controls, reconstitution was performed
in the absence of added protein and lipid, respectively. Each
transport assay contained 15.3 ug of protein and 0.77 umol of
Zipid (reconstituted vesicles) or 15.3 ug of protein (protein
Only) or 0.77. umol of phospholipids (lipid only).
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6.4 DISCUSSION
Physiologically, lung is a major site for the removal
of circulating adenosine, a potent endogenous vasodilator
(Berne et al, 1983 Bakhle and Chelliah, 1983). In the
present series of experiments, I have been able to isolate,
though in crude form, membrane component(s) responsible for
high-affinity NBMPR binding and uridine transport from
guinea pig lung membranes. These components(s) were
inactive with respect to high-affinity NBMPR binding in the
presence of detergent, but activity was., quantitatively
reversed following detergent removal by dialysis (Data not
shown). The solubilised crude membrane extract exhibited a
mean high-affinity NBMPR binding activity of 35+4 pmol/mg of
protein (Fig. 6.2 and Table 6.1) and an apparent Kd of 1.1
nM. This binding was inhibited by the transported
nucleosides adenosine and uridine. When this preparation
was reconstituted into proteoliposomes, NBMPR-sensitive
uridine transport was observed (Fig. 6.3). This transport
was also inhibited by adenosine, uridine and inosine,
suggesting that the transporter exhibits broad specificity
for both purine and pyrimidine nucleosides. Dipyridamole and
dilazep, potent. inhibitors of nucleoside transport in many
other cell types, were shown to inhibit NBMPR-sensitive
uridine transport into proteoliposomes. IC50 values for
inhibition of NBMPR-sensitiv'e uridine transport by these
vasodilators compare favourably with their apparent Ki
values as inhibitors of high-affinity NBMPR binding to
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intact lung membranes. This result and the fact that the
apparent Ki values for uridine inhibition of high-affinity
NBMPR binding to intact membranes and solubilised membrane
extract also correspond well with the apparent Km of NBMPR-
sensitive equilibrium exchange influx of uridine (Table 6.2
and Fig. 6.4), and also that uridine uptake into the
reconstituted vesicles was inhibited by NBMPR, provide
strong evidence that NBMPR binds directly, to the lung
uridine transport protein.
Table 6.3 summarises kinetic parameters for uridine
transport by the lung nucleoside obtained under zero-trans
influx and equilibrium exchange influx conditions. The
kinetic behaviour of the reconstituted system was compatible
with the simple carrier model, Vmax/Km ratios being under
these two conditions the same (Lieb, 1982 Stein, 1986 see
also Chapter 4). As the transporter orientates randomly
when reconstituted (Chapter 4), it is predicted that the
reconstituted system would exhibit kinetic symmetry.
zt zt
Therefore, assuming that V12=V21 and hence R12=R21 (Lieb,
1982), it was possible to calculate simple carrier
resistance parameters for the reconstituted system (Table
6.3). The relative magnitudes of the two resistance
parameters demonstrates that the loaded and empty carriers
exhibit a 14-fold difference in mobility, measured at 25°C
(i.e. Roo/Ree=14). This compares favourably with a
difference of 21-fold for reconstituted human erythrocyte
band 4.5 polypeptides measured at 15°C (Chapter 4). From
the Km values, the simple carrier affinity constant (K) was
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also calculated for the reconstituted lung system (Table
6.3). The two independent estimates of K were similar, the
mean being 78 uM. This contrasts with the K value of 120 uM
obtained for reconstituted human erythrocyte band 4.5
polypeptides measured at 15°C. The lung value would be
expected to be numerically even smaller at lower temperature
(Plagemann and Wohlhueter, 1984b). As discussed in Chapter
4, K is a composite of both mobility and affinity rate
constants.
The Vmax obtained for the reconstituted system under
zero-trans conditions was 0.97 nmol/mg of protein in 20 s.
This corresponds to an estimated turnover number of 2.2
molecules of uridine transported/site/s, calculated from the
high-affinity NBMPR-binding activity of 28 pmol/mg of
protein (Table 6.3) and assuming that each transporter binds
one molecule of NBMPR. This calculation also assumes that
there is a 20% loss of transporter activity upon
reconstitution (Chapter 4, Table 4.1). To permit a direct
comparison with the turnover number of the reconstituted
human erythrocyte nucleoside transporter, a similar
experiment was performed with reconstituted crude
erythrocyte membrane extract at 25°C under identical
conditions. The Vmax obtained was 2.8 nmol/mg of protein. in
10 s and the preparation exhibited a high-affinity NBMPR
binding activity of 80 pmol/mg of protein (Data not shown).*
By calculation, this corresponds to an estimated turnover
number of 4.4 molecules/site/s, twice that of the
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reconstituted lung membrane extract. In intact cells, the
turnover number for uridine transport at 25°C varies from
140-180 molecules/site/s in erythrocytes from various
species to 8-30 molecules/site/s in cultured non-erythroid
cells, a difference of 4.5-23 fold (Young and Jarvis, 1983).
It remains to be established whether low turnover numbers
are a peculiarity of cultured cells or are a general
property of non-erythroid cells and tissues. Differences in
turnover number between different cell types might possibly
reflect variations in membrane lipid composition (Chapter 4)
and would not be expected in vesicles reconstituted with
same exogenous lipid. Another kinetic difference in
nucleoside transport between erythrocytes and cultured cells
concerns the relative mobilities of the loaded and empty
carriers (see General Introduction, Section 1.3.1b and
Chapter 4, Section 4.3.1d). Again, this might reflect lipid
effects. As mentioned earlier in this Discussion, the ratio
of Ree:Roo for the reconstituted lung system was similar to
that for the reconstituted human erythrocyte transporter.
In conclusion, n-octylglucoside can be used to
solubilise the nucleoside transporter from guinea pig lung
membranes. It was established that the lung transporter
could be reconstituted into liposomes and that the resulting
proteoliposomes exhibited NBMPR-sensitive uridine transport.
The reconstituted lung transporter exhibited similar kinetic
properties to the human erythrocyte protein. Therefore, the
present results suggest that these two transporters are
functionally similar. As detailed in the Introduction to
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this Chapter, the two transporters also exhibit similar
apparent molecular weights on SDS-polyacrylamide gels. It
is therefore anticipated that the two transporters exhibit
extensive structural.homology. In this context, it should
be noted that the amino acid sequences of the human liver
and erythrocyte glucose transporters have been shown to be
highly homologous, and perhaps identical (Mueckler et al,
1985).
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The preceding Chapters describe a detailed kinetic
analysis of reconstituted nucleoside transporters
solubilised from human and pig erythrocyte membranes and
guinea-pig lung plasma membranes. Evidence for the
asymmetrical binding of PCMBS to the human erythrocyte
nucleoside transporter is also presented. This Chapter
attempts to draw these investigations together. Choice of
nucleoside permeants for reconstitution studies of
nucleoside transporter function is also discussed.
7.2 CHEMICAL ASYMMETRY OF THE HUMAN ERYTHROCYTE NUCLEOSIDE.
TRANSPORTER
From the results presented in Chapter 2, it is
envisaged that the nucleoside permeation site of the
erythrocyte transporter exists in two orientations. NBMPR
interacts preferentially with the outward facing-
conformation of the nucleoside permeation site (Jarvis et
al, 1982a) whereas its inward-facing conformation possesses
a thiol group reactive to PCMBS. This thiol group is
presumbly not exposed when the permeation site is in its
outward-facing conformation or when the inward-facing
conformation is occupied by substrate.. The present results
are consistent with the simple molecular model. of
erythrocyte nucleoside transporter proposed by Jarvis and
Young (1982) (see also Chapter 1, Fig. 1 .2)...
The erythrocyte nucleoside transport system represents
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the best studied NBMPR-sensitive nucleoside transporter.
Functionally similar systems are widely distributed in
mammalian cells (see e. g. Young and Jarvis, 1983).
Recently, it has been recognised that some lines of
neoplastic and other cells exhibit NBMPR-insensitive
nucleoside transport activity. For example, the Walker 250
rat carcinoma and the Novikoff rat hepatoma have nucleoside
transporters insensitive to nanomolar concentrations of
NBMPR (Gati et al, 1986 Belt, 1983a b), while other
cultured neoplastic cells such as L1210, L5187Y and P388
murine leukaemia cells, transformed hamster fibroblast, He].a
cells and rat erythrocytes exhibit mixed NBMPR-sensitive and
NBMPR-insensitive transport (Dahlig-Harley et al, 1981
Belt, 1983a,b, Eilam and Cabantchik, 1977; Plagemann and
Wohlhueter, 1985 Jarvis and Young, 1986a). These two
transporters are apparently kinetically similar with respect
to nucleoside permeation (Belt, 1983a,b Plagemann and
Wohlhueter, .1984a). However, they differ with respect to
inhibition by PCMBS. This organomercurial inhibits NBMPR-
sensitive transport by binding to thiol group(s) located
within the inward-facing conformation of the nucleoside
permeation site as described in this Thesis. In contrast,
the PCMBS-reactive thiol(s) in NBMPR-insensitive
transporters are accessible from the external membrane
surface (Belt, 1983a Belt and Noel, 1985 Jarvis and Young,
1986a). It nevertheless seems likely that there is a.high
degree of structural homology between the two types of
transporter, inde.ed they may even represent different
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functional states of the same protein. The difference in
sensitivity to NBMPR inhibition may simply reflect a
structural or conformational alteration in the permeation
site region of the transporter which selectively decreases
the affinity of the transporter for NBMPR binding. In this
context, it is interesting that several mutant cell lines
derived from S49 murine lymphoma cells (which normally
exhibit pure NBMPR-sensitive transport) have been shown to
possess mixed NBMPR-sensitive and NBMPR-insensitive
transport (Aronow et al, 1985 Cohen et al, 1985). 1,1210
mutants with altered NBMPR-sensitive nucleoside transport
activity* show parallel changes in NBMPR-insensitive
transport (Belt and Noel, 1986).
Interestingly, the human erythrocyte glucose
transporter possesses PCMBS-reactive thiol(s) which are
accessible from the external membrane surface (Batt et al,
1976). Although the human erythrocyte glucose and nucleoside
transporters are separate carriers, they exhibit similar
molecular properties (Wu et al, 1983b Jarvis et al, 1986a
see also General Introduction). For example, the two
transporters are glycoproteins (Liehard et al, 1984, Kwong
et al, 1986) which co-purify in the column void volume
during DEAE-cellulose ion-exchange chromatography (Jarvis
and Young, 1981). They also co-migrate on SDS-.
polyacrylamide gels with indistinguishable. apparent
molecular weight (Kwong et al, 1986). It is considered
likely that the molecular similarities between the human
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erythrocyte glucose and nucleoside transporters might
reflect some degree of structural homology. In this
context, it should be noted that nucleosides can be regarded
as modified pentoses. Recently, it has been established
that the the amino acid sequence of the human erythrocyte
glucose transporter and those of several bacterial
H+/pentose transporters are highly homologous (Maiden et al,
1QR7).
7.3 DO NBMPR BINDING ACTIVITY AND URIDINE TRANSPORT ACTIVITY
CO-PURIFY?
Kinetic and inhibitor studies suggest that NBMPR binds
to the permeation site of erythrocyte nucleoside transporter
(see e. g. Jarvis and Young, 1986b). Thus, assays of high-
affinity NBMPR binding have been used to partially purify
nucleoside transporters from detergent-solubilised human and
pig erythrocyte membrane extracts (see Chapters 3-5).
However, it is possible that only the binding component of
the nucleoside transport complex might be isolated under
these circumstances. Therefore, the partially-purified
nucleoside transporters from these two species were
reconstituted into proteoliposomes. Uridine transport
activity of the reconstituted nucleoside transporters was
compared with the'activity of high-affinity NBMPR binding.
The partially-purified human erythrocyte band 4.5
preparation exhibited 9.6-fold purification of uridine
transport activity and 6.7-fold enrichment of ligand-binding
activity compared with the crude membrane extract, a ratio
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of 1.4 (Chapter 3, Table 3). Similarly, the uridine
transport activity of partially-purified pig erythrocyte
band 4.5 polypeptides was enriched 30-fold from the crude
membrane extract by DEAE-cellulose ion-exchange
chromatography, but there was only a 20-fold increase in
high-affinity NBMPR binding, a ratio of 1.5 (Chapter 5,
Table 5.1). However, such a comparison of uridine transport
activity between reconstituted crude membrane extracts and
reconstituted partially-purified band 4.5 polypeptides
assumes that these two preparations exhibit ..identical Km
values and turnover numbers for uridine transport. Detailed
kinetic analysis of vesicles reconstituted with crude human
erythrocyte membrane extract and with the human erythrocyte
band 4.5 preparation has revealed that these assumptions are
not valid, there being a 2.2-fold difference in turnover
number for uridine transport by the reconstituted crude
membrane extract (1.8 molecules per site per s at 15°C for
zero-trans influx) compared with that for the partially-
purified transporter preparation (4.0 molecules per site per
s) (Chapter 4). In addition, the apparent Km values for
uridine transport by the two reconstituted preparations are
similar, but not identical. Mean apparent Km are 0.18 mM
and 0.25 mM for the reconstituted crude membrane extract and
the reconstituted partially-purified band 4.5 preparation,
respectively (see Chapter 4, Section 4.3.1b and Table 4.6).
Taking these two differences into account, it can be
calculated that measurements of uridine transport activity
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at 50 uM extravesicular concentration overestimate the
degree of purification achieved by a factor of 1.5. This is
exactly the discrepancy noted in Table 3.3 and 5.1. In
other words, there is a very close correspondence between
the two estimates (transport activity and ligand binding) of
transporter purification. My results therefore provide
strong evidence that NBMPR binding and uridine transport are
mediated by the same membrane component.
7.4 LIPID DEPENDENCE OF ERYTHROCYTE NUCLEOSIDE
TRANSPORTERS
Transport activity of the reconstituted human
erythrocyte nucleoside transporter diminishes upon
reconstitution to 6-7% relative to intact erythrocytes when
assayed under zero-trans conditions and 18% when assayed
under equilibrium exchange influx conditions (see Chapter
4). It has been established that the transport proteins are
reconstituted into proteoliposomes with high efficiency by
freeze-thaw-sonication and that most of the transporters
retain their ligand binding activity after reconstitution
(see also Chapter 4). It is therefore envisaged that the
reconstituted nucleoside transporter functions at a much
lower rate than in intact erythrocytes. Consistent with
this conclusion is the observed reduction in the mobilities
of both the loaded and empty carriers in the reconstituted
state. The decrease in transport activity of the
reconstituted transporter is likely to reflect the change of
transporter lipid environment. This view is supported by
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the 2.2-fold lower turnover number observed for the
reconstituted crude membrane extract compared with that for
the partially-purified transporter preparation (Chapter 4),
the latter preparation depending only partially on exogenous
lipid for activity (Chapter 3). In other words, the human
erythrocyte nucleoside transporter exhibits only 3-4%
transport activity with respect to intact erythrocytes when
reconstituted in crude membrane extracts and assayed under
zero-trans conditions.
The transport activity of the purified human
erythrocyte glucose carrier is also reduced upon
reconstitution (Baldwin et al, 1981 Sase et al, 1982).
Thus, the reconstituted glucose transporter exhibits 5%
transport activity relative to intact erythrocytes when
assayed under equilibrium exchange influx conditions
(Baldwin et al, 1981), but only 0.5% activity when assayed
under zero-trans conditions (Kasahara and Hinkle, 1976
Wheeler and Hinkle, 1981). By analogy with the
reconsitituted nucleoside transport system, the difference
in transport activity observed between zero-trans and
equilibrium exchange conditions is likely attributable to
the mobility of the empty carrier being more severely
retarded than that of the loaded carrer. Recently.* Tefft
et al (1986) have demonstrated that the transport activity
of the reconstituted glucose transporter can be modulated by
altering the composition of lipid bilayer.
It has also been established that the high affinity
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NBMPR binding, activity of nucleoside transporters is
dependent upon lipid. Thus, the partially-delipidated pig
erythrocyte nucleoside transporter (see Chapter 5) exhibits
a 5.1 fold increase in apparent Kd for high-affinity NBMPR
binding compared with that for the corresponding crude
membrane extract (Kwong et al, 1987) (7.2 vs 1.4 nM).
Adjustment of the chromatography conditions so that the
transporter is eluted in the column void volume along with
the majority of the solubilised lipid reduces the apparent
Kd to 3 nM (Kwong et al, 1987). Similarly, the partially-
purified human erythrocyte nucleoside transporter exhibits
an apparent Kd (2.4 nM) significantly higher than that of
the membrane ghosts (1 nM) (Jarvis and Young, 1981). Also,
NBMPR-binding activity is reversibly inhibited in the
presence of detergent (Jarvis and Young, 1981). These
findings suggest that lipid environment plays a key role in
determining nucleoside transporter function. My preliminary
reconstituted experiments with liposomes of differing lipid
composition (Chapter 4) support this view and it appears
that the nature of the polar phospholipid headgroup plays a
key role in determining the activity. Interestingly,
phospholipid head group is also a major.. modulator of
transport activity of the reconstituted human erythrocyte
glucose transporter. This is followed in order of
importance by lipid acyl chain length and
saturation/unsaturation > lipid backbone> bilayer
'fluidity' (Tefft et al, 1986).
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7.5 CHOICE OF PERMEANT FOR NUCLEOSIDE TRANSPORTER
RECONSTITUTION STUDIES
Uridine was used as the permeant for the reconstitution
experiments described in this Thesis. Uridine was selected
in preference to other nucleosides because its kinetics of
transport into intact erythrocytes have been extensively
studied. The kinetic parameters obtained in the
reconstituted system could therefore be compared directly
with published values for the intact cells. Transport of
uridine into reconstituted vesicles was inhibited by
adenosine and inosine, suggesting that the reconstituted
nucleoside transporter is of broad specificity, a conclusion.
consistent with observations in intact erythrocytes (Jarvis
and Young, 1983). This property of the reconstituted
transporter was confirmed by the direct demonstration of
inhibitor-sensitive transport of adenosine and inosine in
reconstituted vesicles (Chapter 4). As shown in Fig. 4.1 of*
that Chapter, the large magnitude of NBTGR-insensitive
uptake of adenosine makes this nucleoside unsuitable for
reconstitution studies. As might be expected, my attempts to
demonstrate carrier-mediated adenosine uptake by the
reconstituted lung nucleoside transporter were unsuccessful
(data not shown). In contrast, ino.sine has a 3-fold lower
basal permeability than uridine, making it an. attractive
alternative permeant for reconstitution experiments.
121
7.6 FUTURE TRENDS
It is envisaged that purification, photoaffinity
labelling, reconstitution and gene cloning approaches will
be widely used in future studies of the NBMPR-sensitive
nucleoside transport system. Recently, NBMPR-insensitive
and the Na -dependent nucleoside transport systems have also
been identified in mammalian cells (Le Hir and Dubach, 1984
Schwenk et al, 1984 Jakobs and Paterson, 1986). Further
kinetic and inhibition experiments will provide useful
information on the. functional properties of these transport
systems. Structural studies could then be extended to these
transport systems so as to resolve the molecular and
evolutionary relationships between different functional
classes of nucleoside transporter.
7.6.1 Purification
1. Further purification of the nucleoside transporter from
pig erythrocytes. Gradient-elution ion-exchange chromato-
graphy has allowed a 140-fold partial purification of the
erythrocyte nucleoside transporter from this species
(Chapter 5) (Kwong et al, 1986). However, the pig
preparation is not homogeneous and consists of two
detectable protein' bands, the higher molecular weight
species co-migrating with [3H]NBMPR-labelled protein and the
lower band of Mr 43,000. Further fractionation experiments
will be required to remove the lower molecular weight
protein. Possible approaches include electro-elution from
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SDS-polyacrylamide gels, affinity chromatography and immuno-
affinity chromatography. In this way it is hoped that the
pig erythrocyte nucleoside transporter can be purified to
homogeneity.
2. Immunoaffinity chromatography. This approach has
considerable potential for purification the nucleoside
transporters from both human and pig erythrocytes. Thus,
specific antibodies to the glucose transporter (Boyle et al,
1985) could be used to negatively purify the nucleoside
transporter from human erythrocyte band 4.5 polypeptides.
Preliminary experiments have demonstrated a 76-fold
enrichment of human erythrocyte nucleoside transporter by.
this method (Kwong et al, 1986), a value which is 6-fold
greater than that achieved by ion-exchange chromatography
(Jarvis and Young, 1981). Also, monoclonal antibodies
directed against the pig erythrocyte nucleoside transporter
are now available (Good et al, 1986). It should be
possible to couple these antibodies to an appropriate
support (e. g. Affi-gel 10) and attempt direct purification
of the pig nucleoside transporter. Unfortunately, these
pig monoclonal. antibodies do not cross react with other
species (Good et al, 1986). Their application to studies of
nucleoside transporters from other. species is therefore
limited. Therefore, production of specific cross-reactive
polyclonal/monoclonal antibodies to the pig/human
erythrocyte nucleoside transporters should. be attempted.
This will provide invaluable tools for study of the
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structure and cell biology of nucleoside transporters.
7.6.2 Photoaffinity Labelling Experiments
Phtoaffinity labelling experiments using NBMPR have
been extended to a variety of other cell types and tissues,
providing evidence that NBMPR-sensitive nucleoside
transporters from different sources have broadly similar
molecular weights to that of the human erythrocyte system.
It is envisaged that this technique will continue to prove
useful in the characterisation of NBMPR-sensitive nucleoside
transporters from different sources. The technique of
photoaffinity labelling will also be widely used in future
purification studies (see Chapter 5). Development of
appropriate photolabile substrate probes will provide
invaluable tools for identification and characterisation of
membrane component(s) responsible for NBMPR-insensitive and
Na+-dependent nucleoside transport. They may also resolve
the controversial problem of whether NBMPR binds to the
permeation site on the NBMPR-sensitive nucleoside
transporter.
7.6.3 Reconstitution Studies
Any further purified protein-preparations will need to
be incorporated into proteoliposomes and assayed for
nucleoside transport activity. Where appropriate, glucose
transport assays will also be required to test- the
homogeneity of the preparation.
,Activities of many integral membrane proteins are
governed by their lipid environment (see e.g. Stubbs and
124
Smith, 1984). As shown in Chapter 4, reconstituted
nucleoside transport activity can also be modulated by
modification of its lipid environment. Effects of lipid
modulation on appropriate reconstituted transport parameters
(e. g. Km and turnover number) should be systematic analysed
with respect to bilayer factors such as lipid head group,
livid acyl chain length, saturation and unsaturation, and
lipid. backbone.
7.6.4 Amino Acid Composition and Sequence of the Nucleoside
Transporter
The purified nucleoside transporter (e. g. pig, human)
should be subjected to controlled proteolysis (e. g. trypsin
digestion) (Janmohamed et al, 1986) and the resulting
polypeptides. separated and analysed for N-,.' C-terminals,
amino acid composition and sequence. Such experiments will
not only generate a partial amino acid sequence for the
transporter, but also provide information for the
construction of cDNA probes for gene cloning studies (see
below).
7.6.5 Gene Cloning
The complete amino acid sequence- IIof the nucleoside
transporter can be determined by recombinant DNA techniques.
For example, antibodies against the purified nucleoside
transport, protein can be used to screen a. HepG2 cDNA'
library in the expression vector gt11 (Young and Davis,
1983) for recombinant phage that expres-s nucleoside
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transporter antigenic determinants (Mueckler et al, 1985).
Polycloncal antibodies will be more useful in preference to
monoclonal antibodies since they recognise a variety of
antigenic determinants and are therefore more successful
than those raised against a single determinant. The
positive clones identified will almost certainly contain
cDNA inserts less than the full length clone containing the
entire coding region of the protein. The largest insert
would therefore be labelled by nick-translation and used as
a hybridization probe. Eventually, it should be possible to
isolate a cDNA clone containing a full length copy of the
mRNA. The amino acid sequence of the protein can then-.
deduced from the cDNA sequence and the arrangement of the
polypeptides in the lipid bilayer constructed from
appropriate hydropathy plots (Mueckler et al, 1985). If
the partial amino acid sequence of the nucleoside transport
protein is known (see above), an appropriate cDNA probe can
be constructed to initiate screening of the cDNA library
directly.
APPENDIX 1




Facilitated transport of D-glucose has been extensively
studied both in mammalian and avian erythrocytes. Human
erythrocytes and fetal erythrocytes from other mammalian
species are capable of rapid, stereoselective transport of
glucose (Widdas, 1980). In contrast, pig erythrocytes are
totally deficient in glucose transport activity, the cells
relying on plasma inosine as their physiological energy
substrate (Jarvis et al, 1980a Young et al, 1985 1986).
Mature, adult-type erythrocytes from sheep.and other non-
primate species exhibit intermediate rates of stereospecific
glucose transport (Mooney and Young, 1978 Albert, 1984
Wagner et al, 1984). In most cases, glucose uptake is
inhibited by cytochalasin B. However, in rabbit
erythrocytes, carrier-mediated D-glucose., transport is
cytochalasin B-insensitive (Regan and Morgan, 1964 Albert,
1984). A stereoselective, cytochalasin B-sensitive glucose
transporter has also been characterised in avian
erythrocytes. Transport of glucose in these cells, in
contrast to mammalian erythrocytes, is stimulated by anoxia
and catecholamines (Whitfield and Morgan, 1973 Whitfield et
al, 1974).
By contrast, there are only two published studies of
sugar transport in fish erythrocytes. Ingermann et al
(1984) reported a high cytochalasin B-sensitive glucose
transport activity in erythrocytes from the Pacific hagfish
(Eptatretus stouti), a representative of the most,primitive
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group of living vetebrates. In an earlier study, Boils et
al (1971) were unable to demonstrate stereospecific glucose
uptake in erythrocytes from the brown trout (Salmo trutta).
The possibility that pig erythrocytes may not be unique with
respect to glucose transport-deficiency led me to
investigate sugar transport in fish erythrocytes in more
detail. This Appendix presents a study of non-metabolised
3-0-methyl-D-glucose (3-0MG) transport in erythrocytes from'
three different fish species (Anguilla japonica, Monopterus
albus and Salmo gairdneri). Erythrocytes from the yellow
eel and rainbow trout (M. albus and S. gairdneri,
respectively) were found to be totally deficient with
respect to cytochalasin B-sensitive 3-0MG transport activity
and catecholamines had no effect on sugar transport in these
cells. In contrast, erythrocytes from the white eel (A.
japonica) exhibited highly variable rates of cytochalasin B-
sensitive 3-0MG transport ranging from 0-19.5 mmol/l. cells
per h (5 mM extracellular sugar, 20°C) in different fish.
Cytochalasin B-sensitive 3-OMG-uptake in this species was




White eels (Anguilla japonica) and yellow eels
(Monopterus albus) were obtained locally in Hong Kong and
maintained in fresh-water aquaria. Rainbow trout (Salmo
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gairdneri) were obtained from a commercial source in
Cambridge, U.K. and also maintained in fresh water aquaria.
Fish were not fed while in captivity. It should noted that
yellow eels are only 'eel-like' in appearance, belonging to
an completely different order of synbranchiformes.
A1.2.2 Cell Collection and Preparation
Fish were bled from the dorsal aorta and blood samples
were collected into heparin. Erythrocytes were washed free
of plasma by three washes in a mediumn containing 150 mM
NaCl, 5 mM D-glucose and 15 mM MOPS (pH 7.5 at 20°C). The
buffy coat was discarded. The washed cells were
resuspended to a haematocrit of approximately 10% and left
overnight at 4°C. This was to ensure that the cells were at
a steady-state with respect to the incubation medium and not
in a catecholamine-stimulated condition (Bourne and Cossins,
1982).
A1.2.3 Haemoglobin Estimation
The haemoglobin content of cell suspensions was
determined by absorbance measurements of cyanmethaemoglobin
(1:50 dilution with Drakin's solution (100 mg NaCN and 300
mg K3Fe(CN)6 per 1. distilled water) at 540 nm. This value
was used to estimate the volume of cells in the original
suspension, calculated from an experimentallly-determined
extinction coefficient for packed erythrocytes of 218 for
fish erythrocytes. There was no significant difference
(Students' t test) in the value of this coefficient between
the three different species of fish. The coefficients
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obtained for A. japonica, M. albus and S. gairdneri were
220+4, 213+6 and 221+5, respectively (mean+S.E.(5)).
A1.2.4 ATP Assays
Erythrocyte ATP content was determined by a firefly
luciferin-luciferase assay as described by Brown (1982).
A1.2.5 Transport Measurements
The experiments were performed at 20°C using an
isotonic incubation medium containing 150 mM NaCl and 15 mM
MOPS (pH 7.5). Uptake of 3-0-methyl-D-[U-14C]glucose was
initiated by mixing equal volumes (0.15 ml) of prewarmed
cell suspension (haematocrit 20%) with incubation medium
containing the appropriate concentration of radioactive
permeant (0.7 uCi/ml). For incubations in the presence of
cytochalasin B or phloretin, cells were equilibrated with
inhibitor for 30 min at 20°C before addition of 3-0-methyl-
D-[U- 14C] glucose-containing medium. Uptake was terminated
by addition of 1 ml ice-cold stopping solution (150 mM NaCl,
15 mM MOPS, 1.25 mM KI, 1 uM HgCl22 100 uM phloretin (pH
7.5)) (Weiser et al, 1983). Cells were rapidly washed 4
times with 1 ml portions of ice-cold stopping solution using
an Eppendorf 5414 microcentrifuge (10 s, 12,000x0. The
washed cell pellets were finally lysed with 0.5 ml 0.5%
(v/v) Triton X-100 in water and 0.5 ml 5% •(w/v)
trichloroacetic acid was added. The precipitates were then
removed by centrifugation (12,000xg for 2 min) and 0.9 ml
aliquots of protein-free supernatant counted for
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radioactivity by-scintillation spectroscopy with appropriate
quench correction.
A1.3 RESULTS
A.1.3.1 Variable 3-0-Methyl-D-glucose Transport in Eel (A.
Japonica) Erythrocytes.
A.1-3-1a Time course of 3-0MG uptake
Representative time courses of 3-0MG uptake (5 mM,
extracellular concentration) by erythrocytes from two
different eels, measured both in the presence and in the
absence of 10 uM cytochalasin B, are shown in Fig. A1.1.
Cells from both fish exhibited cytochalasin B-sensitive and
1
cytochalasin B-insensitive components of 3-0MG uptake
However, there was a considerable difference in the
cytochalasin B-sensitive uptake rate in-the two animals,
cells from fish A exhibiting an initial rate of cytochalasin
B-sensitive 3-0MG uptake of 6.9 mmol/l. cells per h compared
with 1 mmol/l. cells per h for erythrocytes from the second
eel (fish B), a difference of 7-fold. In contrast,
(cytochalasin B-insensitive 3-0MG uptake rates were similar
in the two fish (0.16 and 0.15 mmol/l.. cells per h for
1. Cytochalasin B-sensitive 3-OMG'uptake is defined as the
the difference in uptake measured in the presence and In the.
absence of 10 uM cytochalasin B. Cytochalasim B-insensitive
5-OMG uptake is defined as the residual uptake observed in
the presence of 10 uM cytochalasin B.
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Uptake of 3-0MG (5 mM extracellular-concentration, 20°C) was
measured in erythrocytes from two representative eels (A.
japonica) both in the absence() and in the presence()
of, 10 uM cytochalasin B. See text for other experimental






erythrocytes from eels A and B, respectively).
Intracellular[ 14C]-3-0-methyl-D-glucose in cells from fish
A reached a level of 2.9 mmol 3-OMG/l. cells after 2 h.
This corresponds to 89% equilibration with intracellular
water, calculated assuming that fish erythrocytes contain
66% (v/v) water (D.A. Fincham and J.D. Young, personal
communication). In contrast, the intracellular 3-0MG level
in the erythrocytes from the second eel was 1.1 mmol/l.
cells after 2 h and corresponds to 33% equilibration with
intracellular water. In subsequent experiments, a 5 min
incubation period was used to measure initial rates of 3-0MG
uptake.
A1.3.1b Distribution of 3-0-methyl-D-glucose transport
activity in erythrocytes from different eels
Fig. A1.2A shows initial rates of cytochalasin B-
sensitive 3-0MG uptake (5 mM extracellular sugar, 20°C)
measured in erythrocytes from 50 individual eels. Initial
rates of cytochalasin B-sensitive 3-0MG uptake were in the
range of 0-19.5 mmol/l. cells per h. One fish exhibited no
detectable inhibitor-sensitive sugar uptake and is defined
as transport-deficient. The remaining 49 transport-positive
type fish were divisible into three broad groups on the
basis of cytochalasin B-sensitive 3-0MG uptake rate 0.07-
1.1 (31%), 2.5-13.6 (57%) and 17.2-19.5 (12%) mmol/l.'
cells per h. Initial rates of cytochalasin B-insensitive 3-
0MG uptake were low and much less variable (0.18-0.'6 mmol/l.
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Initial rates of 3-0-methyl-D-[U- C]glucose influx (5 mM, 20°C) were
determined as in the absence and in the presence of 10 uM cytochalasin B
described in Section A1.2.5. Panel A shows the distribution of
cytochalasin B-sensitive 3-OM uptake activity. Panel B shows the
corresponding distribution for the cytochalasin B-insensitive uptake
component. Each point(•) represents the 3-0MG permeability of •the
cells from an individual fish. (0) represents data from one fish
whose erythrocytes were totally deficient in cytochalasin B-sensitive
transport activity.
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cells per h) (Fig. A1.2B). Storage of cells at 4°C in
glucose-containing medium for further periods of 24 and 48 h
had no effect on cytochalasin B-sensitive 3-0MG uptake. For
example, cells from one fish gave cytochalasin B-sensitive
uptake rates of 0.86, 0.88 and 0.85 mmol/l. cells per h (5
mM 3-0MG) after 24, 48 and 72 h storage, respectively.
Keeping the cells in plasma also had no effect on transport
activity (0.86 and 0.87 mmol/l. cells per h at 0 and 10 h
after blood was taken, repectively).
Of 20 fish tested, intracellular ATP levels ranged
from 1.7-5.2 mmol/1 cells (Fig. A1.3, see also Geoghegan
and Poluhowich, 1974), a maximum 3-fold difference.' On the
other hand, cytochalasin B-sensitive 3-0MG uptake rates
ranged from 0.12 to 17.16 mmol/l. cells' per h, 143-fold
difference. There was no correlation between sugar
permeabilities of erythrocytes from different fish and
intracellular ATP levels.
A1.3.2 Characterisation of Cytochalasin B-Sensitive 3-0MG
Transport in Eel (A. Japonica) Erythrocytes.
A1.3.2a Concentration dependence of 3-0MG uptake
Fig. Al.4 shows a typical concentration dependence
curve for 3-0MG uptake by eel erythrocyte at 20°C measured
over the concentration range 0.5-10 mM in the presence and
in the absence of 10 uM cytochalasin B. The cytochalasin B
sensitive component of 3-0MG uptake was saturable and
conformed to simple Michaelis-Menten kinetics.Kinetic
constants estimated from an v/s vs v plot were: Km 1.64 mM
Fig. A1.3 Relationship between cytochalasin B-sensitive 3-








0 5 10 15 20
Lytocnaiastn B-sensitive 3-OMG uptake
(mmol/I. cells per h)
Cytochalasin B-sensitive 3-0MG uptake rates (5 mM 3-0MG) for
erythrocytes from 20 eels (A. japonica) are plotted-against
intracellular ATP concentration as measured by the method of.
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Initial rates of 3-0MG uptake (0.5-10 mM) were measured at
20°C in the presence
cytochalasin B. Apparent Km and Vmax values for the
cytochalasin B-sensitive components of transport, estimated










and in the absence
of 10 uM
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and Vmax 9.2 mmol/l. cells per h. Cytochalasin B-
insensitive 3-0MG uptake was linear over the same
concentration range, possibly representing non-mediated
diffusion of sugar into the cells (see Section A1.3.4).
Apparent Km and Vmax values for 5 eels exhibiting a 11-
fold range in 5 mM cytochalasin B-sensitive 3-0MG transport
activity are presented in Table A1.1. Apparent Km values
differed by a maxium of 2.2 fold (range 1.6-3.6 mM) compared
with 9.2 fold for Vmax (1.0-9.2 mmol/l. cells per h). Thus,
individual variation in 3-0MG uptake activity resulted
largely from differences in Vmax of the sugar transport
system.
A1.3.2b Cross-inhibition studies
To investigate the substrate specificity of the
cytochalasin B-sensitive saturable component of 3-0MG
uptake in eel erythrocytes, various D- and L-hexoses were
tested as inhibitors of 3-0MG transport (5 mM permeant, 5
or 10 mM inhibitor at 200C). The results are presented in
Table A1.2. Of the hexoses tested, D-glucose, D-galactose
and D-deoxyglucose were found to be effective inhibitors of
cytochalasin B-sensitive 3-0MG uptake and inhibition was
concentration dependent. The degree of inhibition was in
the order of D-deoxyglucose D-glucose D-galactose and is
consistent with the relative affinities of these sugars for
the human erythrocyte sugar transport system (apparent Km of
D-deoxyglucose D-glucose D-galactose- (Naftalin and
Holman, 1977). L-Glucose, which is not a substrate for the
Table A.1.1 Summary of kinetic constants for cytochalasin B-sensitive
3-0MG transport in erythrocytes from five different eels
Cytochalasin B-sensitive
VmaxKm3-OMG uptake rate






The concentration dependence (0.5-10 mM) of 3-OM uptake by erythrocytes
from A. japonica was measured in the absence and in the presence of 10
uI1 cytochalasin B as described in the legend to Fig. A1.4. Apparent Km
and Vmax values for cytochalasin B-sensitive transport were estimated
from v/s vs v plots. The cytochalasin B-sensitive 3-OMG uptake rate was
measured at 5 mM extracellular 3-OMG as described in text.
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Various D- and L-hexoses were tested as inhibitors of
cytochalasin B-sensitive 3-0MG transport. Initial 3-0MG
uptake rates( 10 uM cytochalasin B) were measured at 5 mM
extracellular concentration in the absence and in the
presence of inhibiting sugar (5 or 10 mM) added
simultaneously. None of the compounds tested had a
significant effect on cytochalasin B-insensitive 3-0MG
uptake. Values are means of duplicate estimates. The
control cytochalasin B-sensitive uptake rate in the cells
used in this experiments was 17.2 mmol/l. cells-per h.-
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mammalian hexose transport system, had no detectable effect
on 3-0MG uptake in eel erythrocytes.
A1.3.2c Effect of cytochalasin B and phloretin on 3-0MG
uptake by eel Erythrocytes
Cytochalasin B and phloretin are potent inhibitors of
sugar transport in a number of cell types, (e. g. human,
avian and hagfish erythrocytes, muscle cells and adipocytes
(Jung and Rampal, 1977; Simons, 1983a; Wardzala et al,
1978, Ingermann et al, 1984)). Fig. A1.5 shows
concentration dependence curves for these..two compounds as
inhibitors of saturable (cytochalasin B-sensitive) 3-0MG
uptake in eel erythrocytes. IC50 values were 0.125 and 80
uM (5 mM extracellular 3-0MG) for cytochalasin B and
phloretin, respectively. To determine apparent Ki, the
results were fitted by least squares .,analysis to the
equation:
V= (VoKi/ (Ki+I))
where Vo is the inhibitor-sensitive rate; I, the inhibitor
concentration and Ki, the inhibition constant. This
equation assumes that inhibition is proportional to the
binding of inhibitor at a single class of sites (Wilkinson,
1961 Snedecor and Cochrane, 1967; Simons, 1983a). The
inhibition constants obtained were 0.104 0.11 uM for
cytochalasin B and 48 4 uM for phloretin. The apparent Ki
obtained for cytochalasin B compares with an. estimate of
0.1-0.2 uM for the apparent Kd of cytochalasin B binding to
human erythrocyte glucose transporter (Taylor and Gagneja,
Fig. Al-5 Inhibition of 3-0MG uptake in eel (A. japonica)
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Erythrocytes were pre-incubated in the absence and in the
presence of phloretin
at 201C. Initial rates of 3-0MG influx (5 mM) were then
measured as described in Section A1.2.5 and corrected for
the cytochalasin B-insensitive component of uptake
(determined in the presence of 10 uM cytochalasin B).
Values are the means of duplicate estimates. Control
cytochalasin B-sensitive 3-0MG uptake rates were 1.6 and 1.2
mmol/l. cells per h for the cytochalasin B and phloretin
inhibition experiments, respectively. Phloretin (500 uM)





or cytochalasin B for 30 min
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1975 Jung and Rampal, 1977). In contrast, the apparent Ki
for' phloretin inhibition of glucose transport in human
erythrocytes is 0.5-2.5 uM (Jennings and Solomon, 1976
Krupka, 1985), a range which is 20-100-fold lower than the
apparent Ki observed in fish erythrocytes. Similar high
apparent Ki values (27.6-42.7 uM) for phloretin inhibition
of sugar transport have been reported for avian erythrocytes
(Simons, 1983a).
A1.3.3 Effects of Catecholamines on 3-0MG Transport in Eel
(A. Japonica) Erythrocytes
A1-3-3a Time course of 3-0MG transport in eel erythrocytes
in the presence and in the absence of nor-
adrenaline
As in avian erythrocytes (Whitfield et al, 1974), 3-0MG
uptake by eel erythrocytes was increased by catecholamines.
Fig. A1.6 shows typical time. courses of 3-0MG uptake in
noradrenaline-treated (100 uM, 2 h preincubation) and
control (untreated) erythrocytes measured in the absence and
in the presence of 10 uM cytochalasin B. The cytochalasin
B-sensitive 3-0MG uptake rate in noradrenaline-treated cells
was increased from 0.7 to 2.2 mmol/l., cells per h. In
contrast, the cytochalasin B-insensitive component of
transport remained unchanged.
Fig. A1.6 Effect of noradrenaline on the time-course of 3-






Uptake was measured at 20°C and 5 mM extracellular 3-0MG in
the presence (open symbols) and in the absence (closed
symbols) of 10 uM cytochalasin B.
erythrocytes preincubated for 2 h in the absence of
catecholamine,






cells pre-incubated in the presence
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A1.3.3b Time and concentration dependence of catecholamine
stimulation of 3-0MG transport
The magnitude of catecholamine stimulation of
cytochalasin B-sensitive 3-0MG transport depended both upon
the period of exposure to catecholamine and upon the
catecholamine concentration (see also Whitfield et al,
1974). Noradrenaline and adrenaline were equally
effective, maximum stimulation occuring at concentration in
the range 50-100 uM (Fig. A1.7). There was no detectable
stimulation of 3-0MG transport at catecholamine
concentrations below 0.01 uM and half-maximal stimulation
occured at 1 uM. This catecholamine concentration is
similar to that required to half-maximally stimulate 3-0MG
uptake into goose erythrocytes as reported by Whitfield et
al (1974). As shown in Fig. A1.8, catecholamine'stimulation
of eel erythrocyte transport activity increased
progressively with time, reaching a maxium after 2 h, the
preincubation period used in previous and subsequent
experiments.
Table A1.3 summarises a series of catecholamine
stimulation experiments on 7 individual fish arranged in the
order of increasing basal cytochalasin B-sensitive 3-0MG
uptake activity. Interestingly, the one fish which
exhibited no detectable 3-0MG uptake (Fig. A1.2) did not
respond to catecholamine stimulation. Fish 2-7 showed.
variable 3-0MG uptake rates in the range 0.24'-9.51 mmol/..
cells per h (5 mM 3-0MG) and were sensitive to catecholamine
stimulation. However, there was no obvious correlation
Concentration dependence or catecnoiamineFig. Al .7
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Cells were pre-incubated with varying concentrations
-10 -2
(10 -10 M) of adrenaline
for 2 h. Initial rates of 3-0MG transport (5 mM) were then
measured as described in text. Catecholamine-sensitive 3-
0MG uptake rates were calculated as the difference in uptake
rate measured in control cells incubated in the absence of










Fig. Al .8 Effect of preincubation time on catecholamine-
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Erythrocytes were preincubated at 20°C with 100 uM of
either noradrenaline
length of time. After incubation, initial rates of
cytochalasin B-sensitive 3-0MG uptake (5 mM) were measured
as described in the text. Catecholamine sensitive 3-0MG
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This table summarises a series of catecholamine-stimulation experiments
from seven individual fish, each exhibiting different basal cytochalasin
B-sensitive 3-0MG uptake activities. Cells were treated with adrenaline
or noradrenaline (both at 100 uM) for 2 h before assay of initial rates
of cytochalasin B-sensitive 3-OM transport at an extracellular
concentration of 5 mM. Results are means of duplicate estimates.
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between the basal cytochalasin B-sensitive flux and that
induced by maximal catecholamine stimulation (100 uM, 2 h
preincubation). The average increases in initial rate of
cytochalasin B sensitive 3-0MG uptake were 0.56+0.06 and
0.57+0.11 mmol/l. cells per h in the presence of adrenaline
and noradrenaline, respectively. Catecholamine-induced
stimulation of sugar transport in transport-positive type
fish was, therefore, independent of the basal cytochalasin
B-sensitive 3-0MG permeability of the cell.
A1.3.3c Concentration dependence of '3-OMG uptake by
noradrenaline-treated and control eel erythrocytes
Fig. A1.9 compares the concentration dependence of 3-
0MG uptake (range 0.05-5mM) in control cells and cells
preincubated with noradrenaline. Cytochalasin B-sensitive
3-0MG uptake in both noradrenaline-treated and control cells
was saturable' and conformed to simple Michaelis-Menten
kinetics. Kinetic constants estimated from the v/s vs v
,plots were: Km 1.88 and 1.75 mM and Vmax 2.8 and 1.0 mmol/l.
cells per h for noradrenaline-treated and control cells,
respectively, an 2.8-fold increase in Vmax with no
significant change in Km. In agreement with the results
presented in Fig. A1.6, catecholamines had no effect on
cytochalasin B-insensitive 3-0MG uptake.
A1.3.4 Uptake of D- and L-Glucose by Eel (A. Japonica)
Erythrocytes
Table Al.4 shows that, in addition to cytochalasin B-
Fig. A1.9 Concentration dependence of 3-0MG uptake by
noradrenaline-treated and control eel (A.
Japonica) erythrocytes.
Cells were incubated for 2 h at 20°C in the absence and in
the presence of 100 uM noradrenaline. Initial rates of 3-
0MG uptake (0.5-5 mM) were measured as described in text.
Symbols: control erythrocytes, biradrenaline-
treated erythrocytes, control erythrocytes + 10 uM
cytochalasin B, noradrenaline-treated erythrocytes + 10
uM cytochaladin B. Kinetic constants for adrenaline-treated
and control erythrocytes estimated from plots
were: 1.88 and 1.75 mMand 2.8 and 1.0 mml1/1.
cells per h, respectively.
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sensitive 3-0MG uptake, eel erythrocytes exhibited
cytochalasin B-sensitive, stereospecific transport of
glucose. The observed cytochalasin B-sensitive D-glucose
uptake rate (5.85 0.01 mmol/l. cells per h at 5 mm
extracellular D-glucose) was similar to that for 3-0MG
uptake in the same cells (6.9 0.1 mmol/l. cells per h) and
was equivalent to the stereospecific glucose uptake rate of
5.91 0.1 mmol/l. cells per h, defined as the difference in
permeability between D- and L-glucose. L-Glucose uptake
was not inhibited by cytochalasin B (0.09 0.01 and 0.08+0.01
mmol/l. cells per h in the absence and i-n the presence of
cytochalasin B, respectively). Interestingly, these L-
glucose uptake rates are approximately half of the rate of
cytochalasin B-insensitive uptake of D-glucose. In other
words, cytochalasin B-insensitive glucose uptake was
partially stereospecific. The difference between D- and L-
glucose uptake rates corresponds to 0.07 0.02 mmol/l. cells
per h. A similar observation has been made with respect to
D- and L-glucose uptake in cytochalasin B-treated pigeon
erythrocytes (Simons, 1982a).
In addition, it should be noted that the cytochalasin
B-insensitive 3-0MG uptake rate-was 5-6 fold and 10-fold
greater than that of D- and L-glucose, respectively (Table
A1.4) demonstrating that 3-0MG diffuses through the membrane
lipid bilayer faster than D- and L-glucose due to its more
hydrophobic nature (Hillman et al, 1959).
Table A1.4 D- and L-glucose uptake by eel (A. japonica)
erythrocytes.
Uptake rate
(mmol/1. cells per h)




Initial rates of 3-OMG, D-, or L-glucose uptake (5 mM extracellular
concentration) were measured in the absence and in the presence of 10 uM
cytochalasin B. Values(+ S.E.) are means of triplicate estimates for
cells from one fish. represents the difference in the uptake rate
measured in the presence and in the absence of 10 uM cytochalasin B.
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A1.3.5 Sugar Uptake in Yellow Eel (M. Albus) and Rainbow Trout
(S. Gairdneri) Erythrocytes
As detailed in preceeding sections of this Appendix, erythrocytes
from individual A. japonica exhibit considerable variation in
cytochalasin B-sensitive sugar permeability. These experiments were
extended to two other species of fish. As shown in Table A1.5,
erythrocytes from the yellow eel (M. albus) and rainbow trout (S.
gairdneri), like the brown trout (Bolis et al, 1971), exhibited no
detectable cytochalasin B-sensitive 3-OM uptake either in the absence
or in the presence of 100 uM catecholamines. Similarly, D-glucose
uptake by erythrocytes from M. albus was not inhibited by cytochalasin B
(see also Table A1.5). In agreement with the data for cytochalasin B-
insensitive D- and L-glucose uptake in A. japonica (Table A1.4), D-
glucose uptake by yellow eel cells was greater than that for L-glucose,
although the magnitudes of the fluxes were smaller. This observation
eliminates the possibility that the A. japonica difference was due to
incomplete inhibition of saturable D-glucose uptake by cytochalasin B.
A1.4 DISCUSSION
Of the three species of fish examined, erythrocytes from both
the yellow eel (M. albus) and the rainbow trout (S. gardneri)
exhibited uniformly. low rates of 3-ONE uptake in the range 0.10-
0.15 mmol/l. cells per h (5 mM extracellular 3-OM, 20°C). D-glucose
uptake rates in M. albus were lower, with a mean value of approximately
50 umol/l. cells per h at 5 mM extracellular D-glucose. Sugar
Table A1.5 Sugar uptake in yellow eel (M. albus) and rainbow trout
(S. aairdneri) erythrocytes.
Uptake rate
(mmol/l. cells per h)


















Uptake'of 3-OMG, D- and L-glucose were measured at 5 mM extracellular
concentration in the presence and absence of 10 uM cytochalasin B. For
catecholamine-treated cells, erythrocytes were preincubated with 100 uM
noradrenaline for 2 h. Values(+ S.E.) are means of triplicate
estimates for erythrocytes from n fish. -represents the
cytochalasin B-sensitive uptake rate.
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uptake in erythrocytes from these two species was not
inhibited by cytochalasin B and was insensitive to
catecholamine stimulation. Erythrocytes from one white eel
(A. japonica) were also transport-deficient with respect to
cytochalasin B-sensitive 3-OMG uptake. In marked contrast,
erythrocytes from other white eels exhibited significant,
highly variable rates of cytochalasin B-sensitive 3-OMG
transport in the range 0.07-19.5 mmol/l. cells per h when
assayed under identical conditions. This variability was
not seasonal, did not depend upon the time animals were
retained in aquaria before bleeding or upon the length or
weight of the eels and was not correlated with intracellular
ATP levels.
The stress hormones adrenaline and noradrenaline are
released into the fish blood stream during handling and
bleeding and have been shown to stimulate erythrocyte ion
transport and cause cell swelling (DeVries and Ellory, 1981
Bourne and Cossins, 1982). A similar phenomenon occurs in
avian species (Kregenow, 1975) and catecholamines have shown
to increase cytochalasin B-sensitive sugar trasport in both
pigeon and goose erythrocytes (Whitfield and Morgan, 1973
Whitfield et al, 1974 Bihler et al 1982). However,
catecholamine effects cannot account for the variation in 3-
OMG uptake rates seen in the present study. Erythrocytes
were washed free of plasma and stored overnight in glucose-
containing medium at 4°C before assay of transport
activities (see METHODS). In addition, although the-cells
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were sensitive to catecholamine stimulation, the magnitude
of the catecholamine-induced increase in 3-0MG transport was
independent of the basal cytochalasin B-sensitive 3-0MG
permeability of the cells (Table A1.3). Fresh cells stored
either in plasma or in buffer showed equivalent rates of 3-
0MG transport. Cells from the one white eel which were
totally deficient with respect to cytochalasin B-sensitive
3-0MG transport did not respond to catecholamine
stimulation. It is therefore likely that erythrocytes from
A. japonica exhibit genetically-determined variation with
respect to cytochalasin B-sensitive sugar transport and
therefore represent an intermediate situation between the
hagfish whose erythrocytes exhibit a high cytochalasin B-
sensitive sugar permeability (Ingermann et al 1984) and the
yellow eel and rainbow trout whose erythrocytes are devoid
of cytochalasin B-sensitive transport activity.
Erythrocytes from the brown trout are also likely to be
transport-deficient (Bolis et al 1971). Genetically-
controlled transport polymorphisms have been identified in
erythrocytes from a numbers of mammalian species. These
include amino acid transport in sheep and horse erythrocytes
(Young et al. 1975 Fincham et.al, 1985), cation transport
in erythrocytes from sheep, goat, cattle, buffaloes and dogs
(Tucker, 1971 Ellory, 1977 Ellory and Tucker, 1983),
nucleoside transport in sheep erythrocytes (Young,- 1978
1983) and sugar transport in cattle erythrocytes.
Cytochalasin B-sensitive 3-0MG transport in
erythrocytes from A. japonica was shown to be saturable
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(apparent Km 2.2 mM), inhibited by other D-hexoses (but not
by L-glucose) and by phloretin. In these respects the
system resembles sugar transporters in both avian and
mammalian erythrocytes. Direct transport experiments with
D- and L-glucose provided further evidence of
stereospecificity. As shown in Table A1.1, transport
variation between erythrocytes from different fish was a
consequence of differences in Vmax rather than Km. As in
avian erythrocytes, the transporter was stimulated by
catecholamines. The mechanism of stimulation remains to be
investigated. Kinetically, catecholamines increased the
Vmax of transport without changing apparent Km. It seems
likely that this effect results from a modification of the
intrinsic properties of carriers already in the cell
membrane rather than as a consequence of recruitment of
transporters from an intracellular pool as occurs with
insulin (Cushman and Wardzala, 1980 Suzuki and Kono, 1981).
Whitfield et al, (1974) reported that catecholamine
stimulation of sugar transport in avian erythrocytes is,
associated with a lowering of intracellular ATP. This
effect is not mediated though the B-adrenergic receptor.
Stimulation of sugar transport in avian 'erythrocytes can
also be brought about by metabolic depletion or increased
cytoplasmic Cat (Whitfield and Morgan, 1973; Bihler et al,
1982,' 1985 Simons, 1982a, b). These effects ar'e
interrelated since metabolic depletion leads to lower
intracellular ATP levels and also Cat release from
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intracellular stores while high intracellular Ca+2 enchances
ATP depletion by stimulation of the Ca+2 pump (Bihler et al,
1985). It remains controversial whether ATP depletion
stimulates sugar transport directly or via changes in
cytosolic Ca+2. Recently, Carruthers (1986 a, b)
demonstrated that ATP reduces both the apparent Km and Vmax
for- D-glucose uptake in human erythrocyte 'ghosts' (Hebert
and Carruthers, 1986), providing direct evidence for ATP
modulation of sugar transport. This may be mediated by
phosphorylation of the transporter (Witters et al, 1985)
and/or through an allosteric modifier sites for ATP
(Carruthers, 1986a,b).
Physiological catecholamine concentrations in fish
plasma may rise to 0.5-1.5 uM during stress (Mazeaud and
Mazeaud, 1981 Bourne and Cossins, 1982). Such
catecholamine levels would be sufficient to induce a half-
maximal stimulation of glucose transport activity (Fig
A1.7), raising the possibility that erythrocyte glucose
permeability may increase in vivo in response to prolonged
stress. In contrast to trout cells (Bourne and Cossin,
1982), erythrocytes from the white eel do not swell in the
presence of adrenaline or noradrenaline (D.A. Fincham,
personal communication). Changes in glucose transport
activity are therefore not a consequence of cell volume
changes.
As detailed in Section A1.3.4, cytochalasin B-
insensitive sugar transport in fish (and avian) erythrocytes
is partially stereospecific, D-glucose permeability being
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significantly higher than that for L-glucose. It has been
suggested that this pathway may reflect stereoselective
diffusion of glucose across the lipid bilayer (Simons,
1983a). However, as noted in Fig. 5.4 of that Chapter of
this Thesis, D- and L-glucose exhibit equivalent
permeability coefficients in phospholipid vesicles.
Similarly, pig erythrocytes exhibit equivalent rates for
cytochalasin B-insensitive D- and L-glucose transport (Young
et al, 1985). An alternative possibility is that a
component of this flux in fish and avian erythrocytes
represents mediated transport via a cytochalasin B.-
insensitive transport system. Cytochalasin B-insensitive
sugar transport has been observed in rabbit erythrocytes
(Regan and Morgan, 1964; Albert, 1984). Rates of
cytochalasin B-insensitive uptake of 3-0MG and D- and L-
glucose in A. joponica were significantly higher than the
correseponding fluxes in M. albus and S. gairdneri.
For M. albus, measured rates of D-glucose uptake are
similar to those reported previously for mature pig
erythrocytes (Young et al, 1985, 1986). For pig
erythrocytes, this low glucose permeability is insufficient
to maintain normal ATP:ADP ratios (Kim and McManus, 1971
Young et al, 1985). In contrast to mammalian erythrocytes,
and by analogy with avian erythrocytes, fish erythrocytes
have the potential to metabolise glucose via TCA cycle
(Kregenow, 1975). However, additional sources of metabolic
energy may still be required. One potential candidate is
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inosine, the physiological energy source used by pig
erythrocytes (Jarvis et al, 1980a; Young et al, 1985; 1986).
Preliminary experiments have established that erythrocytes
from both eel species are capable of rapid NBMPR-sensitive
nucleoside transport (approximately 2x105 transporter per
cell as determined by [3H]NBMPR binding).
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[G-sH]NBMPR (specific radioactivity, 17-37 Ci/mmol and
98% radiochemically pure) was purchased from Moravek
Biochemicals, Brea, CA. [2- 14C] Uridine (specific
radioactivity, 53 mCi/mmol and 98% radiochemically pure),
D-[U- 14C] glucose (specific radioactivity, 278 mCi/mmol and
14
98% radiochemically pure), L-[1- C]glucose (specific
radioactivity, 58 mCi/mmol and 98% radiochemically
pure), 3-0-methyl-D-[U-14C]glucose (specific radioactivity,
295 mCi/mmol and >98% radiochemically pure), [U- 14C]-
adenosine (specific radioactivity, 500 mCi/mmol) and
[8- 14C] inosine (specific activity, 57 mCi/mmol) were
purchased from The Radiochemical Centre, Amersham,
Buckinghamshire, United Kingdom.
A2.2 CHEMICALS
Soybean phospholipid (Asolectin) was obtained from
Associated Concentrates, Woodside, NY, USA. Nonradioactive
NBTGR was a generous gift from Professor A.R.P. Paterson,
Cancer Research Group (McEachern Laboratory), University of
Alberta, Edmonton, Alberta, Canada. Dilazep was a gift from
Hoffmann La Roche and Co., Basel, Switzerland.
Dipyridamole, (2,2' ,2'' ,2 '-(4,8-dipiperidinopyrimido [5,4-
d]pyrimidine-2,6-diyldinitrilo) tetraethanol) (Persantin
injection) was provided by Boehringer Ingelheim, Bracknell,
Berkshire, United Kingdom. Molecular weight standards for-
SDS-polyacrylamide gel electrophoresis, ammonium persulphate
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and TEMED, acrylamide ( 99.9% pure), Bio-beads SM-2 were
from Bio-Rad Laboratories, Richmond, California, USA. Sodium
dodecyl sulphate (lauryl) (sequanal grade) was from Pierce
Chemical Company, Rockford, Illinois, USA. EDTA, EGTA,
sodium dodecyl sulphate, trichloacetic acid were from E.
Merck, Darmstadt, F.R.G.. Sodium phosphate and ammoium
sulphate were from Riedel-de Haen, Seelze, Switzerland.
Dextran T-70 from Pharmacia Fine Chemicals, Hounslow,
Middlesex, U.K. Non-radioactive. adenosine, uridine,
inosine, 3-0-methyl-D-glucose, D-glucose, L-glucose, NBMPR,
NBTGR were from Sigma, St. Louis, MO, USA. Triton X-100,
HEPES, N'N'-methylene-bis-acrylamide, n-octylglucoside,
PCMBS, PMSF, POPOP9 PPO, Sephadex G-50 (fine), DEAE-
cellulose DE-52, DTNB, DL-glyceraldehyde-3-phosphate, G-NAD,
dithiothreitol and dimyristoyl phosphatidylcholine were also
from Sigma. All other reagents were of analytical grade.
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